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Abstract 
The protozoan parasite Toxoplasma gondii (T. gondii) is an important zoonotic 
pathogen, which has the ability to infect all warm blooded mammals including 
humans, with approximately one third of the human population predicted to be 
infected.  Transmission of the parasite to the foetus during pregnancy can result in 
miscarriage, however, a child infected during pregnancy may go on to develop 
clinical symptoms such as retinochoroiditis (ocular toxoplasmosis), hydrocephalus or 
learning difficulties in later life.  Post-natally acquired infection in humans is 
generally asymptomatic, however, individuals who are immunocompromised may 
develop ocular toxoplasmosis or toxoplasmic encephalitis.  T. gondii type II is 
reported to be the predominant genotype in Europe and the United States, but 
currently very little information exists about the prevalence and genotypes present 
within Great Britain.  Consumption of T. gondii tissue cysts from raw or 
undercooked meat is a main source of infection for humans, with infected pork being 
considered a high risk.  Currently the “gold standard” for assessing the viability of 
infective T. gondii tissue cysts is by an in vivo mouse bioassay.  However, more 
recent ethical requirements to reduce, refine or replace experimental animals raises 
the question as to whether molecular technologies could be incorporated into these 
studies to reduce mouse numbers.   
The main aims of this PhD were to: (i) determine the prevalence and genotypes of T. 
gondii within different wildlife populations and humans in Great Britain; (ii) 
determine whether vaccination of pigs with a live attenuated strain of T. gondii  
would reduce the load of viable T. gondii tissue cysts within this species; (iii) study 
the viability and dissemination of tissue cysts from oocyst and bradyzoite infected 
pigs and (iv) to compare mouse bioassay with molecular detection of T. gondii DNA 
from experimentally infected pigs. 
The main findings of this work show that the prevalence of T. gondii within 
carnivorous wildlife varied from 6.0% to 44.4% depending on the host species with 
type II being the predominant lineage identified, however, type III and two alleles for 
type I were also present.  In humans, serological detection of the parasite from a 
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group of Scottish blood donors from Glasgow and Dundee (n=1403) was determined 
at 13.0%, molecular detection of T. gondii in human brains (n=151) from the Sudden 
Death Brain Bank show a prevalence of 17.9%.  A correlation between increasing 
age and an increase in the detection of parasite was identified from both study 
groups.  T. gondii strain genotyping using DNA extracted from human brains 
identified alleles for type I and III, however, no direct link between cause of death 
and detection of parasite DNA could be made.  Live vaccination and subsequent 
oocyst challenge of pigs showed a significant reduction in the establishment of viable 
T. gondii tissue cysts.  Mouse bioassay clearly demonstrates this result, where 100% 
of mice that were inoculated with homogenised tissues from vaccinated/challenged 
pigs survived, compared to the survival of only 51% of mice, which received 
homogenised tissues from non-vaccinated/oocyst challenged animals.  In addition, 
porcine tissues from pigs challenged with either oocysts or bradyzoites did not show 
a significant difference in mouse survival following bioassay of these tissues.  
Challenge with either stage of the parasite (oocysts or bradyzoites) showed a 
preference to form tissue cysts in brains and highly vascular muscles (tongue, 
diaphragm, heart or masseter) of pigs.  The findings, comparing mouse bioassay with 
molecular detection of parasite DNA from homogenised porcine tissue (prior to 
inoculation into mice), showed similar levels of detection.  However, mouse bioassay 
was more sensitive and also provides evidence of parasite viability.  
In conclusion, this research not only provides current figures for prevalence and 
genotypes of T. gondii in both wildlife and humans in Great Britain, it also 
successfully answers the question as to whether live vaccination of pigs with the S48 
strain can reduce the tissue cyst burden.  These promising results show the potential 
of a vaccine against T. gondii in producing safer pork for human consumption.  
Although the mouse bioassay still remains the most sensitive method for the 
detection and viability assessment of tissue cysts, further research should be carried 
out in this area, perhaps incorporating a technique such as magnetic capture qPCR, to 
enable an effective in vitro technique to be developed. 
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Chapter 1: Introduction 
1.1 History of Toxoplasma gondii 
The apicomplexan protozoan parasite Toxoplasma gondii (T. gondii) is one of the 
most successful parasites worldwide due to its ability to infect all warm blooded 
animals including humans.  The parasite was first discovered in 1908 by Charles 
Nicolle and Louis Manceaux at the Pasteur Institute in Tunis, who identified the 
parasite in a desert rodent, named a gundi (Ctenodactylus gundi), and initially 
presumed it was a species of Leishmania.   In the same year a Brazilian scientist, 
named Alfonso Splendore, discovered the parasite in a rabbit (Oryctolagus 
cuniculus) from Sao Paulo and again mistakenly identified it as Leishmania 
(Splendore, 1908).  However in 1909 following experimental infection and 
microscopic analysis the parasite was renamed to Toxoplasma gondii as described by 
Nicolle and Manceaux (Nicolle & Manceaux, 1909) due to the bow shaped 
morphology of the extracellular tachyzoite stage of the parasite; Toxo is derived 
from Greek for bow, plasma meaning life and gondii after the original host it was 
identified in (the gundi).  
In 1939 the first identified case of congenital toxoplasmosis was reported from a 3 
day old child who had developed seizures (Wolf et al., 1939).  The baby only 
survived for one month and following post mortem cerebral calcification, 
retinochoroiditis, and hydrocephalus were observed.  This is now known as the 
classical triad of symptoms of congenital toxoplasmosis (Sabin, 1942).   
In the 1950’s T. gondii parasites were discovered in enucleated eyes (Wilder, 1952), 
this type of ocular toxoplasmosis (see Figure 1-1) was presumed to be a consequence 
of congenital transmission of the parasite, however, more recent studies have also 
described a greater number of cases than expected of ocular toxoplasmosis due to 
postnatally acquired infection (Burnett et al., 1998; Gilbert et al., 1999; Montoya & 
Remington, 1996). 
It was not until 1970 that cats were identified as the definitive host for the parasite, 
when the first description of the sexual development of T. gondii in the small 
Toxoplasma gondii in animal and human hosts 
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intestine of cats was published (Frenkel et al., 1970; Hutchison et al., 1970). This 




Figure 1-1: Image of lesions on the retina due to ocular toxoplasmosis.  Scarring 
of the retina (retinochoroidal necrosis – the large white area in the right of the 
image) due to T. gondii can ultimately cause blindness as well as other visual 




Another important part in the history of Toxoplasma was in the 1980’s when AIDS 
patients were found to develop clinical symptoms of the parasite (Luft & Remington, 
1988).  T. gondii was identified as a major opportunistic infection for these immuno-
compromised patients, where either newly acquired infection or recrudescence of 
latent infection would frequently cause toxoplasmic encephalitis (Luft & Remington, 
1992). 
The most recent developments for T. gondii are its possible effect on behaviour in 
both humans and animals.  A study in 2000 showed that rats, which were infected 
with the parasite, were less fearful of cats (Berdoy et al., 2000) and further research 
has also described how mice infected with the parasite are attracted to cat urine 
(Ingram et al., 2013).  These behavioural changes are presumed to increase the 
chance of predation by cats, and hence complete the parasite life cycle.  Although the 
Toxoplasma gondii in animal and human hosts 
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link to T. gondii infection and behavioural problems in humans is not fully 
understood, several reports have linked infection to schizophrenia (Torrey & Yolken, 
2003), increased risk taking and road traffic accidents (Flegr et al., 2009) and an 
increased risk of suicide (Lester, 2012).  Also, the emergence of genetically different 
strains (atypical strains) of the parasite have been linked to several fatal cases of 
acquired infection in immuno-competent individuals (Carme et al., 2002; Carme et 
al., 2009b), further highlighting the potential public health risk of the parasite (as 
further described in section 1.4.1.2). 
 
1.2 Life cycle of the parasite 
It was not until the 1970’s that the life cycle of the parasite was fully understood with 
the discovery of T. gondii oocysts in cat faeces (Hutchison et al., 1969; Hutchison et 
al., 1971). This discovery was important as felids are presumed to be the only 
definitive host, and following primary infection can shed millions of T. gondii 
oocysts into the environment.  There are three infective stages of the parasite; 
sporozoites (oocysts), bradyzoites (tissue cysts) and tachyzoites.  These three stages 
also equate to the three main transmission routes which are involved in the life cycle: 
1) Horizontal transmission - ingestion of oocysts consumed from the environment; 2) 
Horizontal transmission - consumption of bradyzoites (tissue cysts) from infected 
meat which is either raw or undercooked; 3) Vertical transmission - T. gondii 
tachyzoites can be passed on to the unborn foetus via the placenta resulting in 
congenital toxoplasmosis (see Figure 1-2).  
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Figure 1-2: Life cycle of T. gondii. The three different stages of the parasite 
(oocysts, tissue cysts and tachyzoites) are transmitted by either: 1) - vertical 
transmission of oocysts from the environment; 2) vertical transmission from 
tissue cysts within intermediate hosts; and 3) horizontal transmission of 
tachyzoites from mother to foetus during pregnancy.  Adapted from Hunter and 
Sibley. Nature Reviews Microbiology 2012 Nov; 10:766-778 
 
Sexual replication of the parasite only occurs in the intestine of the definitive host 
(felids), whist asexual replication can occur within most likely all warm blooded 
intermediate hosts (Tenter et al., 2000).  Following ingestion of tissue cysts by the 
cat (for example by consuming an infected rodent when hunting), proteolitic 
enzymes in the gut and small intestine break down the cyst wall, releasing 
bradyzoites which then begin to replicate asexually (merogony) within the epithelial 
cells of the small intestine (Frenkel & Dubey, 1972).  After successful replication, 
five morphologically distinct stages of the parasite are formed followed by gamete 
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formation and the sexual stage of the life cycle, which begins 2 days after ingestion 
of tissue cysts by the felid host.  Fertilisation of the female macrogamete by the male 
microgamete results in the formation of a zygote which then develops into an oocyst 
(containing two sporoblasts).  The unsporulated oocyst is released from the infected 
intestinal epithelial cell and excreted in the cat faeces along with thousands of other 
oocyts that have been produced in the same way.  Once in the environment the 
sporoblasts within the oocyst begin to sporulate by endogeny, resulting in the 
development of four sporozoites per sporoblast.  This development stage is vital as 
oocysts only become infective after sporulation in the environment, a process which 
takes approximately 1 to 5 days, however successful sporulation is dependent on the 
right environmental conditions, as both temperature and humidity are essential for 
this developmental stage (Ferguson et al., 1979).  Each sporulated oocyst measures 
approximately 11 to 13µm in diameter, it contains two ellipsoidal sporocysts (which 
measure 6x8µm), and within each of these structures four sporozoites can be found 
(Dubey & Frenkel, 1972).  In soil sporulated oocysts are extremely resistant to 
environmental conditions and with a favourable mild moist climate they can remain 
infective for over 12 months (Frenkel et al., 1975), whist in seawater they have been 
shown to survive for up to 54 months (Lindsay & Dubey, 2009).   
Transmission of oocysts to intermediate hosts (including animals and humans) by 
ingestion results in another asexual cycle within its host.  A combination of digestive 
enzymes and stomach acid in the gut rupture the oocysts, releasing sprozoites into 
the intestinal lumen.  The parasite quickly invades and multiplies within surrounding 
host cells, transforming into the rapidly multiplying form of the parasite – 
tachyzoites (approximately 7x3µm in size).  The tachyzoites replicate asexually 
within the host cell by a process called endodyogeny, which eventually causes the 
host cell to burst, and tachyzoites are released which invade other cells nearby.  
Tachyzoites are also disseminated throughout the host via the bloodstream, where 
tachyzoites can infect muscle and nervous tissue where they develop into much 
slower dividing bradyzoites.  The bradyzoites are enveloped by a cyst wall (tissue 
cysts), and the cysts, of approximately 10 to 100µm, will remain within various host 
tissues throughout its lifetime (Dubey et al., 1998a).  Each tissue cyst may contain 
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hundreds of bradyzoites, and the life cycle of the parasite can continue following 
ingestion of infected tissues containing these parasitic cysts.  The life cycle induced 
by the bradyzoite stage of the parasite replicates in a similar fashion within the host 
as the sporozoite stage, as once the digestive enzymes in the gut breakdown the 
tissue cyst wall, bradyzoites are released which invade nearby cells in the lamina 
propria and transform into rapidly multiplying tachyzoites. 
The final route of transmission is via tachyzoites which are passed through the 
placenta from mother to foetus during pregnancy.  In several hosts (including 
women, sows, ewes and goats) transmission of T. gondii to the foetus only occurs 
following primary infection during pregnancy, as infection prior to this results the 
host developing a protective immune response.  However, in mice, congenital 
transmission can continue for several generations, due to either primary or persistent 
infection of the host (Beverley, 1959; Marshall et al., 2004).  Therefore rodents can 
also act as a reservoir for the parasite and hence an increased risk of exposure to the 
definitive host, the cat. 
The life cycle of T. gondii can potentially continue indefinitely as even in the 
absence of the definitive host,  transmission can occur between intermediate hosts 
from consumption of tissue cysts via carnivory and transplacentally following 
ingestion of tissue cysts during pregnancy (Tenter et al., 2000).   
 
1.3 Tissue cyst and bradyzoite development 
Bradyzoites (brady = slow in Greek) are the slow replicating stage of the parasite and 
although they can develop in almost any visceral organ they are most commonly 
found in the brain and muscular tissues such as skeletal and cardiac muscle (Dubey, 
1988).  Because tissue cysts remain within an infected host throughout its lifetime, 
this stage of the parasite is critical for the transmission of T. gondii to carnivorous 
hosts.  Tissue cysts can vary in size depending on their age, from 5µm in diameter 
for young cyst to 100µm for a mature cyst (see Figure 1-3).   
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Figure 1-3: T. gondii tissue cysts from an infected mouse brain. Homogenised 
mouse brain (10µl), unstained, visualised using light microscopy.  Individual 
bradyzoites can be seen within the cyst.  (Image © A. Burrells 2013) 
 
The larger the cyst the greater the number of bradyzoites it contains, older cysts may 
contain hundreds to thousands of bradyzoites whist in contrast a younger cyst may 
only contain a couple of bradyzoites, with each crescent shaped bradyzoite 
measuring approximately 7 x 1.5µm (Mehlhorn & Frenkel, 1980).  After ingestion of 
a tissue cyst by a carnivorous host, proteolytic enzymes in the stomach and small 
intestine break down the cyst wall to release the bradyzoites.  The morphological 
structure of bradyzoites means they are suitably adapted for transmission via the gut, 
as they are resistant to destruction by proteolytic enzymes and have been shown to be 
resistant to stomach acid and pepsin for up to 2 hours (Jacobs et al., 1960a).  Once 
bradyzoites are released the cell cycle continues with the formation of tachyzoites 
followed by the formation of new tissue cysts, as previously described (see section 
1.2).  Although the immune system generally controls parasite replication and 
maintains tissue cysts, causing no harm to the infected host, reactivation of latent 
infection can occur when the host’s immune system is immunocompromised, with 
the rupture of the tissue cyst wall causing conversion of bradyzoites to tachyzoites 
and subsequent multiplication and establishment of the parasite within nearby cells. 
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1.4 The genome of Toxoplasma gondii 
T. gondii has a 65Mb genome, comprising of 14 chromosomes which range from 
approximately 2Mb – 7.5Mb as shown in Figure 1-4  (Khan et al., 2005b).  The 
genome is closely related to another apicomplexan protozoan parasite, Neospora 
caninum (N. Caninum), and it is thought that around 28 million years ago the two 
parasites diverged from a common ancestor, due to the speciation of the definitive 
hosts (cats - T. gondii, dogs N. Caninum) (Reid et al., 2012).  In comparison to other 
apiocomplexan parasites, such as Cyptosporidium parvum (C. Parvum) and Theileria 
parva (T. parva), the genome of T. gondii is significantly larger, it contains more 
introns, more predicted genes and has a lower gene density (Ajioka & Soldati, 2001).  
One suggested reason for the difference in size compared to other apicomplexans 
could be due to the large number of secondary hosts which T. gondii is able to 
establish within (Roos, 2005).   
In 2005, in order help facilitate forward genetic analysis, a composite genome map 
was derived from genetic crosses and linkage analysis of the three main archetypal T. 
gondii lineages (I, II, III) (Khan et al., 2005b).  The results from this work assisted 
researchers involved in mapping drug resistance genes and also to aided those 
studying the genes involved in transmission and infectivity.  The genetic linkage map 
which was generated (see Figure 1-4) , identified 250 species specific markers, of 
which 12 are most commonly used for strain genotyping by PCR-RFLP (for further 
information see section 1.4.2).  Figure 1-4 details each of these individual markers 
and also highlights markers which are strain specific and those which are present on 
all three archetypal strains.  
The online genome database ToxoDB (http://toxodb.org/toxo/) provides further 
detailed information about the genome and the functional genomics of T. gondii.  It 
also provides genome sequence information (including the facility to BLAST 
sequences), gene expression and proteomics data (Gajria et al., 2008), which helps 
support research on the parasite.  The database also contains detailed information for 
genetic maps and single nucleotide polymorphisms (SNPs), representing strains for 
the tree archetypal T. gondii lineages; GT-1 (type I strain), Me49 (type II strain) and 
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VEG (type III strain).  Identification of SNPs between the three main lineages are 
used to define the different strains of the parasite by PCR-RFLP (Ajioka et al., 1998; 
Sibley et al., 1992) (see section 1.4.2).
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Figure 1-4: Genetic linkage map of T. gondii.  The map shows the 14 different chromosomes with individual markers to the right of 
each chromosome. Adapted from Khan et al (2005b)
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1.4.1 Genetic variation of Toxoplasma gondii  
 
1.4.1.1 Predominant lineages 
Research into the virulence of T. gondii in mice, and molecular characterisation of 
the parasite using multilocus restriction fragment length polymorphism (multilocus 
RFLP), from both animals and humans, identified the three predominant lineages of 
the parasite, which were designated as Type I, II or III (Howe & Sibley, 1995; Sibley 
& Boothroyd, 1992).  From this research, and others, it has been demonstrated that 
Type I isolates have limited genetic diversity but are highly virulent in mice. This 
lineage is rarely isolated, with only 10% of strains collected in Europe and the USA 
being type I, however this lineage has been linked to reactivation of the parasite in 
immunocompromised individuals (Khan et al., 2005a).  Type II is found to be less 
virulent in mice however it is the isolate, which is predominant in human 
toxoplasmosis cases, and also the predominant lineage in sheep and pigs in the USA 
and Europe.   
Type III isolates were originally deemed as non-virulent in mice, however more 
recent research states that they are “usually more virulent in mice than type II 
isolates” (Darde, 2004).  Type III is relatively rare in humans but more common in 
animal hosts, with a study in chickens in North America exhibiting a higher 
prevalence of Type III compared to Type II strains (Dubey et al., 2003).   
Although early characterisation of the parasite studied its virulence in mice (Sibley & 
Boothroyd, 1992), the pathogenicity of the parasite can differ depending on its host 
species. The majority of infections in both animals and humans are asymptomatic, 
however, some host species can be vulnerable to initial infection, causing clinical 
symptoms and even death. Examples of this are evident in Australian marsupials 
(Canfield et al., 1990; Dubey et al., 1988), and also other animal species, such as 
lemurs, moved into zoos or wildlife parks (Dubey et al., 2009; Hermosilla et al., 
2010; Juan-Salles et al., 2011).  This vulnerability is thought to occur due to 
susceptible animals being more geographically isolated from the definitive host 
(felids), where they have evolved in areas where, until relatively recently, cats have 
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been absent.  Subsequently these animals could be more sensitive to T. gondii 
oocysts, with the immune system unable to deal with the infection effectively (Innes, 
1997). 
 
1.4.1.2 Atypical lineages  
Molecular characterisation using multilocus RFLP has identified strains which have 
unique genotypes compared to the three predominant lineages (type I, II and III).  
Initially most of these atypical genotypes were isolated from exotic animals in 
geographically remote areas, however more recently multilocus RFLP has 
highlighted the presence of atypical alleles in poultry, pigs and sheep in Brazil (da 
Silva et al., 2011; Dubey et al., 2007a; Frazão-Teixeira et al., 2011).  Primary 
infection of atypical strains in humans has been linked to severe toxoplasmosis and 
ocular disease, with outbreaks reported in French Guiana, Brazil and Suriname 
(Carme et al., 2009a; Demar et al., 2007; Vaudaux et al., 2010). 
The main characteristics of these atypical strains is that they consist of novel alleles 
as well as shuffled combinations of alleles representing the three predominant 
lineages (Grigg & Suzuki, 2003). 
Molecular genotyping of atypical strains found in South America, has shown a 
greater genetic diversity than the predominant lineages found in North American and 
European isolates, although with the development and further use of molecular 
genotyping, atypical genotypes are beginning to also be identified in North America 
and Europe (Dubey et al., 2008a; Dubey et al., 2008b; Herrmann et al., 2010). 
Other strains that cannot be classified into the three main predominant lineages also 
exist, these strains have been isolated on multiple occasions and appear to occur in 
specific hosts, or be linked to a specific geographical region.  Type X is a genotype 
which has been predominantly been found in Californian sea otters (Conrad et al., 
2005; Sundar et al., 2008).  Microsatellite genotyping of French 
immunocompromised patients with toxoplasmosis identified new genotypes which 
were recovered from several patients; these were named Africa I, Africa II and 
Toxoplasma gondii in animal and human hosts 
Chapter 1: Introduction  13 
Caribbean I (Ajzenberg et al., 2009).  Further research in Gabon has identified the 
same African genotypes as well as an additional Africa III genotype (Mercier et al., 
2010) 
Research from North America has identified a fourth clonal lineage, this lineage was 
initially classified as Type X and was originally isolated from Californian sea otters 
(Conrad et al., 2005; Sundar et al., 2008) (for further information see section 1.5).  
More recently this genotype has also been found in wild animals and in rare cases 
humans from North America, resulting in a defined, highly clonal, separate lineage 
belonging to haplogroup 12 (Khan et al., 2011).  At the time of writing, T. gondii is 
described to be composed of 15 different haplogroups, which defines six major 
clades (see Figure 1-5), this definition is based on analysis of the genetic diversity of 
950 T. gondii isolates which were collected worldwide (Su et al., 2012).   
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Figure 1-5: The fifteen haplogroups of T. gondii (1-15) defining six major clades 
(A-F).  Strains typed in black to do not correspond with the major clades.  
Representative strains for each haplogroup are highlighted in yellow. Adapted 
from Su et al (2012)  
 
Parasite strains which have undergone sexual recombination to generate mixed 
infections have also been identified by multilocus RFLP in both animal and human 
hosts (Aspinall et al., 2003; Lindstrom et al., 2008).  Sexual recombination can only 
occur in the intestine of the felid host and its development must be due to infection 
with two strains of the parasite at the same time.  
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Despite the identification of atypical genotypes and mixed infections their 
occurrence is rare compared to the  identification of predominant lineages, however 
with the development of new molecular tools, the sensitivity of detection has 
increased and therefore the possibility of discovering these unusual strains (if they 
are present) is becoming more likely. 
 
1.4.2 Techniques for T. gondii  strain genotyping 
Genotyping of T. gondii is important for understanding the epidemiology and 
population genetics of the parasite, with different strains of T. gondii causing 
different clinical symptoms in both humans and animals (Grigg et al., 2001; Wang et 
al., 2013).  Identification and tracking of these strains is important for understanding 
their virulence and their epidemiological impact.  Initially, studies which focused on 
strain genotyping incorporated methodology based on multilocus enzyme 
electrophoresis (MLE)  (Darde et al., 1992), however, current research has focused 
on two typing methods; multi-locus nested PCR-restriction fragment length 
polymorphism (Mn-PCR-RFLP) and microsatellite sequence typing (MLST), with 
Mn-PCR-RFLP most commonly used in epidemiological studies.  The markers 
currently used for Mn-PCR-RFLP only span specific regions of the T. gondii 
chromosome (see Table 1-1), therefore, it is possible that there may be an under 
estimation of the genetic diversity of T. gondii using this technique alone.  Direct 
sequencing of PCR products, generated using either of these methods, will not only 
confirm the detection of SNP’s, but will also identify insertions and deletions which 
may be present, providing additional information about genetic polymorphisms 
which may be present within an isolate (Sibley et al., 2009).  However, using 
sequence based technologies can be expensive and may not always be a cost 
effective option for large scale epidemiological studies. 
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1.4.2.1 Mn-PCR-RFLP 
Mn-PCR-RFLP is based on digestion of PCR products by specific restriction 
enzymes which detect SNP’s.  The digested PCR products differ in size depending 
on the strain of T. gondii and the PCR marker used, resulting in bands of different 
sizes which are used to identify a particular allele for the parasite (see section 2.12.4, 
Figure 2-2).  In order to detect not only clonal lineages (type I, II and III), but also 
atypical or mixed genotypes, a series of 10 to 12 markers are often used, which spans 
eight chromosomes and the plastid of T. gondii (see Table 1-1).  This includes the 
following markers; BTUB, GRA6, SAG2 5’, SAG2 3’, SAG3, SAG1, altSAG2, c22-
8, c29-2, L348, PK1, and Apico (Dubey et al., 2014; Pena et al., 2013), however, 
other studies which incorporate only five or six markers (BTUB, GRA6, SAG2 5’, 
SAG2 3’, SAG3 and Apico) have been reported (Boughattas et al., 2010; Burrells et 
al., 2013; Khan et al., 2005a).   
 
Table 1-1: Mn-PCR-RFLP primers and T. gondii chromosome number.  
Mn-PCR-RFLP Marker T. gondii chromosome number 












Genotyping by MLST is not as widely used as Mn-PCR-RFLP.  The technique 
identifies nucleotide polymorphisms, which differ between different T. gondii 
strains, and generally incorporates five microsatellite markers (TUB2, W35, TgM-A, 
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B18, and B17) across five different chromosomes of the parasite (see Table 1-2) 
(Ajzenberg et al., 2005).  Primer pairs are used in a multiplex assay which 
incorporates fluorescent labelling of the 5’ ends with fluorescein (6-
carboxylfluorescein [6FAM] or hexchloro-6-carboxyfluorescein [HEX]).  The PCR 
amplicons generated are accurately sized using an automatic sequencer and 
GeneScan analysis software (Fekkar et al., 2011). 
 
Table 1-2: Microsatellite markers and T. gondii chromosome number. 
Microsatellite 
marker 
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1.5 Toxoplasma gondii infection in wildlife 
All warm blooded wildlife species are intermediate hosts of T. gondii, which can 
become infected by ingestion of environmental oocysts, or in the case of omnivores 
and carnivores, via ingestion of both oocysts and tissues cysts.  Therefore, it is 
important to consider this population when studying the epidemiology of the 
parasite.  Although the prevalence in the majority of wildlife is high (Lopes et al., 
2011; Wendte et al., 2011), clinical signs of disease are rarely reported.  However, in 
animal species which have evolved in an environment relatively free of cats (and 
subsequently T. gondii), not only are these animals more likely to have a low parasite 
prevalence, but once infected they are more likely to show clinical signs of disease.  
Animals at risk include Australian marsupials, wildlife species imported into zoos 
(such as lemurs and flying foxes)  and marine mammals (such as dolphins), where  
infection with the parasite in these species has proven to be fatal (Gonzales-Viera et 
al., 2013; Juan-Salles et al., 2011; Parameswaran et al., 2010; Sangster et al., 2012).  
Sea mammals can be particularly susceptible to T. gondii infection, such as sea 
otters, porpoises, dolphins and different species of whales and seals (Gibson et al., 
2011).  Sea mammals can act as sentinel species, providing an indication of the 
levels of oocyst contamination in the marine ecosystem.   
T. gondii infection in Californian Southern sea otters (Enhydra lutris nereis), is one 
of the best described and referenced examples.  During 1997 – 2001 the mortality 
rate of this species of sea otter mysteriously began to increase, at the same time it 
was shown that the seroprevalence of T. gondii in these animals was also high, with 
42% (n=116) of live sea otters being infected with the parasite and 62% (n=107) of 
dead otters were also found to be infected (Miller et al., 2002).  In one particular area 
of Californian coastline (Morro Bay) 87% (n=23) of sea otters tested positive for the 
parasite.  Land-based surface run off or exposure to coastal plumes of municipal 
sewage was suspected to cause the high seroprevalence (and resulting mortalities) 
observed (Miller et al., 2002).  In particular, flushable cat litter, which may contain 
T. gondii oocysts, could readily enter the sewerage system and hence contaminate the 
marine environment.  Further research into this outbreak identified two different 
strains of T. gondii; type II – which accounted for 40% if infections, and a novel 
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genotype, known as type X (now reclassified and referred to as haplogroup 12 -  
Khan et al (2011)), accounted for 60% of infections (Miller et al., 2004).  The 
authors also reported that sea otters from the Morro Bay area (where T. gondii 
seroprevalence was highest), were eight times more likely to be infected with type X.  
Several years later, further research identified wild felids from the same area of 
California to be infected with the type X strain, it was suspected that surface run off, 
which contained T. gondii oocysts, had resulted in contamination of one of the otter’s 
main source of food - shellfish (Miller et al., 2008). 
Novel or atypical genotypes identified within different wildlife species are frequently 
described, ranging from a wild puma in Mexico (Dubey et al., 2013a), to racoons in 
Wisconsin (Dubey et al., 2007b), marsupials in Western Australia (Pan et al., 2012) 
and capybaras in Brazil (Yai et al., 2009).  However, this diversity is not evident 
throughout all wildlife populations.  European studies more commonly describe the 
type II archetypal lineage to be most prevalent, which has been  identified in 
carnivorous wildlife from Great Britain (Burrells et al., 2013), deer, fox, and 
mallards from France (Aubert et al., 2010), arctic foxes from Norway (Prestrud et 
al., 2008), and pigeons from Portugal (Waap et al., 2008). 
Despite type II being the predominant T. gondii lineage identified within Europe, 
worldwide their appears to be a greater degree of genetic diversity observed in 
wildlife populations, compared to those isolates identified from humans and 
livestock (Ajzenberg et al., 2004; Wendte et al., 2011), and as the molecular tools 
used to study parasite diversity advance, it is likely that an increased number of novel 
genotypes will be discovered within different wildlife species, perhaps even from 
animals in Europe. 
  
1.6 Toxoplasma gondii infection in livestock 
The following sections provide details of T. gondii in the four main livestock species; 
pigs, sheep, cattle and chicken.  Livestock are intermediate hosts of the parasite and 
seroprevalence can vary depending on the species, how the animal is housed, feeding 
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habit and also whether cats or rodent are present on the farm.  Comparisons between 
results are difficult, as the methodology between various studies tends to vary.  
However, some trends amongst the data can be clearly observed, for example the 
increased prevalence in free range animals such as pigs and chickens when they 
compared to their indoor reared counterparts (Dubey, 2010; van der Giessen et al., 
2007) . 
 
1.6.1 Pigs (Sus scrofa) 
1.6.1.1 Clinical signs of infection with T. gondii 
Pigs are an important food source for humans and can acquire T. gondii infection by 
ingestion of oocysts from the environment or from consumption of tissue cysts from 
infected animals such as rodents.  Although clinical signs or mortalities due to T. 
gondii infection in pigs is uncommon, outbreaks of severe disease have been 
reported.  However, in the rare event where T. gondii has been reported to cause 
clinical signs, it has generally been referred to as a sporadic outbreak.  One such 
reported outbreak occurred in China in 2010, where T. gondii infection proved lethal 
in fattening pigs from the Gansu province (Li et al., 2010).  Infection resulted in a 
morbidity of 57% (549/960) with a mortality rate of 2% (19/960), with pigs 
presenting signs of anorexia, depression and above average rectal temperatures (40 – 
42
o
C).  T. gondii infection was confirmed by IgG and IgM ELISA and also by mouse 
bioassay from 2 infected pigs.  Further investigation linked this outbreak to ingestion 
of contaminated feed, and cats were found to reside within the feed warehouse. 
Porcine abortion caused by T. gondii infection has also been reported, although again 
a rare occurrence in this livestock species.  In 1979 spontaneous abortion in five 
sows from Ontario, Canada were linked to the parasite.  The foetuses aborted near 
term and upon histopathological examination Toxoplasma cysts were evident in the 
alveolar macrophages of the lung and intracellular parasites morphologically similar 
to Toxoplasma were also identified in myocardial cells.  The sow had a high antibody 
titre against the parasite, and sections of placenta were also shown to be infected 
(Hunter, 1979).  The farm described was known to have a rodent problem which can 
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increase the transmission of T. gondii to pigs (Kijlstra et al., 2008).  A more recent 
abortion outbreak occurred in Jeju Island, Korea, where pregnant sows showed 
clinical signs which included: fever, anorexia, depression, recumbency, abortion and 
in a few cases, death.  Upon histopathological investigation including 
immunohistochemistry, T. gondii tachyzoites were observed in four adult sows and 
five aborted piglets from the same litter (Kim et al., 2009).  Infection of sows with 
Toxoplasma have also resulted in the birth of still born piglets (Thiptara et al., 2006), 
similar to clinical signs observed in cases of ovine toxoplasmosis. 
Although a number of other outbreaks of porcine abortion and severe clinical disease 
in naturally infected pigs have been reported, disease is generally subclinical.  A 
more commonly observed symptom is a slight increase in rectal temperature during 
the initial stages of infection, which may persist for 1-2 days.  Presentation of more 
acute clinical symptoms (although rare) are likely to be linked to age, immune status, 
and even breed of the animal (Dubey, 2009). 
Clinical symptoms in pigs which have been experimentally infected with 
Toxoplasma are similar to those described above, but can prove fatal when pigs are 
inoculated with large numbers of oocysts (≥ 4x10
4
) (Dubey et al., 1998b; Garcia et 
al., 2008). 
 
1.6.1.2 Pigs and T. gondii tissue cysts 
As the symptoms of clinical toxoplasmosis are not considered as a problem in pigs, 
the main reason to implement a control strategy to prevent or reduce the 
establishment of T. gondii tissue cysts in this species is to reduce the number of 
parasites entering the human food chain and their subsequent transmission.  The 
ability of the parasite to infect all warm blooded mammals, combined with its cyst 
forming nature, T. gondii is readily found within the muscles and organs of infected 
pigs which are often used for human consumption (Bayarri et al., 2012; Dubey et al., 
2005a; Wang et al., 2012).  Following ingestion of T. gondii oocysts or bradyzoites, 
infective tissue cysts can develop in the host within 6-7 days.  The prevalence of the 
Toxoplasma gondii in animal and human hosts 
Chapter 1: Introduction  22 
parasite in pigs reared indoors is likely to be lower than those animals which are 
outdoor reared, due to an increased risk of exposure to environmental oocysts 
(Kijlstra et al., 2004; van der Giessen et al., 2007).  The seroprevalence of T. gondii 
in pigs has been shown to increase with age (Dubey et al., 1995b), and as 
seropositivity is likely to reflect the presence of infective tissue cysts within the 
animal (Dubey et al., 1995a), it can be presumed that older pigs are more likely to 
harbour infective tissues cysts.  
 
1.6.1.3 Increased risk of Toxoplasma gondii infection in outdoor reared 
pigs 
The prevalence of Toxoplasma in pigs has declined in the past 30 years.  This is most 
likely due to a change in farming practices where intensive well managed indoor 
farming methods have been introduced (Dubey, 2009; Edelhofer, 1994).  Reports 
which describe current seroprevalence levels in pigs vary dramatically, they depend 
on the country (including regional differences), the farming method, the age of the 
animal and the test methodology used (see Table 1-3).   However, the recent demand 
for “animal friendly” farming has led to a re-introduction of outdoor reared pigs.  
Transmission of T. gondii to pigs from the consumption of infected rodents has also 
been shown to be a direct source of infection, particularly in animals reared outdoors 
in animal-friendly production systems (Kijlstra et al., 2004), where outdoor reared 
and organically raised pigs have generally been shown to have a higher prevalence of 
the parasite.  A study by Dubey et al (2012) has shown the prevalence of T. gondii in 
an organic pig farm in Northern USA to be 90.9% (30/33), which is significantly 
higher than the figure reported for pigs raised in conventional indoor housing (2.7%) 
(Hill et al., 2010a) (see Table 1-3).  A study examining the parasite in Argentinean 
sows also showed a similar trend; animals which had been bred indoors compared to 
sows reared outdoors had a prevalence of 4.5% (4/88) and 40.2% (45/112) 
respectively (Venturini et al., 2004).  Although not such a significant difference, van 
der Giessen et al (2007) found the prevalence of T. gondii in conventionally raised 
pigs in the Netherlands to be 0.38% (1/265), whilst those animals which were 
outdoor reared had a prevalence of 5.62% (10/178), however when examining the  
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number of farms where pigs tested positive for T. gondii, those pigs which had been 
reared in a free-range system (where pigs have access to outdoor pens and can forage 
for food as well as obtaining commercial pig feed) were almost 16 times more likely 
(33.0%) to be infected with the parasite than indoor reared animals (4.0%) (van der 
Giessen et al., 2007).  These studies highlight an increased risk of T. gondii exposure 
to pigs which are reared outdoors. 
The source of infection in pigs can either be via oocyst contamination from soil or 
contaminated feed, or from consumption of tissue cysts from infected rodents or 
other small mammals harbouring the tissue cysts stage of the parasite.  
Contamination with oocysts in either feed or soil is thought to be the main source of 
infection for pigs (Lehmann et al., 2003).  However, outdoor housing systems allow 
pigs to come into contact with rodents and other wildlife, and as pigs are omnivores, 
they will consume rodents or rodent cadavers as well as other small mammals and 
birds, which may be infected with T. gondii and harbour infective tissue cysts 
(bradyzoites).  Consumption of other animals by pigs is probable, and several studies 
have demonstrated how rodent control programs can reduce T. gondii seropositivity 
in pigs (Hill et al., 2010b; Kijlstra et al., 2008).  This research highlights the role that 
rodents and other small animals may have as a reservoir for direct transmission of the 
parasite to pigs. 
It is clear that outdoor reared pigs are more at risk of direct exposure to T. gondii 
oocysts and bradyzoites compared to indoor reared animals, these animals are 
therefore at increased risk of T. gondii infection (Davies, 2011), and subsequent 
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Table 1-3: Recent seroprevalence figures for T. gondii in pigs. 




Slovakia IgG ELISA 
923 slaughter  2.06% 
(Turcekova et al., 2013) 
47 sows 4.26% 
Mexico 
IgG ELISA 411 fattening 95.80% (Ortega-Pacheco et al., 
2013) IgM ELISA 397 fattening 92.50% 
North Portugal  MAT 
21 piglets 42.90% 
(Lopes et al., 2013) 180 fattening 5.00% 
53 sows 13.20% 
Ireland LAT 317 slaughter 4.70% (Halova et al., 2013) 
Switzerland P-30 ELISA 
20 finishing  14.00% 
(Berger-Schoch et al., 2011) 120 adult  36.00% 
100 free range 13.00% 
Czech 
Republic 
IgG ELISA 511 slaughtered 36.00% (Bartova & Sedlak, 2011) 
Brazil IgG ELISA 
34 free range 20.60% (Frazao-Teixeira & de 




402 organic 2.74% 
(van der Giessen et al., 
2007) 
178 free range 5.62% 
265 intensive 0.38% 
USA IgG ELISA 6238 finishing indoor 2.70% (Hill et al., 2010a) 
 MAT 33 organic 90.90% (Dubey et al., 2012) 
Argentina MAT 
88 indoor 4.50% 
(Venturini et al., 2004) 
112 outdoor 40.20% 
 
Key:  Finishing / fattening/ slaughter = 20- 24 months of age; piglets = 3 weeks to 3 
months of age; intensive = intensive indoor reared; free range = permanent access to 
pasture, born outside then reared outdoors throughout their lives; organic = free 
range outdoor reared, with 80% of feed originating from organic agriculture. 
 
 
1.6.1.4 Control of T. gondii infection in pigs 
As clinical disease is not considered a problem in pigs, the main reason to implement 
a control strategy to prevent exposure to T. gondii in this species is to reduce the 
transmission of the parasite entering the human food chain.  Pigs are known to 
harbour a greater number of tissue cysts compared to other animals such as sheep, 
goats, cattle and horses (Tenter et al., 2000).  Therefore undercooked or raw pork is 
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potentially a greater source of infection for foodborne toxoplasmosis in humans and 
has possible consequences for food safety (Djurković-Djaković et al., 2013). 
An effective way to reduce infection risk for humans from infected pork is to prevent 
infection and hence the formation of tissue cyst in the animal.  Currently, the most 
successful control measures are those which involve good on-farm management, 
such as ensuring cats are not allowed to enter feed or grain stores and they have 
limited access to pig farms (Gamble et al., 1999).  A study examining a 4 month 
rodent control programme on three organic pig farms, followed by longitudinal 
analysis over seven months, showed that levels of T. gondii infection in pigs fell 
from 10.9% (10/92) to 3.3% (4/122).  The prevalence of infected pigs rose again 
after the control campaign had stopped (Kijlstra et al., 2008).  Rodent control is of 
importance as pigs are omnivores which can consume rodents or rodent cadavers if 
they are present within their housing.  Therefore any on-farm control strategies must 
concentrate on cat and rodent control, both within the farm and the area used for food 
storage.  To further reduce oocyst viability it has been recommended that any cement 
floors be steam pressure washed between groups of pigs (Dubey, 1998b; Lehmann et 
al., 2003).   
Another control strategy is to vaccinate animals against T. gondii to prevent tissue 
cyst formation, hence reducing the transmission of the parasite from infected pigs 
into the food chain.  Although a licensed vaccine for this purpose is currently 
unavailable, research has shown that vaccination using non persistent strains of the 
parasite has currently had more success than a killed vaccine approach (Innes et al., 
2011).  Vaccination of pigs to reduce cyst number has been attempted using several 
different methods, such as using crude rhoptry proteins of T. gondii, a DNA vaccine 
comprised of T. gondii dense granules GRA1 and GRA7, and vaccination with live 
tachyzoites of the TS-4 and RH strains of T. gondii (Garcia et al., 2005; Jongert et 
al., 2008; Pinckney et al., 1994).  Although a reduction in tissue cyst burden has 
been reported by these publications (which are described in further detail – see 
section 1.11.2.2), there is still no vaccination strategy which can prevent or eliminate 
cyst formation in pigs. 
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1.6.2 Sheep (Ovis aries) 
1.6.2.1 Transmission and clinical signs of infection 
As sheep are herbivores, horizontal infection with T. gondii is acquired from the 
consumption of oocysts in the environment, either while the animal is grazing on 
contaminated pasture, from contaminated drinking/surface water, or from feed which 
has been contaminated with oocysts due to the presence of cats in the area where 
feed is stored (Innes et al., 2009a; Skjerve et al., 1998; Vesco et al., 2007).  Once the 
animal is infected it develops an effective immune response to control the parasite, 
despite being infected for life (as also described for all other intermediate hosts, 
including humans). Approximately 14 – 21 days after infection IgG antibody specific 
for T. gondii are detectable.  Initial infection in sheep is generally asymptomatic, 
with little or no clinical symptoms, however, when infection occurs in a naïve 
pregnant ewe, congenital toxoplasmosis can have a devastating outcome.  In these 
animals vertical transmission of the parasite across the placenta occurs and the 
parasite passes to the foetus.  Infection in the first trimester usually results in 
abortion. The result of infection during the second trimester can lead to the birth of a 
stillborn or significantly weaker lamb, whilst when infection occurs during the third 
trimester the lamb may appear healthy when it is born, but it is likely to be 
persistently infected (Buxton, 1990).   Another cause of congenital transmission 
which has been hypothesised, is from the reactivation of the parasite from a 
persistently infected ewe during pregnancy (Morley et al., 2008; Williams et al., 
2005), this route of transmission is thought to be a very infrequent event, and 
therefore does not pose a significant risk (Buxton et al., 2007a; Buxton et al., 2007b; 
Rodger et al., 2006). 
It has been reported that ovine abortion caused by T. gondii affects approximately 1-
2% of the UK’s national flock (Blewett & Trees, 1987) which results in yearly losses 
of an estimated 0.5 million lambs, costing approximately £12 million annually in 
Great Britain alone (Nieuwhof & Bishop, 2005).  Losses in other countries are also 
estimated to be high, for example in Uruguay the cost is predicted to be between 
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US$1.4 - 4.7 million (Freyre et al., 1999).  Although congenital infection results in 
neonatal loss for the pregnant ewe, sheep which are infected can potentially pass on 
the infection to humans, due to the consumption of undercooked or unfrozen meat 
harbouring infective T. gondii tissue cysts (Halos et al., 2010). 
Approximately 14 – 21 days after infection IgG antibodies specific for T. gondii are 
detectable and are thought to remain so throughout the lifetime of the animal, as with 
other species (Dubey & Jones, 2008).  Detection of T. gondii specific IgG by ELISA 
is frequently used to assess the seroprevalence of the parasite, although latex 
agglutination is also another option to test for the presence or absence of IgG 
antibodies against the parasite. As the methodology used can vary from study to 
study, exact comparisons between countries or even different regions can be difficult.   
However, the results of such studies can give an indication of levels of infection. 
The prevalence of T. gondii in sheep can vary from both different countries and 
regions, but the majority of research has highlighted an increase in seropositivity 
with increasing age.  A study examining 125 Scottish sheep flocks (equating to 3333 
sheep) found an overall prevalence of 56.6% (1619/3333) where an increase in 
seropositivity was related to age.  This was particularly evident in sheep which were 
over six years of age, where 73.8% (104/141) tested IgG positive, in addition, this 
work has shown that within each flock (n=125) there was at least one T. gondii 
infected animal (Katzer et al., 2011).  A recent study investigating T. gondii IgG 
seroprevalence from sheep in Greece found that 53.71% (n= 458) of animals were 
positive by ELISA (Anastasia et al., 2013), and similar to results by Katzer et al 
(2011) at least one animal from every flock (n=50) tested positive.  Another study, 
which examined the prevalence of the parasite within sheep flocks in Great Britain, 
found an overall mean seroprevalence of  74.0% (2619/3539), and also described an 
increase in prevalence with increasing age (Hutchinson et al., 2011).  In the 
Netherlands a study into the seroprevalence of T. gondii in Dutch sheep at slaughter 
(n=1179) using a validated in-house IgG ELISA estimated the overall prevalence at 
27.8%, this research also showed a higher seroprevalence (48.1%) in sheep that were 
over one year of age (Opsteegh et al., 2010b).  In Switzerland the prevalence of T. 
gondii based on an ELISA using the P30 antigen to detect T. gondii specific 
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antibodies from meat juice from sheep determined a prevalence of 61.6% (154/250) 
(Berger-Schoch et al., 2011), and when the data was used to analyse seropositivity in 
adult sheep (excluding younger lambs from the analysis) 80.7% (121/150) of animals 
were positive. 
In all of the reported seroprevalence studies highlighted above, there appears to be a 
positive correlation between seropositivity and increasing age of the animal, 
indicating high environmental contamination of T. gondii oocysts, and hence the 
majority of infections are likely to be acquired postnatally (Katzer et al., 2011). 
A licensed vaccine against ovine abortion (Toxovax
®
) is available in the UK, Ireland, 
New Zealand and France from MSD Animal Health.  This live vaccine is composed 
of tachyzoites from the attenuated S48 strain of T. gondii, which was originally 
isolated in New Zealand from an aborted lamb foetus and following years of repeated 
passage in mice the strain lost its ability to differentiate into either bradyzoites or 
oocysts, and remained as the tachyzoite stage of the parasite (Buxton, 1993; 
O'Connell et al., 1988).  Efficacy trials of the vaccine were completed in Scotland at 
the Moredun Research Institute, showing that the vaccine was best administered 3 
weeks prior to mating and that it was effective in protecting against T. gondii 
associated abortion for at least 18 months (Buxton & Innes, 1995).  Although the S48 
strain has the ability to produce a host immune response whereby sheep produce a 
cellular and humoral immune response which involves IFNγ, CD4 and CD8 T-cells 
(as reviewed by Innes et al 2009b), there is no information as to whether the vaccine 
prevents the formation of tissue cysts in sheep or indeed other livestock species 
(AMCSF, 2012). 
 
1.6.3 Cattle (Bos taurus) 
Natural infection in cattle does not appear to give rise to clinical symptoms or 
abortion of the foetus in pregnant cows as observed in sheep (Dubey, 1986) despite 
the seroprevalence in some studies being reported as quite high, for example 83.3% 
(n=504)  in southern Spain (Garcia-Bocanegra et al., 2013), 45.6% (n=406) in 
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Switzerland (Berger-Schoch et al., 2011), 33.8% (n=74) in eastern Poland (Sroka et 
al., 2010), and slightly lower 25.0% (n=995) in cattle over 12 months old from The 
Netherlands, where seroprevalence was determined by a cut off value.  However, in 
The Netherlands this figure rose to 54.5% when prevalence was estimated using the 
frequency distributions (binormal mixture model) (Opsteegh et al., 2011b).  
However, a recent publication describing the prevalence of T. gondii in different 
livestock species from north Portugal reported infection in cattle to be much lower at 
7.5% (n=161) (Lopes et al., 2013).  Despite the high seroprevalence observed in the 
majority of studies, tissues cysts are rarely identified from seropositive animals.  In 
fact, work by Opsteegh et al (2011) found results to the contrary, whereby 3% (2/66) 
of cattle which tested negative by ELISA (where the results tested negative by both 
the cut off value and the binormal mixture model) actually tested positive by MC-
PCR using digested heart tissue.  This result indicates that in this particular study, 
despite the animals being seronegative, T. gondii DNA was present within heart 
tissue of two animals.  This result is interesting as it provides an indication that, in 
cattle, seroprevalence may not be directly linked to the presence of T. gondii DNA, 
and also raises the question as to whether detection of T. gondii DNA reflects the 
presence of infectious parasites (e.g. tissue cysts).  However, evidence of viable 
infective tissue cysts from cattle which have been infected either experimentally or 
naturally infected is rare (Dubey, 1992; Esteban-Redondo et al., 1999). 
 
1.6.4 Chicken (Gallus gallus domesticus) 
Although chickens can become infected with T. gondii it is very rare for infection to 
lead to any clinical signs of toxoplasmosis.  The first reported case was reported from 
a hen in Germany (Hepding, 1939), where chorioretinitis, encephalitis and the 
identification of T. gondii like organisms were found in the retina of the animal. 
More recently only two cases of toxoplasmosis in chickens have been reported 
(Dubey et al., 2007c; Goodwin et al., 1994).  In one of these cases three chickens 
from a group of 14 died suddenly, following post mortem examination on one 
animal, the brain appeared to show lesions, necrosis and perivascular cuffs, also 
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protozoa identified in the brain reacted positively with antibodies against T. gondii.  
The eleven surviving chickens were asymptomatic, however, when a mouse bioassay 
was completed using tissues from brain, heart and leg muscle, all eleven chickens 
contained viable tissue cysts (Dubey et al., 2007c). 
As outdoor reared free range chickens spend the majority of their time pecking at the 
ground or soil in search of food, this species is often used as a sentinel species, 
providing an indication to the amount of environmental contamination from T. gondii 
oocysts. Free range chickens are frequently used for epidemiological studies 
examining the prevalence and also the different T. gondii genotypes present (Dubey 
et al., 2003; Tilahun et al., 2013).   
The prevalence of T. gondii infection in free range chickens varies dramatically, with 
seropositivity as high as 90% (n=20) in Australia (Chumpolbanchorn et al., 2013), or 
even 100% (n=11) in the United States (Dubey et al., 2007c).  In contrast a 
prevalence as low as 1.6% (n=300) in Turkey (Inci et al., 1998) was reported, and 
similarly, a lower prevalence of 18% (n=65) in free range chickens from Ireland has 
recently been described (Halova et al., 2013).  However, it should be noted (as it 
should be for other species), the seroprevalence can vary depending on the age of the 
animal and the methodology used.  The prevalence of T. gondii from indoor reared 
chickens with no outdoor access is generally low (Hill & Dubey, 2013), further to 
this viable T. gondii could not be identified using mouse bioassay from chicken meat 
obtained from supermarkets in the United States (Dubey et al., 2005b).  As 
described, the prevalence of T. gondii in free range chicken appears to be relatively 
high and combined with the ability to detect viable tissues cysts within these animals 
highlights a potential public health risk for consumers of this meat is eaten 
undercooked. 
As previously mentioned, chickens are a particularly useful sentinel species, and they 
play an important role for the isolation and identification of different T. gondii 
strains, providing valuable data about the diversity of the parasite worldwide 
(Lehmann et al., 2006).  Using this livestock species has been most useful for 
assessing the diversity of T. gondii within South America, where new genotypes and 
Toxoplasma gondii in animal and human hosts 
Chapter 1: Introduction  31 
atypical strains are frequently identified from free range chickens (Clementino 
Andrade et al., 2013; More et al., 2012; Pena et al., 2013).   
 
1.7 The presence of T. gondii tissue cysts in meat 
destined for human consumption 
Ingestion of T. gondii tissue cysts from contaminated meat is a major route of 
infection for humans.  In Europe a case control study, which focused on pregnant 
women from Switzerland, Belgium, Italy, Sweden and Denmark, found that between 
30% to 63% of T. gondii infections within this group were linked to undercooked or 
cured meat products (Cook et al., 2000).  The detection of tissue cysts within food 
producing animals is known to vary depending on the species (Figure 1-6).   Cattle 
rarely have detectable tissue cysts, even in animals which have been experimentally 
challenged (Esteban-Redondo et al., 1999), whilst in outdoor reared sheep, pigs and 
goats, tissue cysts are more commonly identified (Dubey et al., 1998a).   
As reviewed in section 1.6 (Toxoplasma gondii infection in livestock), the parasite 
has a high prevalence within the main livestock species commonly farmed to provide 
meat for human consumption.  The exact relationship between seropositivity and 
identification of viable T. gondii tissue cysts within meat for human consumption is 
not known.  
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Figure 1-6: Tissue cyst detection in food producing animals. 
Tissue cysts are detected more frequently in outdoor reared pigs, sheep and 
goats, whilst cysts are rarely detected in cattle (Tenter et al., 2000). 
Once an animal is infected tissue cysts have a preference to establish in specific 
tissues of the host, such as liver, heart, brain, tongue, diaphragm, kidney and skeletal 
muscle (Dubey et al., 1998a).  A recent study has also further highlighted the 
importance of infected skeletal muscle and its role in the transmission of the parasite 
to humans from eating raw or undercooked meat (Swierzy et al., 2013).  Viable 
parasites and tissue cysts have been isolated from cuts of meat and meat products 
destined for human consumption from a variety of livestock species, such as pigs, 
sheep, goats and even cattle (Aspinall et al., 2002; Dubey et al., 1986; Kijlstra & 
Jongert, 2009; Opsteegh et al., 2011b).  Infected pork (in particular from outdoor 
reared pigs) is considered to be the major source of infection (Cook et al., 2000; 
Davies, 2011; Djurković-Djaković et al., 2013; Dubey, 2009).   
In order gain a better understanding of possible sources of human infection due to 
meatborne contamination in The Netherlands, a quantitative microbial risk 
assessment (QMRA) model was designed to assess the number of bradyzoites in 
unprocessed portions of lamb, beef and pork products (Opsteegh et al., 2011a).  The 
results from the model predicted that beef was the most important source of infection 
for the Dutch population, with undercooked / underheated meat products identified 
as the main risk factor for infection.  Interestingly, bradyzoites are not commonly 
isolated from cattle experimentally infected with T. gondii (Esteban-Redondo et al., 
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1999), but a typical Dutch dish consumed in The Netherlands (Filet Americain), 
consists of a raw beef spread seasoned with herbs and spices, as this dish is uncooked 
the potential risk from infection is high.  In other countries traditional or typical 
dishes also consist of raw beef, such as, steak tartar in France, yukhoe in Korea, and 
kitfo in Ethiopia, all of which carry a greater risk of infection from bradyzoites 
(Vitale & Di Marco Lo Presti, 2013).   
In France a study which was undertaken in 2010 identified ovine meat to be 
contaminated with significantly high levels of T. gondii (Halos et al., 2010), and to 
assess the viability of  tissue cysts incorporated a mouse bioassay of ovine hearts 
(n=433) collected at slaughter.  Viable parasites where identified from 5.4% of 
sheep, however this increased dramatically when the age of the animals was taken 
into account, with 42% of adult animals containing viable tissue cysts.   
In Brazil, viable tissue cysts were identified by mouse bioassay in 8.7% (n=149) of 
fresh pork sausage samples collected from eight different factories (Dias et al., 
2005), and research by Belfort-Neto et al (2007) detected T. gondii DNA from 
porcine tongue collected from local abattoirs in 66.0% (n=50) of animals.  This study 
did not include a mouse bioassay, therefore, the viability of infective tissue cysts 
could not be determined from these animals.   
Detection of parasite DNA was also carried out using commercially available meat 
samples from the UK, the results found 38% (n=71) of samples tested where positive 
for the presence of T. gondii DNA (Aspinall et al., 2002).  As detection was carried 
purely by PCR, with no information available regarding the viability of the parasite, 
it is not possible to conclude whether consumption of these meat samples would have 
resulted in infection.  Ideally, research which incorporates molecular detection of the 
parasite in conjunction with a mouse bioassay would help to address the problem 
between presence of parasite DNA within meat for human consumption and its 
ability to cause infection. 
Despite the evidence provided on the presence of tissue cysts within meat and meat 
products, transmission can be reduced if the meat is thoroughly cooked or frozen for 
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C will render tissue cysts non-viable (Dubey et al., 1990; Kotula AW et 
al., 1991).  Generally methods used for salting and curing meat reduce the viability 
of the parasite (Hill et al., 2004), however, there is also recent evidence that T. gondii 
tissue cysts can be resistant to these methods (Bayarri et al., 2012; Pott et al., 2013).   
Finally, the development of a vaccine which could prevent tissue cyst formation in 
food producing animals would dramatically reduce foodborne transmission of T. 
gondii in humans.  From a public health perspective, the disease burden associated 
with foodborne transmission of T. gondii in humans is high, and is further described 
in section 1.8.2 – Disease burden. 
 
1.8 Toxoplasmosis in humans 
Human T. gondii infection is a problem which spans worldwide, with seroprevalence 
estimates ranging from 0 – 100%  depending on the origin of the population studied 
(Tenter et al., 2000).  The overall global trends for the seroprevalence of T. gondii 
were published in 2009 (Pappas et al., 2009), which examined published literature on 
the seroprevalence of the parasite in women of child bearing age (and pregnant 
women) for a period of  ten years (January 1999 – December 2008).   
A global map highlighting the seroprevalence of T. gondii in humans, generated from 
the publication by Pappas et al (2009), is shown in Figure 1-7.  
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Figure 1-7: Worldwide seroprevalence map of T. gondii.  Seroprevalence is 
indicated using the following colours: Dark red = above 60%, light red = 40 – 
60%, yellow = 20 – 40%, blue = 10 – 20%, green = less than 20%, white = 
unknown.  The map shows a high prevalence in South America, South East Asia 
and mainland Europe.  Adapted from Pappas et al (2009) 
 
A high prevalence was reported in humans from South American countries such as 
Brazil and Argentina where seroprevalence has been reported at 77.5% (n=503) and 
53.4% (n=650) respectively (Porto et al., 2008; Rickard et al., 1999), whilst a lower 
prevalence was noted in the majority of European countries, such as the United 
Kingdom (9.1% n=1,897), Denmark (27.8% n=89,873) and the Czech Republic (19.8 
n=1,053) (Kankova & Flegr, 2007; Lebech et al., 1999; Nash et al., 2005).   
However data on the seroprevalence in Germany and France have shown higher 
levels of T. gondii infection (59.0% n=4854, and 54.0%, n=13459 respectively) 
compared to their European counterparts (Fiedler et al., 1999; Tenter et al., 2000).  
Despite the high seroprevalence reported in France, a recent publication reports a 
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reduction in the incidence of T. gondii infection, where levels in pregnant women 
have fallen from 7.5/1000 in 1980 to 2.4/1000 in 2010 (Nogareda et al., 2013).  This 
reduction is presumed to be due to changes in meat production practices, hygiene and 
food habits, with the study also describing a 30% decline in the consumption of 
ovine meat (a food source known to have a high level of contamination - (Halos et 
al., 2010)) as reported by the French Ministry of Agriculture. 
Although the data obtained provides an overview of the seroprevalence of T. gondii 
within the human population, the results described above focus on a particular group 
of the population, pregnant women or women of childbearing age.  Studies which 
include a broad range of the population, including both males and females across all 
age ranges, could provide a better indication of T. gondii seroprevalence in humans. 
 
1.8.1 Clinical symptoms 
Despite a high seroprevalence in humans, the immune system generally keeps the 
parasite under control and most healthy individuals are asymptomatic, however 
patients may experience mild flu like symptoms such as fever, myalgia or asthenia 
(Montoya & Liesenfeld, 2004).  There is also recent evidence to suggest that the 
strain which has caused initial infection can also affect the severity of clinical 
disease.  This has been documented from cases of toxoplasmosis from Brazil and 
French Guiana, where primary infection linked to atypical or genetically distinct 
strains of the parasite have resulted in severe toxoplasmosis and ocular disease 
(Demar et al., 2012; Ferreira et al., 2011).  This majority of these cases are thought 
to be due to consumption of raw or undercooked meat from an infected animal.  One 
such report where severe toxoplasmosis in an immunocompetent individual from 
France (symptoms included; weight loss, night sweats, severe rectinochoroiditis and 
pulmonary toxoplasmosis), was linked to a primary infection of an atypical strain of 
T. gondii, with consumption of raw horsemeat imported from Argentina presumed to 
be the cause of infection (Sobanski et al., 2013).  Although, these cases are relatively 
rare and tend to only be associated with outbreaks from particular geographical areas. 
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It is immunocompromised individuals that are most at risk.  This includes individuals 
who are receiving chemotherapy for the treatment of cancer, those taking 
immunosuppresive drugs following organ transplantation, and AIDS patients.  
Primary infection with the parasite when these individuals are immunocompetent 
may not result in any clinical symptoms, however, when an adequate T-cell response 
is not mounted in times of immunodepression, reactivation of the parasite can occur, 
which can prove to be life threatening (Porter & Sande, 1992).  Clinical symptoms 
are often a result of CNS involvement, in particular toxoplasmic encephalitis, 
causing seizures, cranial nerve disturbances, movement disorders, mental status 
changes, speech abnormalities and focal motor deficits (Montoya & Liesenfeld, 
2004).  Although the brain is most commonly involved, dissemination of the parasite 
to the eyes (ocular toxoplasmosis), and heart (pulmonary toxoplasmosis) have also 
been reported (Kovari et al., 2010; Rothova, 2003). 
In both immunocompetent and immunocompromised women primary infection 
during pregnancy with T. gondii can result in the transmission of the parasite to the 
foetus via the placenta.  The risk of transmission and the severity of disease depends 
on the gestational stage at which the mother first becomes infected.  The risk of 
infection being passed to the foetus increases as gestation progresses, however, 
inversely, the severity of disease decreases with an increase in gestation period 
(Dunn et al., 1999).  For example, a foetus which becomes infected during the first 
trimester often leads to abortion, stillbirth or a child born with severe abnormalities 
of the brain and eyes, such as hydrocephalus, deafness, mental retardation, seizures, 
retinochoroiditis, and even blindness (Robert-Gangneux & Darde, 2012; Swisher et 
al., 1994).  Transmission to the foetus in the third trimester is less likely to cause 
such severe clinical manifestations, but may result in subclinical disease which can 
result in retinochoroiditis or learning difficulties in later life (Weiss & Dubey, 2009).  
The incidence of congenital toxoplasmosis varies depending on country and region.  
In some areas of Brazil (such as the state of Minas Gerais) the rate of infection from 
November 2006 to May 2007 was been reported to affect 1.3/1000 live births, with 
infection as high as 76.9/1000 live births in one particular region (Jequitinhonha) 
(Carellos et al., 2013).  In addition, infants in Brazil with congenital toxoplasmosis 
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more frequently show signs of severe toxoplasmic retinochoroiditis, compared to 
infants with congenital toxoplasmosis in Europe (Gilbert et al., 2008).  The severity 
of disease is presumed to be linked to the high genetic diversity of T. gondii 
identified in animals from this country, and recently this increased parasite diversity 
has been reported from congenitally infected Brazilian babies (Carneiro et al., 2013).  
In the UK, a study conducted between 2002 and 2004 in England and Wales 
estimated congenital infection to affect 3.4/100,000 live births (Gilbert et al., 2006).  
Although this figure is relatively low compared to some other countries, the 
symptoms of disease can have a lifelong effect on the child and the resulting disease 
burden of such cases is further described in section 1.8.2. 
Ocular toxoplasmosis which has been acquired postnatally (as opposed to congenital 
infection) is now thought to account for up to half of all reported cases in England 
and Wales (Gilbert et al., 2006).  In 1995, an outbreak of toxoplasmosis in humans 
from Canada resulted in infection of 110 individuals (Bowie et al., 1997), with 20 
cases of ocular toxoplasmosis linked to the outbreak the following year (Burnett et 
al., 1998).  As previously mentioned, acquired infection has also potentially been 
linked to schizophrenia (Yolken et al., 2009), Alzheimer disease (Kusbeci et al., 
2011), traffic accidents (Flegr et al., 2002a), self-directed violence (Pedersen et al., 
2011) and suicide (Lester, 2010).  It is not completely clear how the parasite can 
cause these disorders, but it is thought that it may be due to an increase in dopamine 
and a decrease in tryptophan within the brain, which, in intermediate hosts, increases 
the chance of predation by the definitive host and hence transmission and completion 
of the parasite’s life cycle (Flegr, 2013). 
 
 
1.8.2 Disease burden 
Symptoms of toxoplasmosis can be lifelong, in particular, children born with 
congenital toxoplasmosis who suffer from learning difficulties or individuals with 
ocular toxoplasmosis (whether acquired postnatally or congenitally) which, at its 
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most severe, can cause blindness.  A small number of studies within Greece, The 
Netherlands and the USA have analysed the disease burden of foodborne pathogens, 
comparing organisms such as Campylobacter spp (Campylobacter), Salmonella 
enteric (Salmonella), Listeria monocytogenes (Listeria), Cryptosporidium parvum 
(C. parvum), Escherichia coli O157:H7 (E. coli O157:H7) with T. gondii (Batz et al., 
2012; Gkogka et al., 2011; Havelaar et al., 2012; Hoffmann et al., 2012).  This 
research has taken into account the annual cost or disability of illness linking it to 
either quality-adjusted life-years (QALYs) or disability-adjusted life- years 
(DALYs).  From these results T. gondii ranked third to Salmonella and 
Campylobacter, based on QALYs in the USA, and from representative data taken in 
2009 from The Netherlands, T. gondii ranked highest among 14 other foodborne 
pathogens when DALY’s were used to classify these pathogens (see Figure 1-8).  In 
Greece the parasite was ranked 5th out of a possible 15 other foodborne pathogens 
using DALY’s for classification.  The high disease burden reported in these 
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Figure 1-8: Disease burden (DALY’s) of T. gondii against other foodborne 
pathogens in The Netherlands from 2009.  Adapted from Havelaar et al (2012)
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1.9  Serological detection of T. gondii 
1.9.1  Sabin Feldman dye test  
There are several different techniques available for serological detection of T. gondii 
antibodies against the parasite from both human and animal samples. Historically, 
the oldest method used for  detection of antibodies to T. gondii is the Sabin Feldman 
Dye Test (SFDT) which was first described in 1948 (Sabin & Feldman, 1948), and is 
still considered the “gold standard” for the serological detection of T. gondii in 
humans (Reiter-Owona et al., 1999).   This method is based on complement 
mediated cytolysis and requires live tachyzoites.  The tachyzoites are mixed with 
heat inactivated test sera and also human seronegative test sera (which acts as an 
accessory factor), and following an incubation period, methylene blue is added and 
results visualised using a light microscope.  Methylene blue will stain live intact 
tachyzoites, therefore, a result is deemed positive if ≥55% of tachyzoites are not 
stained with the dye, and negative if ≤55% of tachyzoites are stained with the dye 
(Udonsom et al., 2010).  Although this test is very sensitive in detecting low levels of 
T. gondii antibodies, it requires the use of live tachyzoites, and therefore maintenance 
of this stage of the parasite in either mice or cell culture.  A similar method to the 
Sabin Feldman dye test, which utilises T. gondii tachyzoites, is the indirect 
immunofluorescent antibody test. 
 
1.9.2  Indirect immunofluorescent antibody testing  
An indirect immunofluorescent antibody test (IFAT), was first reported to be suitable 
for diagnostic use by Fletcher et al (1965).  This method consists of cell culture 
derived whole tachyzoites (which can be cultured and then frozen for long term 
storage) which are fixed onto a microscope slide and incubated with dilutions of test 
serum.  An appropriate secondary antibody coupled with fluorescein isothiocyanate 
(FITC) is used which allows visualisation of the result using a fluorescent 
microscope.  This method is particularly useful for detecting antibodies against T. 
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gondii at the early stages of infection and (along with the Sabin Feldman dye test), is 
thought to be more sensitive and specific compared to methods such as the 
agglutination test and ELISA (Piergili, 2004).   
 
1.9.3  Enzyme linked immunosorbent assay 
The most commonly used technique in diagnostic laboratories for the detection of T. 
gondii infection (in particular IgG and IgM) is the enzyme linked immunosorbent 
assay (ELISA) (Robert-Gangneux & Darde, 2012).  A description of the 
methodology for the detection of T. gondii IgG from human serum is described in 
section 2.10.1.  However an ELISA can also be optimised to detect IgA or even IgE 
antibodies specific to T. gondii.  An avidity assay is an adaptation to the ELISA, 
which incorporates a denaturing agent (such as urea) within serum dilutions to test 
for antibody avidity.  Avidity values are lower during the acute phase of infection 
and increase over time, which can be used for “dating” the infection, to determine 
when seroconversion has occurred, and is particularly useful  in cases of congenital 
toxoplasmosis (Lappalainen et al., 1993). 
 
1.9.4  Modified agglutination test (MAT) 
The modified agglutination test (MAT) was first described in 1959 by Fulton and 
Turk (Fulton & Turk, 1959).  The test incorporates formalin fixed whole tachyzoites 
and is used to detect IgG antibodies raised against T. gondii.  The addition of 2-
mercaptoehtanol (2ME) is used to suppress any non-specific binding from natural 
IgM antibody (Desmonts & Remington, 1980).  The benefit this test has over other 
detection methods is that it does not require a species specific conjugate, therefore, 
enabling detection of IgG antibodies against T. gondii from a variety of different 
hosts, including livestock, wildlife and humans.  The test is also available as a 
commercially available kit, which has been shown to perform as successfully as 
ELISA when testing porcine serum samples, however, MAT was more sensitive at 
detecting T. gondii IgG from porcine tissue fluid (meat juice) (Forbes et al., 2012).  
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1.10 Detection of T. gondii parasites 
1.10.1  Molecular detection of parasite DNA 
Although molecular detection of parasite DNA by the polymerase chain reaction 
(PCR) can be used for the diagnosis of T. gondii infection, it is more commonly used 
in scientific research.  The DNA targets which are most frequently reported in the 
literature include the 110 copy ITS1 region of T. gondii (Hurtado et al., 2001; Tenter 
et al., 1994), the 35 copy B1 region (Burg et al., 1989) and the 300 copy 529bp 
repeat element (Homan et al., 2000).  To improve the sensitivity of these markers, 
nested PCR (nPCR) or quantitative PCR (qPCR) methodologies have been 
developed and successfully used to improve detection thresholds (Jauregui et al., 
2001; Reischl et al., 2003). 
Despite the sensitivity of the markers used for detection of the parasite, they are 
based within regions of the genome which are highly conserved, which has made 
them unsuitable for strain genotyping.  Research which has recently been published 
describes the ability of the B1 gene to discriminate between the three main T. gondii 
lineages (Costa et al., 2011).  This method incorporates high resolution melting curve 
analysis (HRM) for detection of SNPs, and looks promising for future research 
whereby detection and genotyping can be completed using a single reaction.  
Magnetic capture PCR (MC-PCR) for the detection of T. gondii in meat samples has 
recently been described (Opsteegh et al., 2010a), with molecular detection based on 
the 529bp repeat element.  The process requires digestion of a 100g tissue sample to 
form a crude extract, and with the removal of free biotin (using streptavadin 
sepharose to bind the biotin), biotin labelled T. gondii specific capture-oligos (based 
on the 529bp repeat element) are added to the extract which hybridise to any T. 
gondii DNA present.  The addition of streptavidin beads enables magnetic capture of 
T. gondii DNA which has bound to the sequence specific capture-oligos.  A qPCR 
incorporating primers designed to target the 529bp repeat element is then carried out 
on DNA isolated from the technique.  This method may be useful as an alternative to 
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mouse bioassay, however DNA detection of T. gondii tissue cysts, unlike the 
bioassay, does not reflect how viable the tissue cysts are. 
 
1.10.2 Mouse Bioassay 
The mouse bioassay has been described as the gold standard to test for the viability 
of T. gondii tissue cysts from animal tissues (Ware et al., 2010).  The method dates 
back to the 1960’s when it was used to isolate viable tissue cysts from swine, cattle 
and sheep (Jacobs et al., 1960b).  The method has been adapted since this time 
(Dubey, 1998a), and is fully described in section 2.8.1.  Briefly, the method involves 
an acid / pepsin digest of homogenised animal tissue, which is then neutralised and 
inoculated by the intra-peritoneal (IP) route into mice.  After approximately 4 to 6 
weeks, if viable tissue cysts were present in the inocula this can be confirmed by 
either; microscopic identification of parasite tissue cysts from the mouse brain; or 
detection of parasite DNA from the mouse brain.  The technique is sensitive enough 
to detect 1 cyst / 100g of tissue (Rothe et al., 1985), however this does not take into 
account the possible inhomogeneous nature of the distribution of tissue cysts in a 
sample. Although this method is time consuming and requires an in vivo mouse 
model, it is still currently the only way to test both the presence of T. gondii and also 
the viability of the parasites detected. 
 
1.11  Vaccination strategies 
1.11.1  Cats 
As oocysts, shed by the definitive host (the cat), are the primary source of infection 
(Dubey & Beattie, 1988), a vaccine which prevents oocysts shedding would have a 
dramatic effect on the environmental contamination with oocysts (Innes 2009).  A 
reduction in the amount of oocysts in the environment would subsequently reduce T. 
gondii infections in both animals and humans.  
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One of the most successful vaccines shown to reduce oocyst shedding in cats 
incorporated a mutant strain of T. gondii named T-263.  When this strain was used to 
vaccinate kittens, prior to challenge with a non-mutant strain of T. gondii, 84% 
(31/37) of the animals were reported to have not shed any oocysts (Frenkel et al., 
1991).  During a field trial with the same mutant strain (T-263), results showed that 
vaccination of cats on 8 commercial swine farms resulted in an overall reduction of 
the seroprevalence of the parasite in pigs (Mateus-Pinilla et al., 1999).  Despite the 
success of this strain in reducing oocyst shedding in cats, it has never been 
manufactured as a commercial vaccine.  The main reason behind this is due to the 
process in which the strain is produced and maintained in mouse brains and also 
requires a cold storage chain.  In addition, the bradyzoites which are used for 
vaccination are also infective to humans, making administering the vaccine 
potentially hazardous.  A more desirable approach would be a vaccine which 
incorporates recombinant DNA, however studies using this methodology are few in 
number and their success has been limited.  For example, research by Mishima et al 
(2002) using recombinant feline herpesvirus-1 expressing the ROP2 antigen of T. 
gondii did not reduce oocyst shedding in cats.  Whilst Garcia et al (2007) and Zulpo 
et al (2012) noted partial protection against oocyst shedding when cats were 
vaccinated intranasally with crude rhoptry proteins of T. gondii combined with Quil-
A as an adjuvant.  Another approach used by Omata et al (1996), where 
60
Co-
irradiated T. gondii tachyzoites of two different strains of the parasite (RH and 
Beverley), were used to vaccinate cats, however only partial protection was 




Ovine toxoplasmosis is one of the major causes of ovine abortion in both the UK and 
worldwide (as further described in section 1.6.2).  Currently the only commercially 
available vaccine against the disease is Toxovax
®
, which is licensed by MSD Animal 
Health (Milton Keynes, UK).  As previously described in section 1.6.2, the vaccine 
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consists of the tachyzoite stage of the S48 strain of T. gondii, which has lost the 
ability to differentiate into bradyzoites or oocysts, and remains as the tachyzoite 
stage of the parasite (Buxton, 1993; O'Connell et al., 1988).   
Although this vaccine has proved to be successful, a recent study across Scottish 
sheep flocks highlighted that only 24.7% (22/93) of farmers used the vaccine (Katzer 
et al., 2011). The relatively low percentage of farmers vaccinating their ewes may be 
due to a failure in the manufacture of the vaccine in recent years, resulting in reduced 
availability of the vaccine within Europe. 
1.11.2.2 Pigs 
As clinical signs of toxoplasmosis in pigs are rare (as described in section 1.6.1.1).  
From a public health perspective, a vaccine which could reduce the number of viable 
tissue cysts (bradyzoites) in the edible tissues of pigs would be desirable.     
Various vaccination strategies have been employed, but, as yet, no vaccine has been 
shown to provide complete protection against tissue cyst formation.  Initial 
vaccination trials in the 1990’s incorporated either the tachyzoite or oocyst stage of a 
non-persistent strain of the parasite (RH), however, following mouse bioassay of 
porcine tissues, only partial protection from tissue cyst formation was obtained 
(Dubey et al., 1994; Dubey et al., 1998b; Dubey et al., 1991; Pinckney et al., 1994).  
In 2004, Kringel et al also used the RH strain of T. gondii for vaccinating pigs, 
however the vaccine also included an immunostimulating adjuvant by incorporating 
CpG-oligodeoxynucleotides (which enhances the Th-1 immune response).  This 
vaccine provided partial protection against tissue cyst formation following oocyst 
challenge with the VEG strain of T. gondii, with detection of tissue cysts in only 
26.7% (16/60) of mice (following mouse bioassay of porcine tissues).  As further 
discussed in section 5.6, two similar studies incorporated crude rhoptry proteins from 
tachyzoites of the RH and either immunostimulating complexes (ISCOMS) (Garcia 
et al., 2005) or Quil-A (Cunha et al., 2011) as an adjuvant.  When porcine tissues 
from this experiment were assessed for the absence of tissue cysts (using mouse 
bioassay) only partial protection was observed.  Another approach, which has had 
some success, is a DNA based vaccine.  In 2008 a vaccine containing a cocktail of 
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two of the dense granule proteins of T. gondii, GRA1 and GRA7, was shown to 
produce a strong humoral and type I cellular immune response in pigs against T. 
gondii infection (Jongert et al., 2008).  A mouse bioassay on porcine heart tissue 
from the vaccinated pigs in this experiment found two out of a total of three animals 
to be tissue cyst free.   
Although the S48 strain of T. gondii is used in the commercial vaccine against ovine 
toxoplasmosis (Toxovax
®
), it has never been reported whether this strain of the 
parasite has any protective response in the formation of tissue cysts in either infected 
pigs or indeed lambs.  In a recent document produced for the Food Standards Agency 
(AMCSF, 2012), it was stated that one of the gaps in the current knowledge relevant 
to a UK risk assessment was: “Vaccines based on live attenuated strains of 
tachyzoites are effective in reducing morbidity in sheep but it is not known whether 
vaccination has any effect on the formation of tissue cysts”.  Therefore, to address 
this knowledge gap and potentially improve food safety, future research into 
vaccination of pigs to reduce tissue cyst formation should look at the S48 strain of T. 
gondii. 
 
1.11.3  Humans 
A vaccine against toxoplasmosis in humans is, as yet, unavailable. A vaccine for 
humans would be most beneficial for those in vulnerable risk groups such as women 
of childbearing age who are known to be T. gondii seronegative and 
immunocompromised individuals who are again known to be seronegative.  The 
vaccine would also be of use in countries such as Brazil, where not only is the 
seroprevalence of the parasite high in humans, but the frequency of atypical 
genotypes, which can cause ocular toxoplasmosis in non-immunocompromised, is 
also greater.  The only vaccine which has had success against toxoplasmosis is 
comprised of live tachyzoites of the attenuated S48 strain of the parasite, and 
licensed for veterinary use only (primarily breeding ewes).  It is therefore unlikely 
that this live vaccine (or any other vaccine comprised of live tachyzoites) will be 
considered safe for human use, whilst DNA or subunit vaccines are considered safer 
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alternatives, particularly for parasitic infections (Ivory & Chadee, 2004), however,  
these may not be as effective as live vaccines (Innes et al., 2011). 
Research which has focused on DNA and subunit vaccines for humans, has been 
carried out mainly in mice and rats, with the main vaccine candidates comprised of 
crude antigen, recombinant protein or DNA from surface antigens of T. gondii (such 
as SAG1) (Couper et al., 2003), rhoptry proteins (such as ROP2), dense granules 
(such as GRA1, 4, 5 and 7) (Desolme et al., 2000) and combinations of these 
antigens (Martin et al., 2004; Vercammen et al., 2000).   
Recent research using BALB/c mice immunised intranasally with recombinant T. 
gondii actin (rTgACT) has had some success in protecting mice against challenge 
with the RH stain of the parasite (which is fatal in mice) (Yin et al., 2013).  
Intranasal immunisation resulted in a 50% increase in mouse survival, with parasite 
burden on the brains of chronically infected mice reduced by 60% compared to 
control animals.   
Another study from 2013 where mice were vaccinated with DNA from T. gondii 
eukaryotic initiation factor-2α (TgIF2α- which is responsible for parasite viability 
(Joyce et al., 2010)) reported a 44.1% reduction in the formation of tissue cysts in the 
brains of vaccinated mice when compared to control animals (Chen et al., 2013).  
The results from this research also described a strong cell mediated immune response 
following vaccination, with a significant increase in IFNγ and IL-2 from these 
animals.  
In the majority of these experiments mice are used as a model for infection, but just 
how these vaccines will perform in humans is not understood.  It has been reported 
that rats may serve as a better model for T. gondii vaccine research, as in this species 
resistance to the parasite is the same as observed in humans (the RH stain of T. 
gondii is not lethal in immunocompetent humans or rats, but is lethal in mice) and 
may be more useful for studying human acute toxoplasmosis, chronic toxoplasmosis 
and disseminated toxoplasmosis in AIDS patients (Zenner et al., 1999). 
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From published research, it is clear that a vaccine which incorporates antigens from 




 and IFNγ are involved 
in protective immunity to T. gondii and if a greater number of antigens are present in 
a single vaccine, it is more likely that they will be processed and presented to the 
immune system (Innes et al., 2011).  Other factors, which appear to be important and 
should be considered for inclusion for future vaccines, are immunostimulating 
adjuvants and also the route in which the vaccine is administered.  
 
1.12 Aims of the PhD 
The research carried out within this thesis aims to address some of the knowledge 
gaps regarding the prevalence and genotypes of T. gondii from animal and human 
hosts in the UK.  The work will also examine whether a live attenuated strain of the 
parasite (S48) is effective at reducing viable tissue cysts in pigs, additionally, this in 
vivo experiment is designed to enable analysis into which tissues the parasite 
preferentially disseminates to following either tissue cyst or oocyst challenge. 
The research will focus on the following main points: 
 Determine the prevalence of T. gondii in wild mammalian carnivores by 
molecular detection of parasite DNA. 
 
 Determine T. gondii lineages present within carnivorous wildlife in Great Britain 
and whether mixed or atypical genotypes exist in this study population. 
 
 Examine the prevalence of T. gondii infection from two different study groups; 
Scottish blood donors (seroprevalence) and human brain samples from the 
Sudden Death Brain Bank in Edinburgh (molecular detection). 
 
 Discover the rate of seroconversion (or reversion) within Scottish blood donors 
and whether any recent infections are a result of oocyst or tissue cysts infection.  
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 Determine the genotypes present from T. gondii positive human brain samples. 
 
 Evaluate the effectiveness of a live attenuated strain of T. gondii (S48) in its 
ability to reduce viable T. gondii tissue cysts within porcine tissues by mouse 
bioassay. 
 
 Using a mouse bioassay, determine which porcine tissues the parasite 
preferentially disseminates to following challenge with either oocysts or tissue 
cysts. 
 
 Investigate whether detection of parasite DNA using homogenised porcine 
tissues, prior to inoculation into mice, will be as sensitive as mouse bioassay. 
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Chapter 2: Materials and Methods 
 
2.1 Experimental animals 
All experimental animals were used in accordance with Home Office regulations, 
and prior to the study commencing experimental design approved by Moredun 
Research Institute’s experiment committee.  
 
2.1.1 Cats 
Two male cats (Felis catus) aged approximately six months old were obtained from a 
Toxoplasma gondii free colony originating from Spain.  Cats were used for the 
production of oocysts of the Moredun M4 strain.  Animals were fed using a 
commercial cat food that was supplemented with olive oil to prevent constipation, 
which can commonly occur in cats following infection with T. gondii.  Both animals 
were re-homed after use. 
 
2.1.2 Pigs 
Twenty three, six week old Large White/Landrace cross bred pigs (Sus scrofa) of 
mixed gender, were obtained from Scottish Agricultural College, Easter Howgate.  
Animals were separated into five groups depending on experimental challenge (see 
section 5.2.1 for further details of the experimental design).  Animals were fed using 
a commercial pig feed and water was available ad libitum. 
 
2.1.2.1 Temperature monitoring and health status scoring 
Daily rectal temperatures of all pigs were monitored 14 days post vaccination.  At 
day 0 prior to challenge all animals were micro-chipped, iDENTICHIP
®
 with Bio-
Thermo (Animalcare Ltd., York, UK), and temperature monitored for 14 days post 
challenge. 
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Daily monitoring of pigs was completed throughout the experiment.  Animals were 
scored on their health status as described in Table 2-1.  Any animal which obtained a 
score of 6 or above were to be treated and removed from the experiment.   
 
 
Table 2-1: Pig health status scoring system. 
Defined end points: 1) any animal scoring 6 or above,  2) an animal that reaches 
the top score in any of the parameters except for temperature, where 
temperature below 37
o
C and above 41.5
o
C would be defined as the endpoint, or 
two consecutive days above 41
o







38 – 40 (0) 37 – 38 (1) 40 – 41 (1) <37 – 41* (2) 
Demeanour Normal  (0) Depressed  (1) Recumbent  (2) Moribund  (3) 
Body Condition Normal  (0) Thin  (1) Anorexic  (2)  
Faecal 
Consistency 
Normal  (0) Soft  (1) Fluid  (2) 
Fluid and 
Copious  (3) 
CNS Normal  (0) 
Poor coordination, 
circling, head tilt  (1) 
Any signs of onset of 




2.1.2.2 Blood sampling 
Blood sampling was carried out weekly at days 0, 7, 14, 12 and 28 days post 
vaccination, then at days 0, 7, 14, 21, 28, 35 and 42 post challenge.  Blood was 
collected using 2.7ml S-monovette serum tube with an S-monovette 20G x 1.5” 
safety needle (Sarstedt, Leicester, UK).  Blood serum was left to clot overnight at 
4
o
C, tubes centrifuged for 10 minutes at 2000g and serum transferred to a sterile 
1.5ml Eppendorf.  Serum samples were stored at -20
o
C until required. 
2.1.2.3 Post mortem and collection of samples 
All pigs were culled six weeks post challenge by electrical stunning followed by 
severing of the jugular vein and exsanguination.  At post mortem tissues and body 
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Table 2-2: Porcine tissues collected at post mortem. 
* indicates total brain material = 50g, ** indicates 50g of each tissue collected 
Sample  







  5g Bioassay* 
A  CNS 1 (internal capsule + cortex)  -  
B CNS 2 (corpus callosum + cortex)    
C CNS 3 (midbrain + hippocampus)   -  
D CNS 4 (hippocampus + cortex)    
E CNS 5 (pons + cerebellum)  -  
F Cervical spinal cord     
G Thoracic spinal cord     
H Lumbar spinal cord     






 5g Bioassay 
 A Prescapular LN     - 
 B Distal jejunal LN    - 
C Ileon (Peyer's patches)    - 
E Mesenteric LN  -  - 
F Retropharyngeal LN  -  - 







 5g Bioassay** 
A Heart (interventricular septum)    
B Chop (Longisimus dorsi, 7 toracic)   -  
C loin (middle)  -  
D Fore right limb (triceps)  -  - 
E Fore left limb  (triceps)  -  
F Hind right limb (semitendinosus)  -  - 
G Hind left limb (semitendinosus)  -  
H Neck (Trapezius)  -  - 
I Diaphragm    
J Tongue   -  
K Masseter    
5 Lung (caudal lobe)    - 
6 Liver    - 
7 Kidney    - 
8 Right Eye  -  - 
9 Left Eye  -  - 






 5g Bioassay 
A Blood serum - -  - 
B Right Humor Vitreo - -  - 
C Right Humor Acuoso - -  - 
D Left Humor Vitreo - -  - 
E Left Humor Acuoso - -  - 
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2.1.3 Mice 
Porton mice, which are a minimally inbred stain, were used for both bioassay, tissue 
cyst production (sections 2.8 and 2.7 respectively), and used to maintain the 
Moredun M4 isolate of T. gondii (see section 2.4.1).  Food and water was supplied 
ad libitum. 
 
2.1.3.1 Health status scoring 
Mice inoculated with T. gondii were observed twice daily and scored on their health 
status as described in Table 2-3.  Any animals that showed signs of infection i.e. 
obtained a health status sore of three or above, were removed from the experiment. 
 
 
Table 2-3: Mouse health status scoring system. Total score = A + B.  Animals 
were killed using a Schedule 1 procedure if an animal reached a maximum score 
in either category (A or B), or if an animal has a total score of 3 for three 
consecutive days.  
 
Category Description Score 
   
A 
Coat Condition 
(max score 2) 
Sleek/glossy coat 0 
Ruffled coat 1 
Stary stiff coat 2 




(max score 3) 
Bright and active 0 
Hunched 1 
A reluctance to move 1 
Tottering gait  1 
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2.1.3.2 Post mortem and collection of samples 
Mice that showed either signs of infection or that had survived until the end of the 
experiment were culled by cervical dislocation (Schedule 1 procedure).  Blood 
samples were taken and brain and heart tissue were collected.  Each tissue sample 
was stored separately in a sterile vial containing 1ml PBS (see Appendix 8.1.6). 
 
2.2 Human samples 
All human samples were obtained with appropriate ethical consent. 
 
2.2.1 Blood serum 
Serum samples originated from Scottish National Blood Transfusion Services 
(SNBTS) blood donors, from two cohorts located in both Glasgow (n=1102) and 
Dundee (n=301).  Serum had previously been collected for a Health Protection 
Scotland Cryptosporidium study, and was obtained from Dr Kevin GJ Pollock 
(Health Protection Scotland, Glasgow, UK) and Dr Claire Alexander (Scottish 
Parasite Diagnostic Laboratory, Glasgow, UK).  Samples were collected over four 
donation periods which spanned from 24
th
 April 2006 until 09
th
 February 2009 (2006 
– 2009).  The number of serum samples tested using the T. gondii human IgG ELISA 
(see section 2.10.1) totalled 3274, which included repeat donations from individuals 
across all collection periods.  Each donor completed a questionnaire, which included 
basic information such as age, gender, and location.  
 
2.2.2 Brain tissue 
Brain tissue was obtained from the Medical Research Council Sudden Death Brain 
and Tissue Bank (MRC Sudden Death Brain and Tissue Bank, Edinburgh, Scotland). 
The Brain Bank has local Research Ethics Committee approval (LREC 2003/8/37) 
and works within the legal framework of the Human Tissue (Scotland) Act 2006.  
Brain tissue was taken from 151 individuals who had died of sudden death (no 
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known underlying illness or disease).  To access these samples a research application 
was submitted using the Integrated Research Application System (IRAS – 
myresearchproject.org.uk).  The application was reviewed and subsequently 
approved by the South East Scotland Research Ethics Committee (NHS Lothian, 
Edinburgh, Scotland), with the following reference numbers; REC number 
11/AL/0113, IRAS project number 69852 (see Appendix 8.4).  From each individual 
(n = 151), approximately 1g of tissue from three specific regions of hind brain; pons, 
cerebellum and medulla (see Figure 2-1) were collected.  DNA extraction (see 
section 2.11.2) and detection of T. gondii (see section 2.12.2) was carried out using a 




Figure 2-1: Regions of the human brain.  Regions pooled and processed for 
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2.3 Wildlife samples 
Tissue samples were collected from six different wildlife species, Eurasian badger 
(Meles meles), ferret (Mustela furo), Red fox (Vulpes vulpes), American mink 
(Neovison vison), European polecat (Mustela putorius), and stoat (Mustela erminea), 
from various locations throughout Great Britain, as described in Table 2-4.  Badger 
and stoat tissue samples were collected following fatal impacts with motor vehicles 
(badgers were collected with the permission of Scottish Natural Heritage).  Where 
possible full necropsy was performed on the carcasses with tissue samples collected 
under sterile conditions.  All other samples were kindly provided by The University 
of Edinburgh, The National Museums Scotland and The Food and Environment 
Research Agency (see Table 2-4).  All tissues processed showed no visible signs of 
decay or putrefaction.  Samples were stored at -20
o
C prior to DNA extraction and 
PCR amplification. 
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Table 2-4: Samples collected for detection of T. gondii by PCR analysis. 
Species Provider
Locations 
of samples Tissue samples collected
No. of 
animals































Scotland brain, tongue, neck muscle 65





Scotland brain, tongue, heart, lung, 
liver, kidney, spleen, spinal 
cord, clotted blood, 
submandibular lymph 
node, neck muscle, hind 
leg muscle
64






Scotland brain, tongue, heart, lung, 
liver, kidney, spleen, 
clotted blood, neck 
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2.4 Toxoplasma gondii strains 
Five different strains of T. gondii were used thought the PhD as described in sections 
2.4.1 and 2.4.2. 
 
2.4.1 M4, S48 and RH 
The Moredun M4 strain was initially isolated at Moredun Research Institute from a 
case of ovine toxoplasmosis in October 2006.  Genotyping using PCR-RFLP has 
identified M4 as a type II strain. 
S48 is an ‘incomplete’ strain of the parasite which was originally isolated from a 
case of ovine abortion in Wallaceville, New Zealand (Hartley & Marshall, 1957; 
Wilkins et al., 1987).  This strain is used in the commercial vaccine against ovine 
toxoplasmosis, Toxovax
®
, and has been genetically classified as a type I strain of the 
parasite.  Due to repeated passage of the parasite in mice (over 3000 times), this 
strain has lost the ability to differentiate into the two infectious stages of the parasite, 
bradyzoites and oocysts, (Buxton & Innes, 1995; O'Connell et al., 1988)  
The RH strain was initially isolated in 1937 from a case of acquired toxoplasmosis in 
a six year old boy (Dubey, 2008; Sabin, 1941).  According to the Toxoplasma 
database (ToxoDB), this strain has been genetically classified as a type I.   
During this research M4, S48 and RH were cultured in the laboratory (see section 
2.5) from tachyzoites which had been stored in LN2 at Moredun Research Institute.  
 
2.4.2 NED and B1 
Tachyzoites from both NED and B1 strains were purchased from the Toxoplasma 
Biological Resource Centre (BRC Toxoplasma, Limoges, France).  The B1 strain 
was originally isolated in 2001 from an aborted bovine foetus in Portugal (Canada et 
al., 2002) and has been classified by BRC Toxoplasma to have a type I genotype.  
The NED strain of the parasite was isolated in 1989 from a case of human 
toxoplasmosis in France (Darde et al., 1992) and has been classified by BRC 
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Toxoplasma as a type III strain.   On arrival both strains were immediately stored to 
LN2.  When required, tachyzoites were cultured in the laboratory as described in 
section 2.5. 
 
2.5 Growth and maintenance of tachyzoites in cell 
culture 
 
2.5.1 Initial growth 
For initial growth of the parasite, tachyzoites, which had been cryopreserved in LN2 
at approximately 1x10
7
, were thawed quickly (no longer than two minutes in a 37
o
C 
water bath) and the outside of the vial decontaminated with 70% ethanol.  Contents 
of the vial were transferred to a 15ml tube and washed with 10mls 5% FCS IMDM 
(see Appendix 8.1.4) at 900g for ten minutes and the pellet resuspended in 10mls 2% 
FCS IMDM (see Appendix 8.1.5).  Five milliliters of the parasite resuspension were 
added to two T25 flasks containing Vero cells (ATCC No. CCL-81), which, 24 hours 
previously had been cultured at a concentration 1x10
5
 per flask with 2% FCS IMDM 






2.5.2 Maintenance   
Maintenance of tachyzoites was achieved using Vero cells in a similar fashion to the 
initial growth of the parasite (see section 2.5.1).  A T25 flask containing 1x10
5
 Vero 
cells per flask with 5% FCS IMDM was prepared 24 hours in advance of sub-





Previously infected flasks were monitored for tachyzoite growth, when 
approximately 60 -70% of Vero cells were infected, cells were detached from the 
flask using a cell scraper.  Tachyzoites were counted using a Neubauer 
haemocytometer and 2x10
5
 sub-cultured into the new T25 flask containing 1x10
5
 
Vero cells per flask, ensuring media was replaced with 5ml 2% FCS IMDM prior to 
the addition of tachyzoites.  Greater numbers of tachyzoites were produced in an 
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identical manor, however, a T75 tissue culture flask containing 3x10
5
 Vero cells with 
addition of 1x10
6
 tachyzoites were used.  
 
2.6 Oocyst production 
 
2.6.1 Oral infection of cats 
Two male cats (see section 2.1.1) were used as T. gondii donors by infecting each 
animal with approximately 10
3
 tissue cysts (half a T. gondii infected mouse brain, 
refer to section 2.7 for details), mixed with cat food.  Faeces were collected daily 
from 3 days post infection until 20 days post infection and examined for oocysts (see 
section 2.6.2 and Appendix 8.3) 
 
2.6.2 Identification, extraction and purification of oocysts 
using salt floatation and differential centrifugation. 
 
2.6.2.1 Identification 
To identify oocysts from cat faeces the Saturated Salt Floatation Technique was 
used, as described in Buxton et al (1988).  Briefly, approximately 1g of faeces was 
suspended in 10mls sterile dH2O and centrifuged for 5 minutes at 1000g.  The 
supernatant was discarded and the pellet resuspended in 10mls saturated sodium 
chloride (NaCl) solution (see Appendix 8.1.8), and centrifugation repeated as 
previously.  The meniscus was transferred to a McMaster slide and visualised under 
the microscope for the presence of oocysts.  The oocysts were identified by their 
spherical structure and measured approximately 11 to 13µm.  If oocysts were present 
the remainder of the sample was processed as described in section 2.6.2.2 
 
2.6.2.2 Extraction and purification 
Cat faeces were diluted 1:10 with water and homogenised in a Waring laboratory 
blender (Fisher Scientific, Loughborough, UK) to form a suspension, then filtered 
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through 1mm mesh to remove hair and lumps of debris.  Fifty milliliter aliquots of 
the suspension were centrifuged for ten minutes at 1000g and the pellet resuspended 
in 50mls saturated NaCl solution, followed by further centrifugation at 1000g for 20 
minutes.  The resulting meniscus (approximately 5-10mls) was carefully removed, 
diluted 1:10 with dH2O and centrifuged for 20 minutes at 1000g.  Supernatant was 
removed and the resulting pellet resuspended in 20mls 50% saturated NaCl solution 
and centrifuged for 20 minutes at 1000g, again the meniscus removed and further 
diluted 1:10 with dH2O followed by centrifugation at 500g for 20 minutes.  The final 
pellets were resuspended in 2% sulphuric acid (H2SO4) and an aliquot diluted 1:50 
with dH2O for counting using a Neubauer haemocytometer.  For processing larger 
quantities of faeces the methodology was up-scaled using 200ml of faeces 
suspension and an appropriate increase in reagent volumes.  Although some oocysts 
may have already sporulated, a maximum number of sporulated oocysts is desirable 
and should therefore undergo further sporulation (see section 2.6.3). 
 
2.6.3 Sporulation of oocysts 
Only sporulated oocysts are infective and therefore for infection studies a maximum 
number should be sporulated.  Purified oocyst (see section 2.6.2.2), were transferred 
to a T25 or T75 tissue culture flask (size dependant on final volume) which 
contained a hole within the lid which allowed a small piece of rubber tubing to be 
inserted.  The flask was then connected to an air pump which was set to slowly 
release air bubbles into the oocyst H2SO4 suspension.  The flask was then incubated 
at 23
o
C for 4 days before being examined for signs of sporulation by light 
microscopy.  Once approximately 90% had sporulated, using a differential oocyst 
count (number of sporulated vs. number of non-sporulated oocysts), oocysts were 
stored at 4
o
C and used for infection studies within 2 months. 
 
2.6.4 Preparation of oocyst  inoculum 
Sporulated oocysts (see section 2.6.3) were washed in sterile 1x PBS (see Appendix 
8.1.6) and centrifuged at 1000g for ten minutes.  The pellet was resuspended in a 
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suitable volume of PBS for counting and the number of sporulated oocysts counted.  
The volume of the PBS/oocysts suspension was adjusted depending on the number of 
infective oocysts required. 
 
2.7 Tissue cyst production 
At Moredun Research Institute Porton mice (see section 2.1.3) were routinely used 
for the production of tissue cysts.  Mice were orally infected with 1x10
4 
M4 
tachyzoites (see sections 2.4.1 and 2.5) and if tissue cysts were required an 
appropriate number of mice culled at least six weeks post infection.  Remaining mice 
were maintained for use until individual animals began to show clinical signs of T. 
gondii infection, at which point the affected mouse was culled (as described in 
section 2.1.3.1). 
 
2.7.1 Homogenisation of infected mouse brains 
Following mouse post mortem (see section 2.1.3.2) an entire mouse brain was 
homogenised by passing through an increasing gradient of fine gauge needles.  
Briefly, one millilitre of PBS was added to each individual mouse brain, an 18G 
needle was attached to a one ml plastic syringe and the mouse brain passed through 
the needle at least five times to form a homogenate.  The brain homogenate was then 
passed through a 21G needle followed by a 25G needle, ensuring that the brain 
material could pass through each needle five times. 
 
2.7.2 Determining numbers of tissue cysts by light 
microscopy and preparation of tissue cyst inoculum 
To determine the number of tissue cysts in mouse brain homogenate (see section 
2.7.1), 10µl was placed onto a McMaster slide and the number of tissue cysts 
counted across the entire field.  Once the number of tissue cysts present in 10µl of 
homogenate was determined, the inoculum was prepared according to the number of 
tissue cysts required using sterile PBS. 
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2.8 Mouse Bioassay 
Porton mice (see section 2.1.3) which are known to be particularly sensitive to T. 
gondii infection were used for all mouse bioassays. 
 
2.8.1 Pepsin/Acid digest of porcine tissues for mouse 
bioassay 
All porcine tissues, used for mouse bioassay, were digested with pepsin/acid as 
described by (Dubey, 1998a). Briefly, connective tissue, fat and epithelium from 
muscle tissue (50g) was removed and cut into 1-2cm pieces.  Cut tissues were 
homogenised at low speed for 15 seconds in a robust household blender, and then at 
high speed with the addition of 100mls sterile saline for 30 seconds.  The 
homogenate was transferred into a 500ml glass Duran bottle and the blender rinsed 
with 100mls sterile saline to ensure removal of all homogenate. Two hundred and 
fifty millilitres of pre-warmed (37
o
C) acid/pepsin solution (see Appendix 8.1.1) was 
added to the homogenate and incubated for 60 minutes at 37
o
C, with frequent mixing 
during incubation.  The homogenate was then filtered through two layers of gauze 
into a 500ml jug and poured into two 250ml polycarbonate centrifuge bottles, which 
were centrifuged for 10 minutes at 1200g.  The supernatant was gently poured off 
and the sediment, from both 250ml tubes, were combined with 20mls PBS in a 50ml 
tube.   To neutralize the solution 15mls of 1.2% sodium carbonate (see Appendix 
8.1.9) was added by gently mixing (mixture will effervesce and lid should be 
unscrewed after mixing to release air).  The neutralised solution was centrifuged for 
10 minutes at 1200g, supernatant was poured off gently and pellet resuspended in 
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2.9 Antigen preparation from tachyzoites 
 
2.9.1 RH tachyzoite culture for antigen preparation 
Tachyzoites of the RH stain (see section 2.4.1) were grown in pre-cultured Vero cells 
(ATCC No. CCL-81) in IMDM with 2% FCS (see section 2.5) at a ratio of 1:5 (Vero 
cells : T. gondii tachyzoites).  The tachyzoites were cultured until all Vero cells were 
lysed and free tachyzoites were visible in the medium.  The medium containing 
tachyzoites was pooled from each flask and antigen prepared as described in 2.9.2. 
 
2.9.2 Antigen preparation 
Culture medium containing free RH strain tachyzoites (see 2.9.1) was centrifuged for 
10 minutes at 675g and supernatant discarded.  The pellet was washed twice with 
50mls PBS (675g for 10 minutes), and the final pellet resuspended in 25mls of PBS.  
Parasite number was calculated using a Neubauer haemocytometer and adjusted to a 
final concentration of 10
9
 tachyzoites / ml in antigen extraction buffer (see Appendix 
8.1.2), with saponin and octylglucosideare (Sigma-Aldrich Company Ltd., Dorset, 
UK) added at a final concentration of 0.5% each.  The suspension was incubated for 
16 hours at 4
o
C on a blood tube rotator, followed by centrifugation for 30 minutes at 
50,000g at 4
o
C.  The supernatant was collected and antigen concentration measured 
using a Pierce BCA Protein Assay Kit (ThermoFisher, Northumberland, UK). 
Aliquots of supernatant were prepared and stored at -80
o
C until use. 
 
2.10 Enzyme linked immunosorbent assay (ELISA) 
 
2.10.1 T. gondii human IgG ELISA 
An in house human IgG ELISA was adapted from the methodology by Opsteegh et 
al (2010) and the final optimisation of the ELISA is described.  Microwells of a 
Greiner Bio-One 96 well medium binding plates were coated with 100µl of 
solubilized RH antigen (see section 2.9,) at a concentration of 6µg/ml in carbonate 
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buffer pH9.6 (see 8.1.3) and incubated at 4
o
C overnight.  Following incubation plates 
were washed 3 times with 300l PBS (pH7.2) containing 0.05% Tween 20 (PBST – 
see Appendix 8.1.7).  Control sera and test sera were diluted 1/100 in PBST and 
100l of the dilution added to the appropriate microwell, in duplicate.  Plates were 
incubated at room temperature (22 – 25
o
C) for 1 hour.  Plates were washed three 
times with PBST as previously, followed by addition of 100l conjugate (anti-human 
IgG alkaline phosphotase – Sigma Aldrich, Dorset, UK) to each microwell, diluted 
1/1000 in PBST.  Plates were incubated for 1 hour at room temperature.  Following 
incubation each well was washed 3 times in PBST as previously and 100l of 1-step 
PNPP (Thermo Scientific Pierce, Cramlington, Northumberland, UK) was added to 
each well.  The plate was incubated in the dark at room temperature for 30 minutes.   
Optical density (OD) was measured at 405nm using a Dynex-MRXII microplate 
reader (Dynex Technologies Limited, Worthing, West Sussex, UK) installed with 
Revelation software.  Cut off values were determined as described in section 4.2.7.3. 
 
2.10.2 Commercial T. gondii  IgG ELISA (ID.vet) 
The ID Screen Toxoplasmosis Indirect Multi-species ELISA kit (ID.vet, Montpellier, 
France) was used for porcine and mouse serum samples.  The supplied manufactures 
instructions were followed.  Briefly, 10l of test serum was diluted in 90l of 
Dilution Buffer 2 and added to the supplied microwells, which are pre coated with 
recombinant T. gondii tachyzoite surface protein (SAG1) as the antigen, and 
incubated for 45 minutes at room temperature.  Diluted serum was then removed and 
wells washed three times with 300l of Wash Solution, followed by the addition of 
100l Conjugate 1X.  Microwells were incubated for 30 minutes at room 
temperature, conjugate removed and wells washed three times with 300l Wash 
Solution. 100l of the Substrate Solution was added to each well and incubated for 
15 minutes at room temperature, the reaction was then stopped with 100l Stop 
Solution and read at an O.D of 450nm.   
According to the manufacturer’s instructions an ELISA was valid if the mean value 
of the positive control O.D. (ODpc) was greater than 0.035 (ODpc > 0.035), and if the 
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ration of the mean O.D. values for the positive and negative controls (ODpc and 
ODnc), were greater than 3.5 (ODpc/ODnc > 3.5). 
 The interpretation of the result was classed as percent seropositivity (SP) value 




A sample with an SP value of 50% or higher was positive, a negative result was an 
SP of 40% or less, and the result classed as doubtful if the SP was between 40% - 
50%. 
 
2.11 DNA Extraction 
 
2.11.1  Precellys method 
DNA was extracted from approximately 1g of homogenised tissue.  Briefly, tissue 
was placed into a CK28 precellys tube (tubes prefilled with ceramic beads with a 
diameter of 2.8 mm - Peqlab, Sarisbury Green, Hampshire, UK), containing 1000l 
Nuclei Lysis Solution (Promega, UK), and the tissue homogenised using a 
Precellys® 24 homogeniser (Peqlab) using two cycles of 50 seconds at 380g 
(6500rpm). 400µl of homogenate was further processes with 900µl Nuclei Lysis 
Solution (Promega), and incubated overnight in a water bath at 55
o
C (the remaining 
unused tissue homogenate was stored at -20
o
C for future use).   Once removed the 
lysate was allowed to cool to room temperature, 300l Protein Precipitation Solution 
(Promega) was added and mixed for 20 seconds using a vortex, then incubated on ice 
for 5 minutes.  Following incubation the mixture was centrifuged at 13,000g for 5 
minutes and the resulting supernatant transferred to a 2ml Eppendorf tube, containing 
900l isopropanol, mixed by inversion and incubated at -20
o
C overnight.  The DNA 
was pelleted by centrifugation at 13,000g for 5 minutes, supernatant removed and 
DNA pellet washed with 600l 70% ethanol.  Centrifugation was repeated for 2 
OD sample - ODnc
ODpc - ODnc
SP = x 100
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minutes at13,000g, supernatant removed and the DNA pellet allowed to briefly air 
dry.  The final pellet was re-suspended in 200l distilled H2O.  The DNA was stored 
at 4
o
C for immediate use or at -20
o
C for longer term storage. 
 
2.11.2 GentleMacs method 
For larger quantities of DNA, approximately 5 - 8g of tissue was place into a 
gentleMACS M tube (Miltenyi Biotec, Woking, Surrey, UK) containing 6mls of 
Nuclei Lysis Solution (Promega) and samples homogenised at using a GentleMacs 
tissue dissociator (Miltenyi Biotec).  All the homogenate was transferred into a 15ml 
centrifuge tube and incubated overnight at 55
o
C. Following incubation samples were 
allowed to cool to room temperature and 1.5ml Protein Precipitation Solution 
(Promega) was added and mixed by inversion several times, then incubated on ice 
for 5 minutes.  Samples were centrifuged at 1200g for 30 minutes and the 
supernatant transferred into a 15ml centrifuge tube containing 7.5ml isopropanol.  
After gentle mixing by inversion, precipitated DNA was centrifuged for 10 minutes 
at 1000g and the pellet washed with 2ml 70% ethanol, supernatant removed and 
pellet briefly air dried and resuspended in 700l distilled H2O. The DNA was stored 
at 4
o
C for immediate use or at -20
o
C for longer term storage. 
 
2.12 Polymerase chain reaction 
 
2.12.1 Standard PCR reaction 
Standard 20µl PCR reactions contained 2µl 10x custom PCR mix – SM0005 (45mM 
Tris-HCl. 11mM (NH4)2SO4, 4.5mM MgCl2, 0.113mg/ml BSA, 4.4µM EDTA and 
1.0mM dATP, dATC, dGTP, dTTP – ABgene, Epsom, Surrey, UK), 0.75 units 
BioTaq (Bioline, London, UK), and 2µl DNA.  Positive control DNA was included 
in all PCR runs and consisted of T. gondii DNA derived from tachyzoites grown in 
tissue culture, negative controls were also included and consisted of sterile dH2O or 
DNA extraction controls.  All reactions were made to a final volume of 20µl with 
Toxoplasma gondii in animal and human hosts 
Chapter 2: Materials and Methods  70 
sterile dH2O.  Primers, their concentration, and cycling conditions varied depending 
on the specific reaction (see sections 2.12.2 and 2.12.4). 
 
2.12.2 Diagnostic nested ITS1 PCR 
The nested PCR targets the multicopy 18S-5.8S rRNA internal transcribed spacer 
(ITS1) region of the parasite, and is routinely used at Moredun Research Institute for 
diagnostic purposes for detection of T. gondii infection within DNA from host tissue 
samples.  Primers and methodology were adapted from Buxton et al (2001), and 
Hurtado et al (2001).  To improve the sensitivity of the technique, each reaction was 
carried out in triplicate. 
First round reactions were conducted as described for the standard PCR reaction (see 
section 2.12.1), using 5µM of primers NN1-ext-F and NN1-ext-R ((Buxton et al., 
2001) (see Table 2-5).  Cycling conditions were 5 min at 95
o
C, followed by 35 cycles 
of 1 min at 95
o
C, 1 min at 55
o
C, 1 min at 72
o
C, and a final extension period of 5 min 
at 72
o
C. To reduce unused primers from the primary PCR, first round PCR products 
were diluted 1:5 with dH2O.   The conditions for each second round reaction were 
identical to the first, except 2µl of diluted first round product was used instead of 
DNA, and 5µM of primers Toxo_NP-1_F and Toxo_NP-2_R ((Hurtado et al., 2001), 
(see Table 2-5) were used. All PCR products were visualised following 
electrophoresis in 2% agarose gels incorporating Biotum Gel Red™ (Cambridge 
Bioscience Ltd, Cambridge, UK). 
 
Table 2-5: Primers used for diagnostic PCR. 
Primers 5' - 3' (external forward, external reverse Nested PCR
internal forward, internal reverse') Product Size (bp)
NN1_ext_F tca acc ttt gaa tcc caa
NN2_ext_R cga gcc aag aca tcc att
Toxo_NP-1_F gtg ata gta tcg aaa ggt at
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2.12.3  Host actin and inhibition control PCR 
To ensure DNA was present for each animal and to ensure that any negative result 
was not due to PCR inhibition, a PCR reaction which amplified host actin was 
carried out from the diluted ITS1 first round products.  The reaction used the same 
standard PCR as previously (see section 2.12.1) but contained 2µl diluted first round 
product, with 4µM of primers Uni_Actin_F3 and Uni_Actin_R3 (see Table 2-6). 
Cycling conditions were as previously described for the diagnostic nested ITS1 PCR 
(see section 2.12.2).  All PCR products were visualised following electrophoresis in 
2% agarose gels incorporating Biotum Gel Red
™
 (Cambridge Bioscience Ltd, UK). 
 
Table 2-6: Primers used for actin PCR 
Primers 5' - 3' (forward and reverse) Product Size (bp)
Uni_Actin_F3 cat cct gcg tct gga cct




2.12.4 Genotyping Mn-PCR-RFLP 
This method was adapted from work previously described by (Prestrud et al., 2008) 
and (Su et al., 2010) and the methodology summarised in Figure 2-2.  Briefly,  each 
20µl multilocus PCR reaction was set up as described in section 2.12.1, but 
contained 0.1µM of forward and reverse external primers for the following markers – 
5’SAG2, 3’SAG2, SAG3, GRA6 and BTUB (see Table 2-7), 0.75 units BioTaq 
(Bioline, London, UK), 5.85µl dH2O and 2µl DNA.  To improve the sensitivity of 
the technique each reaction was carried out in quadruplicate.  First round cycling 
conditions were 4 min at 95
o
C, followed by 25 cycles of 30 seconds at 94
o
C, 1 min at 
53.7
o
C, and 2 min at 72
o
C.  First round PCR products were diluted 1:1 with dH2O.  
The nested second round reaction used separate internal primers for each marker and 
used the diluted first round PCR products instead of DNA.  Each individual 20µl 
second round reaction contained 2µl 10x custom PCR mix (SM0005), 0.3µM 
primers (individual forward and reverse internal markers for  5’SAG2, 3’SAG2, 
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SAG3, GRA6 and BTUB – see Table 2-7) 0.75 units BioTaq, 13.85µl dH2O, and 2µl 
of diluted first round PCR product.  Cycling conditions were 4 min at 95
o
C, followed 
by 40 cycles of 30 seconds at 94
o
C, 1 min at 60
o
C, and 1.5 min at 72
o
C.  RFLP 
typing was achieved by preparing an enzyme digest which contained 2µl of the 
second round product, 2µl of 10x NEB Buffer 4 (New England Biolabs, Hitchin, 
Herts, UK), 4 units of the appropriate restriction enzyme (New England Biolabs – 
see Table 2-7) made up to a final volume of 20µl in dH2O.  Each digest was 
incubated for 1hr at the appropriate temperature depending on the restriction enzyme 
used (see Table 2-7).  Digested products were visualised following electrophoresis 
using a 3% Metasieve Agarose gel incorporating Biotum Gel Red™ (Cambridge 
Bioscience Ltd, Cambridge, UK).  
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Figure 2-2: PCR-RFLP Genotyping methodology.  An initial multiplex reaction 
followed by nested PCR.  Products generated are then digested by a restriction 
enzyme chosen to detect a SNP which differs between parasite strains. Digested 
products are resolved on a 3% Metasieve agarose gel . 
SECOND ROUND PCR 
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Table 2-7: Primers used for Mn-PCR-RFLP 
 
5'SAG2_ext_F gtc acc tgc aac agg aac ac
5'SAG2_ext_R gca tca aca gtc ttc gtt gc
5'SAG2_int_F gaa atg ttt cag gtt gct gc
5'SAG2_int_R gca aga gcg aac ttg aac ac
3'SAG2_ext_F tct gtt ctc cga agt gac tcc
3'SAG2_ext_R tca aag cgt gca tta tcg c
3'SAG2_int_F att ctc atg cct ccg ctt c
3'SAG2_int_R aac gtt tca cga agg cac ac
SAG3_ext_F caa ctc tca cca ttc cac cc
SAG3_ext_R gcg cgt tgt tag aca aga ca
SAG3_int_F tct tgt cgg gtg ttc act ca
SAG3_int_R cac aag gag acc gag aag ga
GRA6_ext_F att tgt gtt tcc gag cag gt
GRA6_ext_R gca cct tcg ctt gtg gtt
GRA6_int_F ttt ccg aga agg tga cct
GRA6_int_R tcg ccg aag agt tga cat ag
BTUB_ext_F tcc aaa atg aga gaa atc gt
BTUB_ext_R aaa ttg aaa tga cgg aag aa
BTUB_int_F gag gtc atc tcg gac gaa ca
BTUB_int_R ttg tag gaa cac ccg gac gc
SAG1_ext_F gtt cta acc acg cac ctt gag
SAG1_ext_R aag agt ggc agg ctc agt ga
SAG1_int_F caa tgt gca cct gta gga agc
SAG1_int_R gtg gtt ctc cgt cgg tgt gag
alt.SAG2_ext_F gga acc cga aca atg agt tt 
alt.SAG2_ext_R gca ctg ttg tcc agg gtt tt
alt.SAG2_int_F acc cat ctg cga aga aaa cg
alt.SAG2_int_R att tcg acc agc ggg agc ac
C22-8_ext_F tga tgc atc cat gcg ttt at
C22-8_ext_R cct cca ctt ctt cgg tct ca
C22-8_int_F tct ctc tac gtg gac gcc
C22-8_int_R agg tgc ttg gat att cgc
C29-2_ext_F acc cac tga gcg aaa aga aa
C29-2_ext_R agg gtc tct tgc gca tac at
C29-2_int_F agt tct gca gag tgt cgc
C29-2_int_R tgt cta gga aag agg cgc
L358_ext_F tct ctc gac ttc gcc tct tc
L358_ext_R gca att tcc tcg aag aca gg
L358_int_F agg agg cgt agc gca agt
L358_int_R ccc tct ggc tgc agt gct
PK1_ext_F gaa agc tgt cca ccc tga aa
PK1_ext_R aga aag ctc cgt gca gtg at
PK1_int_F cgc aaa ggg aga caa tca gt
PK1_int_R tca tcg ctg aat ctc att gc
Apico_ext_F tgg ttt taa ccc tag att gtg g
Apico_ext_R aaa cgg aat taa tga gat ttg aa
Apico_int_F gca aat tct tga att ctc agt t
Apico_int_R ggg att cga acc ctt gat a







internal forward, internal reverse)
Primers 5' - 3' (external forward, external reverse
Grigg et al.  2001
Khan et al. 
2005a; Su et al. 
2006
Khan et al. 
2005a; Su et al. 
2006
Khan et al. 
2005a; Su et al. 
2006
Khan et al. 
2005a; Su et al. 
2006
Khan et al. 
2005a; Su et al. 
2006
Reference
Howe et al.  1997; 
Su et al.  2006
Howe et al.  1997
Grigg et al.  2001
Khan et al. 
2005a; Su et al. 
2006
Khan et al. 
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2.13 Sequencing and analysis 
 
2.13.1 Purification of PCR products 
All PCR products sent for sequencing were excised from agarose gel and purified 
using the Promega Wizard SV gel and PCR clean up system (Promega, UK) in 
accordance with the manufacturer’s instructions.  Briefly, a band was cut from an 
agarose gel, weighed and transferred into a sterile 1.5ml eppendorf tube to which 
10µl of Membrane Binding solution per 10mg was added and mixed thoroughly.  
The sample was incubated at 60
o
C until the gel slice had completely dissolved.  The 
dissolved mixture was transferred into a SV Minicolumn and Collection Tube and 
incubated at room temperature for 1 minute, followed by centrifugation at 16,000g 
for 1 minute.  The Minicoulmn, which contained the bound DNA, was washed twice 
with Membrane Wash Solution at 16,000g for 5 minutes followed by centrifugation 
for 5 minutes at 16,000g to remove any residual ethanol for the Wash Solution.  
DNA was eluted from the Minicolumn by incubating with 35µl of sterile dH2O at 
room temperature for 1 minute, followed by centrifugation at 16,00g for 1 minute.  
DNA was quantified (see section 2.13.2) and stored at -20
o
C until further use. 
 
2.13.2 DNA quantification 
DNA concentration and purity were determined using a Nanodrop ND1000 
spectrophotometer (Labtech International Ltd, Uckfield, East Sussex, UK).  DNA 
was measured at an absorbance of 260nm, whilst purity was measured using the ratio 
between readings at 260nm and 280nm. 
 
2.13.3 Sequencing 
Purified PCR products were sent to GATC (GATC, Konstanz, Germany) using their 
“Lightrun” sequencing service, where sequencing was performed using an Applied 
Biosystems 3730xl DNA Analyser.  5µl of purified PCR product was sent at a 
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concentration of between 20 and 80ng/µl containing 5µl of the appropriate forward 
or reverse primer at a concentration of 5pmol/µl. 
 
2.13.4 Sequence analysis 
Sequences were analysed using BioEdit software (biological sequence alignment 
editor for windows 95/98/NT/2000/XP).  A free download is available at 
http://www.mbio.ncsu.edu/bioedit/bioedit.html 
 
2.13.5 Sequence databases and search engines 
Sequence databases used throughout included NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and ToxoBD (http://toxodb.org/toxo/). 
 
2.13.6 Submission of sequences to GenBank 
Sequences which were submitted for GenBank accession numbers were completed in 
accordance with BankIt (http://www.ncbi.nlm.nih.gov/BankIt/help.html).   
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 Determine the prevalence of T. gondii in wild mammalian carnivores by 
molecular detection of parasite DNA. 
 
 Identify the most sensitive and informative PCR-RFLP markers to enable 
genotyping of T. gondii positive wildlife samples. 
 
 Determine the T. gondii lineages present within carnivorous wildlife in Great 







The work described herein forms the basis of a peer-reviewed publication (see 
Appendix 8.5): 
Burrells  A, Bartley P. M, .Zimmer I. A., Roy S, Kitchener  A. C., Meredith  A., 
Wright S. E., Innes E. A., Katzer F. (2013) Evidence of the three main clonal 
Toxoplasma gondii lineages from wild mammalian carnivores in the UK.  
Parasitology 140, 1768-1776 
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3.1 Introduction 
Wildlife are known intermediate hosts for T. gondii, infected animals harbour tissue 
cysts containing hundreds (even thousands) of infective bradyzoites (Dubey et al., 
1998a).  Studying wildlife provides an indication of the prevalence of T. gondii and 
the strains present in the environment.  Studying carnivorous wildlife is particularly 
important as these animals become infected not only via T. gondii oocysts in the 
environment, but also via carnivory, consuming other infected host species.  It is this 
feature which makes wild mammalian carnivores a useful sentinel species, providing 
an indication to not only the prevalence but also the strains present within the 
environment.   
Molecular characterisation of the parasite using multilocus nested PCR-RFLP can 
identify the predominant lineages, as well as recombinant or mixed infections, which 
contain a combination of alleles from type I, II and III (Su et al., 2006).   This 
technique has been used to identify the alleles present in a variety of species 
worldwide, including wildlife, livestock and humans (Canon-Franco et al., 2013; 
Halova et al., 2013; Wang et al., 2013), and has also been used to identify atypical 
strains which are comprised of unique genotypes (Pena et al., 2013).  Although 
research of T. gondii in wildlife has been carried out worldwide on a range of 
species, including grey wolves (Canis lupus), bobcats (Lynx rufus) and white-tailed 
deer (Odocoileus virginianus) in the US (Dubey et al., 2013b; Yu et al., 2013) and 
red foxes (Vulpes vulpes), rodents and roe deer (Capreolus capreolus) in Europe 
(Aubert et al., 2010; Herrmann et al., 2012), recent figures regarding the prevalence 
of T. gondii in British wildlife is limited and is predominantly based on serological 
detection other than molecular detection.  The added bonus of T. gondii detection 
using molecular technologies is the ability to complete strain genotyping using PCR-
RFLP, which cannot be achieved using serology based methods.   
Serological data from the United Kingdom has found a T. gondii seroprevalence in 
red foxes of 20% (Hamilton et al., 2005), whilst in Eurasian badgers (Meles meles), 
the prevalence was found to vary between 39.0% - 77% (Anwar et al., 2006).  
Another study examined the prevalence of the parasite in wild brown rats (Rattus 
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norvegicus), and found a mean seroprevalence of 35.0% (Webster, 1994).  In 
addition, although not considered a wildlife species, the prevalence within 125 sheep 
flocks (which included a representative sample of the entire Scottish flock), 
described an overall T. gondii seroprevalence of 56.6% (Katzer et al., 2011).  This 
indicates a high level of environmental contamination from T. gondii oocysts.  
Unfortunately none of the work previously described allowed parasite strain 
genotyping, which can have epidemiological importance, particularly when 
comparing genotypes to those found in livestock and human infections.  One study 
which identified the different T. gondii alleles present in woodmice (Apodemus 
sylvaticus) within North Yorkshire, UK, found evidence of alleles for type I, II and 
III using PCR-RFLP (Thomasson et al., 2011).  However this study only used a 
single RFLP marker (SAG3), meaning mixed infections or atypical strains would not 
be identified.  More recently a study investigating the seroprevalence of T. gondii in 
Eurasian otters (Lutra lutra) from England and Wales found a high incidence of the 
parasite, where 39.5% of animals were seropositive (Chadwick et al., 2013).  Whilst 
in Ireland research by Halova et al (2013) examined both the seroprevalence and 
molecular detection of T. gondii in food producing animals (sheep, pigs, chicken and 
deer).  These results show a greater number of animals to be positive by serological 
detection (seropositivity ranged from 36% in sheep, 18% in chickens, 4.7% in pigs, 
and 6.6% in deer) when compared to molecular detection of the parasite from 
diaphragm samples (T. gondii DNA was detected in 13% of pigs, 4.2% of deer and 
3.6% of sheep).  However, the study also used meat digestion liquids to detect T. 
gondii DNA from pigs previously used in a Trichinella spp survey, using this 
methodology an increase in the molecular detection of the parasite was observed 
with 50% of animals reported as T. gondii positive. 
Within this study host DNA from wild mammalian carnivores was used to not only 
detect the presence of parasite DNA, but also genotype the parasite using multilocus 
nested PCR-RFLP across five markers (SAG3, GRA6, 5’SAG2, 3’SAG2 and 
BTUB).  However, initial testing of twelve markers (additional markers included 
SAG1, altSAG2, C22-8, C29-2, L358, PK1 and Apico) was also carried out and five 
were selected as the most informative and sensitive to be used for this study.  Using 
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five markers will not only identify alleles for the predominant T. gondii lineages but 
will also enable identification of mixed or atypical genotypes.   
Therefore the aim of this study was to determine the prevalence of T. gondii in wild 
mammalian carnivores by PCR, and to genetically characterise the genotype present 
using five of the most sensitive and informative PCR-RFLP markers. 
 
Toxoplasma gondii in animal and human hosts  
Chapter 3: Prevalence and genetic diversity of T. gondii from wild mammalian 
carnivores in Great Britain  81 
3.2 Materials and methods 
 
3.2.1 Optimisation and sensitivity of nested PCR-RFLP 
markers 
Initially twelve PCR-RFLP markers (see  
Table 2-5) were used to test the sensitivity of each marker and to enable optimisation 
of the PCR conditions.  Murine host DNA which had been spiked with tachyzoite 











tachyzoites / ml.  Methodology for the 
genotyping Mn-PCR-RFLP was followed (see 2.12.4) using all twelve primers 
described in Table 2-7.  However, during thermal cycling (see 2.12.4) the annealing 





C.   
 
3.2.2 DNA from wildlife samples 
Tissue samples were collected from Eurasian badger, red fox, American mink, 
European polecat, and stoat, as described in section 2.3 and also further detailed in 
Table 2-4.  DNA extractions were completed using 1g of tissue as described in 
section 2.11.1 
 
3.2.3 Detection of T. gondii by ITS1 PCR 
All DNA samples were amplified using the diagnostic nested ITS1 PCR (see 2.12.1) 
and electrophoresed in 2% agarose gels.  A sample was regarded as positive if an 
amplicon of 227bp was present in one or more of the three reactions per sample.  
Multiple negative controls (dH2O) as well as extraction controls were included in 
each PCR run, and results only accepted if these reactions were negative. 
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3.2.4 Detection of host DNA 
DNA samples were amplified using an actin PCR to ensure host DNA was present 
and that PCR inhibitors were absent (see section 2.12.3).  This was carried out to 
ensure that any negative result observed was a true negative and not due to PCR 
inhibition. 
 
3.2.5 Genetic characterisation of T. gondii by multiplex 
nested PCR-RFLP 
Genotyping was applied to all T. gondii positive samples (as described in section 
2.12.4) using the five markers identified as the most sensitive and informative 
(SAG3, GRA6, 5’SAG2, 3’SAG2 and BTUB). 
 
3.2.6 DNA sequencing and sequence analysis 
Twenty five SAG3 PCR products were directly sequenced using both forward and 
reverse SAG3 internal primers (see Table 2-7).  Products were purified (see section 
2.13.1) and sequencing completed at GATC Biotech (section 2.13.3), and results 
analysed using BioEdit sequence analysis software (section 2.13.4), and consensus 
sequences generated.  To enable identification of polymorphisms, a 166bp fragment 
of the published sequences representing the three clonal archetypal T. gondii lineages 
were used as reference sequences, which included RH – type I, Pru – type II and 
CEP – type III (GenBank accession numbers AF340227, AF340228, AF340229 
respectively).  Direct sequencing using forward and reverse internal primers was also 
completed to obtain representative sequences for 5’SAG2, 3’SAG2, GRA6, and 
BTUB. 
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3.3 Results 
 
3.3.1 Five most informative and sensitive PCR-RFLP markers 
identified 
Following adjustment of the first round PCR annealing temperature it was found that 
53.7
o
C was the optimum annealing temperature (data not shown) to enable detection 
of parasite DNA over twelve markers (as listed in Table 3-1).  Markers 5’SAG2 and 
3’SAG2 were the most sensitive and reliably detected T. gondii DNA in dilutions as 
low as 10
-1
 per ml (see Table 3-1).  In addition, when these markers are used in 
combination with each other, they can distinguish between the three main archetypal 
lineages.  An additional seven markers (SAG3, GRA6, BTUB, SAG1, C22-8, L358 
and Apico) could detect parasite DNA at a dilution which contained approximately 
one tachyzoite per ml.  The PK1 marker was the least sensitive and was only able to 
detect parasite DNA at a concentration which contained approximately 100 
tachyzoites per ml, as described in Table 3-1. 
The markers SAG3 and GRA6 are two of the most informative markers, as a single 
restriction digest (NciI and MseI respectively – see Table 2-7) of PCR products 
generated from these markers can distinguish between the tree archetypal lineages (I, 
II and III) (Khan et al., 2005a; Su et al., 2006).  Also PCR products generated from 
the BTUB marker can be used to distinguish between the tree archetypal lineages 
using a double restriction enzyme digest (BsiEI and TaqI – see Table 2-7). 
From these results the five most sensitive and informative markers to be used in this 
study were 5’SAG2, 3’SAG2, SAG3, GRA6 and BTUB.  These markers represent 
four distinct loci within the T. gondii genome (as further described in section 1.4). 
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Table 3-1: Sensitivity of detection of T. gondii by PCR with 12 different markers 
using an annealing temperature of 53.7
o
C. Key: “+” = positive result, “-” = 
negative result. 
Marker 
Dilution T. gondii / ml diluted in host DNA 
10
2







5'SAG2 + + + + - - 
3'SAG2 + + + + - - 
SAG3 + + + n/d n/d n/d 
GRA6 + + + - - - 
BTUB + + + - - - 
SAG1 + + + - - - 
alt. SAG2 + + - - - - 
C22-8 + + + - - - 
C29-2 + + - - - - 
L358 + + + - - - 
PK1 + - - - - - 
Apico + + + - - - 
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3.3.2 Prevalence off T. gondii varies between host species 
and tissues tested 
Overall 22.8% (89/390) of the animals tested were positive for T. gondii.  The 
prevalence varied depending on the host species (see Table 3-2), 31.4% (22/70) of 
polecats tested positive, whilst only 6.0% (5/83) of foxes were positive.  Mink, 
badger and ferret had a prevalence of 29.2% (19/65), 25.0% (16/64) and 23.2% 
(23/99) respectively.  Stoats showed a higher prevalence with 44.4% (4/9) of animals 
tested PCR positive, however it should be noted that this group had a lower 
representative sample size and was collected from a geographically smaller area than 
the other species tested.   
Multiple tissues were used to test for the presence of T. gondii in mink, badger and 
stoat.  Mink brain tissue accounted for 20.0% (13/65) of positive samples within this 
species, followed by tongue and heart tissue (10.8% and 1.5% respectively), whilst in 
badgers, brain tissue accounted for 5.0% (3/60) of positive samples, while tongue 
and heart tissue had a positivity of 6.3% (2/32) and 7.7% (4/54) respectively (see 
Table 3-3).  Multiple tissues from the same animal were found to be positive for 
mink, and badger (see Figure 3-1), with an individual badger having up to three 
tissues positive for T. gondii.  
All DNA samples tested were positive for the detection of host DNA.  Therefore any 
negative result observed in the ITS1 PCR (or negative result from the same DNA 
when using the genotyping PCR-RFLP primers), was not due to degraded DNA or 
the presence of PCR inhibitors. 
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Table 3-2: Samples collected for detection of T. gondii and parasite prevalence 
by diagnostic nested ITS1 PCR 
















         






Scotland brain 99 23 23.2 15.3 32.8 
         









Scotland brain 83 5 6.0 1.9 13.5 
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brain 70 22 31.4 20.9 43.6 
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65 19 29.2 18.6 41.8 
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64 16 25.0 15.0 37.4 
         














9 4 44.4 13.7 78.8 
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Table 3-3: Individual tissues collected and T. gondii positivity. 
             
Species   Number of tissues positive / Number of tissues collected (%)   
   Br Tn He Ne Lu Kid Sp Bl Hlm Sln Sc 
Ferret  23/99 (23.2) - - - - - - - - - - 
Red Fox  5/83 (6.0) - - - - - - - - - - 
European Polecat 22/70 (31.4) - - - - - - - - - - 
American Mink 13/65 (20.0) 7/64 (10.8) 1/65 (1.5) - - - - - - - - 
Eurasian Badger 3/60 (5.0) 2/32 (6.3) 4/54 (7.7) 3/54 (5.6) 1/52 (1.9) 1/52 (1.9) 3/52 (5.8) 1/52 (1.9) 2/52 (3.8) 2/37 (5.4) 2/12 (16.6) 
Stoat  2/9 (22.2) 0/2 (0.0) 0/1 (0.0) 2/7 (28.6) 0/1 (0.0) 0/1 (0.0) 0/1 (0.0) 0/1 (0.0) 0/2 (0.0) - - 
             
 
Br = Brain, Tn = Tongue, He = Heart, Ne = Neck Muscle, Lu = Lung, Kid = Kidney, Sp = Spleen, Bl = Clotted Blood, Hlm = Hind leg muscle, Sln 
= Submandibular lymph node, Sc = Spinal Cord 
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Figure 3-1: Samples which were positive for more than one tissue by ITS1 PCR.  



































Toxoplasma gondii in animal and human hosts  
Chapter 3: Prevalence and genetic diversity of T. gondii from wild mammalian 
carnivores in Great Britain  89 
3.3.3 PCR-RFLP genotyping reveals evidence of alleles for all 
three main clonal lineages 
Of the 89 animals that tested positive for T. gondii by ITS1 PCR (see section 3.3.2), 
30 were successfully amplified with PCR-RFLP primers for three or more markers 
across three loci (33.7%).  These included nine polecats, twelve ferrets, six mink, 
two badgers and one fox (see Table 3-4).  Two polecats (Pc07 and Pc26) only 
amplified at a single locus (SAG3), which identified a type I allele in both animals. 
Attempts to amplify products at additional loci in these animals failed.  
A type III lineage was identified across all five markers (four loci) in one polecat 
(Pc39), however, the predominant lineage across all species genotyped was type II 
(90.6%).  PCR-RFLP genotyping across all markers (four loci) for the type II lineage 
was achieved in 23 animals which included five mink, 11 ferrets, and seven polecats. 
Partial typing of the type II lineage was seen in six animals; two badgers, one fox, 
one mink, one ferret and one polecat.  
Within this group of animals, multi locus genotyping highlighted the presence of 
alleles for the three main clonal lineages of T. gondii, with no evidence of 
recombinant genotypes or atypical strains. 
As previously stated, all DNA samples tested positive for the detection of host actin 
DNA, therefore any samples which were negative for PCR-RFLP genotyping were 
not due to PCR inhibition or degraded DNA. 
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Table 3-4: T. gondii PCR-RFLP genotyping from thirty two infected animals across five markers. 
Reference/   PCR-RFLP Marker   
Species Animal ID 5'SAG2 3'SAG2 SAG3 GRA6 BTUB Genotype 
RH - Type I   Reference I or II I or III I I I I 
M4 - Type II    Reference I or II II II II II II 
NED - Type III   Reference III I or III III III III III 
Polecat  Pc39 III I or III III III II or III III 
Polecat    Pc07, Pc26 na na I na na I* 
Polecat   Pc10, Pc21, Pc27, Pc30, I or II II II II II II 
 Pc34, Pc43, Pc53       
Polecat   Pc63 na na II II II II 
Ferret        Ft04 na na II II II II 
Ferret                 Ft02, Ft05, Ft15, Ft39, I or II II II II II II 
 Ft42, Ft49, Ft50, Ft55,       
 Ft64, Ft82, Ft83       
Mink   Mk39 na II II II II II 
                        Mk02, Mk12, Mk38, I or II II II II II II 
 Mk54, Mk08       
Fox                Fx31 I or II II na II na II 
Badger         Ba50, Ba62 I or II na II II II II 
 
na, no amplification.  *based on a single allele identified at the SAG3 locus.  I = type I;  II = type II;  III = type III;  I or II = type I or II;   I or III = type I or 
III;  II or III =  type II or III. 
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3.3.4 Sequencing identified nucleotide differences at the 
SAG3 locus 
Direct sequencing of 25 SAG3 PCR products (11 ferrets, 10 polecats, three mink and 
one badger) which had previously been genotyped by PCR-RFLP is highlighted in 
Figure 3-2).  The results confirm that the type I T. gondii alleles identified in two 
polecats by PCR-RFLP (Pc07 and Pc26) were identical to a 166bp region of the 
archetypal type I lineage RH at the SAG3 locus (GenBank accession no. AF340227).   
The T. gondii strain identified in a polecat (Pc39), which was classified as type III by 
PCR-RFLP, showed 100% sequence identity to the archetypal type III lineage: CEP 
(GenBank accession no. AF340229) as shown in Figure 2-2.  In twenty of the 
animals the T. gondii strain classified as type II by PCR-RFLP also had a sequence 
identity  to the archetypal type II lineage: Pru (GenBank accession no. AF340228).   
Finally, the T. gondii strain identified in two polecats (Pc10 and Pc34) showed slight 
variation compared to the type II archetypal lineage Pru, with sequences from both 
animals showing a single nucleotide substitution (Pc10 at 134bp and Pc34 at 147bp, 
GenBank accession numbers KC928252 and KC928253 respectively), both 
sequences were blasted against the NCBI and ToxoDB databases but did not show 
100% identity to any other sequence.  To ensure PCR error was not responsible for 
the observed single nucleotide polymorphisms, both PCR’s were repeated and 
products re-sequenced which confirmed the results. 
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                       10        20        30        40        50        60        70        80        90                           
                  |    |    |    |    |    |    |    |    |    |    |    |    |    |    |    |    |    | 
Consensus     TGCAACGTCAAAGTGAGAGTTGCCGGGAACCCCAGAAAGTGGGGGAGAGGCGGAGGCGGCCATCCAGGAAGCGGAGGATTGCAGCCGGGA  
I   RH        ..........................................................................................  
II  Pru       .......................T...................A...G......................................A...  
III CEP       ...............................................................................C........A.  
Pc07, Pc26    ..........................................................................................  
Pc39          ...............................................................................C........A. 
Pc10          .......................T...................A...G......................................A... 
Pc34          .......................T...................A...G......................................A... 
Pc21 (4)      .......................T...................A...G......................................A... 
Ft02 (10)     .......................T...................A...G......................................A...  
Mk02 (2)      .......................T...................A...G......................................A...  
Ba62          .......................T...................A...G......................................A...  
 
                      100       110       120       130       140       150       160                               
                  |    |    |    |    |    |    |    |    |    |    |    |    |    |    |  
Consensus     ACTGACGGGGAAACTCAAGCTGGAACAGAAAGTTCAGCCGGCGCGAGTTCGCGAATGGCTTCCGTTGCCCTGGCGT  
I   RH        .....A.......G..............................................................  
II  Pru       ............................G...............................................  
III CEP       ............................................................................  
Pc07, Pc26    .....A.......G..............................................................  
Pc39          ............................................................................ 
Pc10          ............................G..............T................................ 
Pc34          ............................G...........................T................... 
Pc21 (4)      ............................G............................................... 
Ft02 (10)     ............................G...............................................  
Mk02 (2)      ............................G...............................................  
Ba62          ............................G...............................................  
  
Figure 3-2: Sequence alignment at the SAG3 locus.  Consensus sequence indicates the nucleotides shared by a minimum of two of 
the three archetypal clonal lineages RH (I), Pru (II) and CEP (III).  The sequence alignment shown for Pc21 (4) also represents 
identical sequencing for four other polecat samples (Pc27, Pc30, Pc43 and Pc53), whilst Ft02 (10) represents identical sequencing 
for 10 other infected ferrets (Ft05, Ft15, Ft39, Ft42, Ft49, Ft50, Ft55, Ft64, Ft82, and Ft83), and Mk02 (2) represents identical 
sequencing for two other mink samples (Mk08 and Mk54). 
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It should be noted that direct sequencing was also carried out for several other 
amplicons generated from 5’SAG2, 3’SAG2, GRA6 and BTUB.  These sequences 
correlated with the results obtained from PCR-RFLP (see Table 3-4).  Sequencing 
using SAG3 proved to be more informative, providing additional information about 
the genotype than PCR-RFLP alone.   
Representative sequences were submitted to GenBank 
(http://www.ncbi.nlm.nih.gov/genbank) and are available online using the following 
accession numbers; KC928254  – representative of twenty isolates (SAG3 Type II 
allele) KC928250 – Pc07 (SAG3 Type I allele), KC928251 – Pc39 (SAG3 Type III 
allele), KC928252 – Pc10 (SAG3 Type II allele, single base pair substitution), 
KC928253 - Pc34 (SAG3 Type II allele, single base pair substitution), KC928255 
(GRA6 Type II), KC928256 (GRA6 Type III), KC928257 (BTUB Type II), 
KC928258 (5’SAG2 Type II), KC928259 (3’SAG2 Type II). 
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3.4 Discussion 
Data describing the prevalence of T .gondi in wildlife within Great Britain is limited, 
even less information is known about the genotypes, which may be circulating within 
the host populations and subsequently the wider environment.  However research 
carried out in Europe has shown not only further information on the prevalence of 
the parasite, but also on the genotypes within these host species.  The results from 
this chapter help to complete the knowledge regarding the prevalence of T. gondii 
and the genotypes present in the environment within Great Britain.  The results show 
that the prevalence of T. gondii in British wild mammalian carnivores varies between 
6.0% - 44.4% depending on the host species (see Table 3-2).  Analysis of identical 
tissues for the detection of Neospora caninum was recently published (Bartley et al., 
2013), and through personal communication with the author of this manuscript, a 
comparison between this research and the current study has identified seven animals 
(1.8%) infected with both with T. gondii and N. caninum.  This includes one badger, 
one fox and five polecats.   
The overall prevalence of T. gondii may be affected by the number and type of 
tissues available for testing within each species (Table 3-3).   Stoats have the highest 
prevalence (44.4%), however only nine animals were tested by PCR for the presence 
of T. gondii DNA, whereas for the other species examined the sample number was 
greater (n= 64 - 99), as described in Table 3-2.  The availability of only nine stoats 
means that this group does not constitute a representative sample for the species.  To 
fully evaluate the prevalence of T. gondii within stoats a greater number of animals 
should be sampled, however on this occasion we were limited to this small number.  
The lowest prevalence was observed in foxes (6.0%), however a previous serum 
based study in red foxes from the UK found a T. gondii seroprevalence of 20.0% 
(Hamilton et al., 2005).  Other studies within Europe have highlighted a higher 
seroprevalence, including 73.7% (14/19) in France (Aubert et al., 2010), 56.0% 
(115/206) in Ireland (Murphy et al., 2007), and 74.5% (152/204) to 84.7% (149/176) 
in Germany depending on the region (Herrmann et al., 2012). Although it should be 
noted that lower figures are observed for the molecular detection of the parasite.  In 
Belgium 18.8% (57/304) of foxes tested positive for T. gondii by real time PCR (De 
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Craeye et al., 2011) and in Germany 13.4% (20/149) to 18.4% (28/152) of foxes 
were identified as positive by PCR, which differed substantially from the serological 
results of 74.5% to 84.7% (Herrmann et al., 2012).  The work carried out by 
Hermann et al (2012) showed that molecular detection resulted in a lower prevalence 
when compared to serological detection of the parasite.  Unfortunately the tissues 
available for our study did not allow a seroprevalence study to be undertaken, 
however in the future this is something that should be considered, and if serum is not 
available perhaps using meat juice in an ELISA, taken directly from the tissues 
would be something to consider for future experiments (Berger-Schoch et al., 2011; 
Glor et al., 2013) .  Our prevalence rate is lower than many European seroprevalence 
studies, as serum based detection appears to result in an increased T. gondii infection 
detection rate.  Lower values for the molecular detection of the parasite are likely to 
be due to a combination of the inhomogeneous distribution of T. gondii tissue cysts 
in the host and the small sample size used for DNA isolation (approximately 1g of 
tissue).  Testing a greater number of tissue samples from each species by PCR could 
increase the overall detection rates, as it is possible that T. gondii infection was not 
detected in some animals as a particular tissue was not available for testing.   An 
example of this is highlighted within the current study, where a selection of badger 
tissues were positive for T. gondii while corresponding brain samples tested negative 
(see Table 3-3).   It should also be noted that where multiple tissues were collected 
from individual animals (mink, badger and stoat), that more than one tissue could be 
positive for T. gondii by ITS1 PCR.  This was particularly noted in a badger, where 
T. gondii was detected in three individual tissues from this animal (see Figure 3-1).  
Sampling different tissues from the same animal will increase the detection level, for 
example, in badgers, based on the presence of T. gondii DNA in brain alone the 
prevalence rate is only 5% (see Table 3-3), however, by testing multiple tissues from 
each animal the overall prevalence increased to 25%  The inconsistency in the 
detection of the parasite between different tissues from the same animal could reflect 
the infection burden,  which may provide an indication of host resistance or 
susceptibility to T. gondii.   
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Molecular detection of parasite DNA does enable strain genotyping by PCR-RFLP, 
which cannot be achieved by serology based methods.  Genotypic analysis of the 
parasite is important as it can identify recombinant genotypes or atypical strains.  
Different strains of the parasite can be more virulent in different hosts, or when a 
species has not been exposed to the parasite during their evolution (Innes, 1997).  
Examples of this have been observed in Australian marsupials (Parameswaran et al., 
2010), Californian sea otters (Miller et al., 2004); (Sundar et al., 2008) and even 
humans (Carme et al., 2009b; Ferreira et al., 2011).  Our research shows that the 
strain most prevalent throughout Europe and North America (type II), is the main 
lineage identified within the wildlife species tested (see Table 3-4).  However a T. 
gondii type III lineage was identified in one polecat and an allele for type I was 
identified within two different polecats (see Table 3-4), indicating that alleles for the 
three main clonal lineages are present in the British environment.  A recent 
publication, which incorporated genotyping for only one marker (SAG3) in 
woodmice (Apodemus sylvaticus) from an area in North Yorkshire, also described 
the presence of all three alleles within the study population.  A total of 22 samples 
from T. gondii infected mice were genotyped: 12 were identified to contain type I, 
nine as type II and one as type III (Thomasson et al., 2011).  Although information 
relating to strains found in wildlife in Britain is still lacking there are reports of 
parasite genotypes belonging to type III and I lineages in European wildlife and 
livestock (de Sousa et al., 2006; Waap et al., 2008; Berger-Schoch et al., 2011; De 
Craeye et al., 2011), and also evidence of atypical strains (Berger-Schoch et al., 
2011).   Our current study using five RFLP markers did not identify any atypical 
strains or recombinant genotypes within the species tested, however, it should be 
noted that application of additional markers at other loci may identify more novel T. 
gondii genotypes from these samples.  Although we identified type II as the 
predominant linage by PCR-RFLP (see Table 3-4), sequence analysis at the SAG3 
locus provided additional information across the amplicon.  Two isolates identified 
as type II by PCR-RFLP differed by single base pair substitutions (see Figure 3-2), 
which was confirmed by further repeating PCR and sequencing of the original 
samples.  The two sequences (represented by GenBank accession numbers 
KC928252 and KC928254) are unique as they did not show 100% identity to any 
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other sequence within the ToxoDB or NCBI databases.  Additional sequencing of 
these PCR products at the GRA6 locus showed no further base pair polymorphisms 
(data not shown).  Additional nucleotide changes, within the type II lineage, have 
also been reported from T. gondii infected sheep in the Netherlands, where 
sequencing of the GRA6 gene identified a G to A substitution (Opsteegh et al., 
2010a).  This indicates that there is a degree of variability within the type II lineage, 
which is not identifiable by PCR-RFLP analysis alone. 
Not all DNA samples, which tested positive by ITS1 PCR, were successfully 
amplified for genotyping; only 35.6% of positive samples were successfully 
genotyped at three or more loci.  Primers used for the detection of parasite DNA 
were designed around the multicopy ITS1 region (Hurtado et al., 2001), this PCR is 
therefore more sensitive than the genotyping PCR-RFLP, which is based on single 
copy genes, and is merely the result of copy number of the DNA target.  Similarly, 
previous studies found only 22 out of 84 DNA samples from T. gondii positive mice 
could be genotyped at the SAG3 locus (Thomasson et al., 2011), 12 out of 20 T. 
gondii infected fox samples from the Saxony-Anhalt federal state in Germany could 
be genotyped across nine markers (Herrmann et al., 2012), and 31 out of 167 fox 
samples, which were seropositive, could be genotyped across 10 markers (Prestrud et 
al., 2008).  Interestingly, amplification of T. gondii DNA from Pc07 and Pc26 using 
markers 5’SAG2, 3’SAG2, GRA6 and BTUB was unsuccessful despite numerous 
attempts, which included increased concentrations of target DNA.  For these samples 
genotyping was only possible at the SAG3 locus, which identified an allele for type I 
by both PCR-RFLP (see Table 3-4) and direct sequencing (see Figure 3-2).  One 
possible explanation for this is that SAG3 has been reported to be the most sensitive 
genotyping marker (Khan et al., 2005), which suggests that parasite DNA was not 
present at a high enough concentration in the sample to enable detection by 
potentially less sensitive PCR-RFLP markers. 
This study highlights not only the prevalence of T. gondii across a variety of wild 
British mammalian carnivores, but also provides novel data regarding the strains 
present within the environment that could potentially be transmitted to cats, livestock 
and even humans within Great Britain. 
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Chapter 4: Prevalence of T. gondii from human 
hosts in Scotland 
 
Aims 
 Examine the prevalence of T. gondii infection from two different study groups; 
Scottish blood donors (seroprevalence) and human brain samples (molecular 
detection). 
 
 Discover the rate of seroconversion (or reversion) within Scottish blood donors 
and whether any recent infections were a result of oocyst or tissue cysts infection. 
 
 Determine whether age, gender, geographical location, or cause of death may be 
linked to the risk of T. gondii infection. 
 
 Research the genotypes present from T. gondii positive human brain samples. 
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4.1 Introduction 
One third of the human population are predicted to be infected with T. gondii (Tenter 
et al., 2000).  However, current T. gondii prevalence figures for the UK are limited 
and even less information is available specifically for Scotland.   Infection is 
generally asymptomatic, however those who are immunocompromised or women 
who acquire the infection for the first time during pregnancy are particularly at risk 
(Hohlfeld et al., 1989).  Therefore, for women of childbearing age individuals who 
test seronegative for T. gondii are more at risk of miscarriage and future 
complications with the unborn child, if they become infected with the parasite for the 
first time during pregnancy.  The majority of seroprevalence studies have focused on 
pregnant women (Flatt & Shetty, 2012; Fonseca et al., 2012; Gebremedhin et al., 
2013), and are not representative of the population as a whole. 
Research has suggested that T. gondii infection rates for those who live in a rural 
location or work outdoors (such as farmers) are higher, compared to those who live 
and work in more urban/city locations (Nash et al., 2005; Stanford et al., 1990).  It is 
thought this difference is due to an increased risk of exposure from environmental 
oocysts in rural areas. Determining exactly how a seropositive individual became 
infected (whether via oocysts or tissue cysts) has recently become possible, using a 
sporozoite specific antigen (T. gondii embryogenesis-related protein [TgERP]) which 
will enable the identification of individuals infected via oocysts (Hill et al., 2011).  
However this method is only suitable for detecting recent infections (approximately 
six to eight months after initial oocyst infection).  
More recently links have been made between T. gondii infection and various 
psychological problems, such as schizophrenia, suicide and increased risk taking 
behaviour (Flegr et al., 2002b; Lester, 2010; Nascimento et al., 2012).  Currently 
there are no reports in the literature from individuals within the UK regarding these 
psychological conditions and their potential link with T. gondii infection. 
Within this study two different groups of individuals were studied with an objective 
to obtain a current estimate for the prevalence of T. gondii infection in people in 
Scotland.  These two groups included serum samples from a cohort of blood donors 
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(n = 1403) located in Glasgow and Dundee, and human brain tissue from individuals 
located in the Edinburgh area obtained due to sudden death (n= 151).   
Serum samples were obtained from blood donors taken at four different collection 
periods, which spanned the years 2006 – 2009.  Each individual was assigned a 
specific ID number to enable tracking throughout each collection period and which 
also enable the data to be anonymised.  Information regarding age, gender and 
location of residence was also made available from a database generated by Health 
Protection Scotland, who previously selected some of the samples for a longitudinal 
cryptosporidiosis study (Pollock et al., 2013).  Tracking of each individual over time 
also allows for possible detection of T. gondii IgG seroconversion or reversion, as 
without repeated exposure or parasite recrudescence due to immunosuppression, IgG 
levels may fall below detectable levels. In addition collaboration with D. Hill 
(USDA) allowed samples, which had recently seroconverted, to be tested using the 
newly identified sporozoite specific antigen (TgERP) (Hill et al., 2011).  In addition, 
the collection of samples from two different locations (Glasgow = urban environment 
and Dundee = more rural environment), allow for any significant differences to be 
identified between the two regions.  
Human brain tissue was used for the molecular detection of the parasite, and was 
collected over a five year period (2008 – 2012).  This allows generation of additional 
up to date information on the prevalence of the parasite, to determine if there are any 
specific relationships between cause of death and detection of T. gondii, and also to 
identify any trends between age and gender and parasite prevalence.  Strain 
genotyping using PCR-RFLP is also possible on any T. gondii positive samples.  
Although limited information exists on strains that infect immunocompromised 
individuals (such as HIV and organ transplant patients) (Ajzenberg et al., 2002), very 
little data about which strains effect a “healthy” population with no known 
underlying cause of illness is not known.  Information from these individuals would 
also be more representative of the general population. 
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The main aims of this study were to obtain up to date figures for the prevalence of T. 
gondii in the Scottish population, and determine any link between age, gender, 
location or cause of death.  The research will also identify whether seroconversion 
(or indeed reversion) of T. gondii IgG occurs, and finally whether recent infections 
were due to the tissue cyst or oocyst stage of the parasite.  The molecular detection of 
the parasite from human brains allows strain genotyping to be completed, therefore, 
another aim of this research was to identify the genotypes present within the study 
population.
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4.2 Materials and Methods 
 
4.2.1 Human reference sera 
Test reference / control sera was obtained from the Scottish Toxoplasma Reference 
Laboratory (Scottish Toxoplasma Reference Laboratory, Inverness, UK), who 
routinely test human samples for the presence of T. gondii IgG.   The control sera 
supplied had previously been dye tested (see section 1.9.1 for details of this 
technique) and calibrated as international units per milliliter (iu/ml) as defined by the 
World Health Organisation (see Table 4-1).  These controls not only enabled the 
standardisation of an in house T. gondii IgG ELISA, but also acted as reference sera 
for testing other human sera. 
 
Table 4-1: Human reference sera supplied by the Scottish Toxoplasma 
Reference Laboratory.  Sera representing a range of possible infection results. 
 
 
4.2.2 Human test sera  
Human serum test samples (n = 3274) were obtained in conjunction with Health 
Protection Scotland and the Scottish Parasite Diagnostic Laboratory from individual 
blood donors (n = 1403) from two cohorts, Glasgow (n = 1102) and Dundee (n = 







Dye test result 
(IU/ml)
T. gondii  infection 
status
125 30 8
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4.2.3 Human brain DNA samples 
Tissue samples from human brains (n = 151) were obtained from the MRC Sudden 
Death Brain and Tissue Bank over a five year collection period (2008 – 2012) as 
described in section 2.2.2.  Pooled brain tissue consisting of approximately 1g of 
medulla, cerebellum and pons (regions of the hind brain, see Figure 2-1) from each 
individual were used for DNA extraction using the GentleMacs method (see section 
2.11.2). 
 
4.2.4 Human anti T. gondii  IgG ELISA 
In order to test the human sera samples, an in house human anti-T. gondii IgG ELISA 
was optimised during this study.  Control sera, individual test sera and serum blank 
controls were tested in duplicate.  Details of the final methodology used for all test 
sera are described in section 2.10.1.  Miss A. Woodall should be acknowledged for 
her assistance in testing the serum samples using this ELISA.  OD values were 
corrected for blank measurements and plate to plate variation (see section 4.2.7.1).   
 
4.2.5 Detection and genotyping of T. gondii  DNA 
Following the extraction of DNA from human brain tissue (see section 4.2.3), 
samples were used to detect the presence of T. gondii DNA using the diagnostic ITS1 
PCR described in section 2.12.2.  To determine the genotype of T. gondii positive 
DNA samples genotyping was completed using two of the most sensitive and 
informative molecular markers (SAG3 and GRA6), using the methodology described 
in section 2.12.4. 
 
4.2.6 Donor / case information 
For the serology study (blood donors), information was recorded for every blood 
donor, which included details regarding their age, gender and location, this enabled a 
longitudinal serological profile of each individual donor.  For the human brain 
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samples, basic case data was available for each individual which included 
information about age, gender and cause of death.  To ensure individuals could not 
be identified, details for all samples for both the serological detection of T. gondii 
(blood donors), or molecular detection of the parasite (human brain samples) were 
anonymised. 
 
4.2.7 Data analysis 
 
4.2.7.1 Corrected OD values and plate to plate variation 
To analyse any variation between each plate when testing serum samples using the 
human IgG ELSA (see section 4.2.4), positive and negative control samples (see 
Table 4-1) and serum blank controls (both tested in duplicate), were added to each 
plate.  Once all the OD readings were measured, the average OD readings for the 
blank controls on each plate were subtracted from the OD values of the sera on that 
specific plate.  Then, these blank corrected OD values for the serum control samples 
(n = 8 – duplicates of each positive and negative control sample) were plotted against 
their appropriate average blank corrected OD value over all the plates tested (a 
regression line).  Using the appropriate regression line the standardised blank 
corrected OD values for the test sera on that specific plate was calculated (their ODc 
value).  Plates were excluded if; 1) any of the duplicates for more than one of the 
control samples had a coefficient of variation (CV = standard deviation of replicates / 
mean of replicates) above 20%, or 2) if the R
2
 value was less than 0.95.  In addition 
individual sera were excluded from analysis if the CV value was above 20%.  Any 
sera which had an OD value below 0.1 any CV value was accepted (although the OD 
value of both samples from this duplicate had to be below 0.1).  Finally, as some of 
the ODc values were negative a blank value of 0.05 was added for all sera, with all 
values log
10
 transformed.  When a new batch of positive and negative control 
samples were used, their average OD across all plates tested was plotted against the 
average OD of the control samples used on all plates using the previous batch.  Plates 
containing a new batch of positive and negative controls were only accepted if the R
2
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was less than 0.95.  Acknowledgements should be made to Dr M. Opsteegh for 
completion of and assistance with the linear regression plots and plate to plate 
variation (Opsteegh et al., 2010b). 
 
4.2.7.2 Seroprevalence in Scottish blood donors using a binormal 
mixture model 
When a population can be presumed as seropositive or seronegative, the distribution 
can be assumed to follow normal distribution.  As antibody titers are usually 
lognormally distributed (Thrusfield, 2005) the ODc values were log transformed.   
This allows for analysis between the two variables (seropositive or seronegative), 
both of which are presumed to be normally distributed but with a different standard 
deviation and mean.  A binormal mixture model takes these factors into account, and 
estimates two standard deviations, two means and the mixing parameter.  The 
estimated prevalence is determined by the mixing parameter, whereby the area under 
the curve of the positive distribution divided by the total area under both curves.  The 
binomial mixture model was performed in Mathematica (v7.0, Wolfram Research, 
Illinois, USA), as described in Opsteegh et al, 2010.   Acknowledgements should be 
made to Dr M. Opsteegh and Dr A. Swart for completion of and assistance with the 
binormal mixture model (see Figure 4-1). 
 
4.2.7.3 Determining cut off values to asses seropositivity and analysis 
between different groups 
Identifying an individual as either positive or negative for T. gondii enables further 
analysis to be completed, such as difference between seropositivity and gender, age, 
location or identification of seroconversion.  This was carried out using a cut off 
value which allowed each individual to be scored as either seropositive or 
seronegative.  The figure used as the cut off value was obtained using a receiver 
operating characteristic (ROC) curve which incorporated the two distributions from a 
binornal mixture model where the sum of sensitivity and specificity were both 
maximized. 
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4.2.7.4 Identification of sporozoite specific antigen in serum samples 
from individuals that showed signs of seroconversion. 
Using the cut-off value obtained from section 4.2.7.3, 50µl of serum from individuals 
who had been identified as seronegative at one collection period, but who later 
became seropositive in a subsequent collection period (seroconversion), were sent to 
D. Hill (United States Department of Agriculture, Beltsville, USA) for the 
identification of antibodies to the sporozoite specific antigen T. gondii 
embryogenesis-related protein (TgERP).  This protein elicits an antibody response in 
humans (and also mice and pigs), who have previously been exposed to sporulated 
oocysts, therefore identifying individuals that have been infected with this stage of 
the parasite.  Only serum samples from individuals where the ELISA result identified 
recent signs of seroconversion were sent for analysis as the TgERP antibody 
response is only detectable for  6 to 8 months following initial infection (Hill et al., 
2011).  The methodology for the ELISA is described by Hill et al (2011), briefly, 96 
well plates were coated with 2µg/ml TgERP in 0.1M carbonate buffer, pH 9.6 and 
the ELISA completed as described by Gamble et al (2005).  Reference sera for 
positive and negative controls were also incorporated into the ELISA, with all plates 
read using a wavelength of 405ηm.  A positive cut off value was determined using 
the mean OD of the negative reference samples plus three times the standard 
deviation.  Acknowledgements should be made to Dr D. Hill for testing the samples 
from this study.  
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4.3 Serological Results 
 
4.3.1 Seroprevalence, and determination of cut- off value 
using a binormal mixture model  
All results from collection period 1 (n = 947 individuals) were used to formulate a 
binormal mixture model (see Figure 4-1).  Collection period 1 was used to produce 
this model, as once repeat donors had been identified this group contained the 
greatest number of individuals over all collection periods.  Using the statistical 
methodology described in section 4.2.7.2, fitted distributions were plotted and the 
binormal mixture model generated. 
The model describes the overall T. gondii seroprevalence for this donation period, 
which using the binormal mixture model is estimated at 11.0% (104/947) (see Table 
4-2).  As described in section 4.2.7.3 the determination of a cut off value using ROC 
curve analysis could be performed using the data derived from the binormal mixture 
model.  The cut off value was estimated at logODc -0.48, where specificity and 
sensitivity was estimated at 99.0% and specificity at 99.4%.  This cut off value was 
used for further analysis of all donations; determining seropositivity with age, gender 
and location, across all donation periods.  Using the cut off value, T. gondii 
seroprevalence for the first donation period was estimated at 11.9% (see Table 4-2). 
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Figure 4-1: Human serology T. gondii binormal mixture model.  Frequency 
distribution of logODc values generated from Scottish blood donors (n = 947) 
using the human anti-IgG T. gondii ELISA.  Bars represent individual blood 
donors, and the curved line shows the normal distributions.  The black dashed 
line indicates the cut off value (log ODc -0.48) used for subsequent analysis.   
 
Table 4-2: Estimation of T. gondii seroprevalence of blood donors from Glasgow 
and Dundee.  Prevalence was determined using the binormal mixture model and 
then the cut off value (logODc -0.48) extrapolated from the model.  The cut off 
value can be used to further anyalyse the data. *accounts for repeat donations, 
each individual is counted only once. Collection period 1 = 24/04/2006 – 






Total number of 
individuals (n) 
Total number of 







11.0% 947 104 1 
Cut off value 
(logODc -0.48) 
11.9% 947 113 1 
Cut off value 
(logODc -0.48) 
13.0% 1403 183 1-4* 
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4.3.2 Overall seroprevalence determined by cut off value and 
seroprevalence within each collection period. 
Using the cut off value (logODc -0.48) determined in section 4.3.1, the overall 
prevalence of T. gondii during the 4 year collection period (2006 – 2009) was 
estimated at 13.0% (183/1403), as described in Table 4-2 and Table 4-3.  This figure 
took into account repeat donations and included each individual only once 
throughout the entire collection period.  The cut off value (see 4.3.1) was also used to 
determine seroprevalence within each collection period (see Table 4-3).  Again 
repeat donations were common from blood donors throughout an individual 
collection period, and the results ensure that each individual was identified and 
counted only once. In addition, repeat donors which were seropositive were counted 
once as positive, which was based on the first observation of seropositivity.   
Table 4-3: Collection period and T. gondii seropositivity.  Seroprevalence takes 
into account repeat donations from each collection period. *repeat donations 
taken across all collection periods where each individual is counted only once 
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947 947 113 11.9 9.9 – 14.2 
2 26/07/2006 - 
14/08/2007 
















1403 1403 183 13.0 11.3 – 14.9 
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The results show little variation between collection periods and varies from 11.9% 
(113/947) in collection period 1, to 12.9% (105/811) in collection period 2 as 
highlighted in Figure 4-2 and Table 4-3. 
 
Figure 4-2: T. gondii seroprevalence within Scottish blood donors by collection 
period.  Details of each collection period are described in Table 4-3. 
 
4.3.3 Evidence of seroconversion over a four year period 
(2006 – 2009) 
Longitudinal analysis over this four year period allowed individuals to be identified 
and monitored for their T. gondii IgG status (seroconversion or reversion).  Using a 
positive cut-off value of OD 0.41 (D. Hill personal communication) clear 
seroconversion (T. gondii negative to positive) was observed in six individuals (see 
Table 4-4, donor ID’s 404, 414, 342, 963, 1246, and 1312.  One individual became T. 
gondii seropositive at the beginning of collection period four but then reverted back 
to seronegative four months later (see Table 4-4, donor ID 816).  There were also 
three individuals who appeared to become seropositive, however, previous results 
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(potentially borderline positive), and therefore have not be classified as a “true” 
seroconversion (see Table 4-4 donor ID, 215, 721 and 698).
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Table 4-4: Evidence of T. gondii IgG seroconversion or reversion and TgERP antibody response in Scottish blood donors (2006-
2009). 
Donor 
ID pos logODc Odc Town 
Collection 
period Date Status 
TgERP ELISA 
Result 
404 N -0.89 0.13 DUN 1 09/05/2006   0.39 
404 Y 0.25 1.76 DUN 3 13/05/2008   1.38 
404 Y 0.13 1.34 DUN 4 09/09/2008   0.38 
404 Y 0.03 1.06 DUN 4 09/12/2008 SEROCONVERTED 0.27 
414 N -0.63 0.23 DUN 1 09/05/2006   0.22 
414 N -0.77 0.17 DUN 2 15/11/2006   0.17 
414 N -0.99 0.10 DUN 3 20/08/2008   0.12 
414 Y 0.00 1.00 DUN 4 17/12/2008 SEROCONVERTED 0.15 
215 N -0.50 0.31 GLA 1 08/05/2006   0.20 
215 Y -0.27 0.54 GLA 2 04/04/2007   0.29 
215 Y -0.28 0.52 GLA 3 21/07/2008 SEROCONVERTED 0.19 
342 N -0.87 0.13 GLA 1 17/05/2006   0.20 
342 N -0.81 0.16 GLA 2 23/08/2006   0.21 
342 N -1.01 0.10 GLA 4 03/09/2008   0.21 
342 Y -0.02 0.96 GLA 4 03/01/2009 SEROCONVERTED 0.22 
721 N -0.58 0.26 GLA 1 07/06/2006   0.18 
721 N -0.52 0.30 GLA 2 04/09/2006   0.22 
721 Y -0.43 0.37 GLA 3 22/04/2008   0.20 
721 N -0.55 0.28 GLA 3 29/07/2008   0.23 
721 Y -0.22 0.60 GLA 4 25/11/2008 SEROCONVERTED 0.32 
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Table 4-4 continued: 
Donor 
ID pos logODc
a Odc Town 
Collection 
period Date Status 
TgERP ELISA 
Result 
698 N -0.51 0.31 DUN 1 22/05/2006   0.17 
698 Y 0.12 1.30 DUN 2 23/01/2007 SEROCONVERTED 0.16 
963 N -0.66 0.22 GLA 1 10/07/2006   0.25 
963 Y -0.29 0.52 GLA 4 19/02/2009 SEROCONVERTED 0.25 
1,246 N -0.79 0.16 GLA 3 30/07/2008   0.14 
1,246 Y -0.36 0.44 GLA 4 18/12/2008 SEROCONVERTED 0.14 
1,312 N -0.79 0.16 GLA 3 06/08/2008   0.23 
1,312 Y -0.08 0.84 GLA 4 06/12/2008 SEROCONVERTED 0.14 
816 N -0.80 0.16 GLA 1 21/06/2006   0.15 
816 N -0.74 0.18 GLA 2 25/10/2006   0.24 
816 N -0.74 0.18 GLA 3 16/06/2008   0.28 
816 Y -0.37 0.43 GLA 4 08/11/2008 SEROCONVERTED 0.23 
816 N -0.93 0.12 GLA 4 05/02/2009 REVERSION 0.25 
Cut off values:  a) logODc cut off value for T. gondii IgG ELISA = -0.48   b) OD cut off value for TgERP analysis = 0.41. 
Key: Y = positive IgG result, N = negative IgG result 
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4.3.4 Distribution of seroprevalence between two locations, 
Glasgow and Dundee determined by cut off value 
When using the data from all individuals over the four year period, and the cut off 
value described in section 4.3.1, no difference was observed between donations from 
Glasgow and Dundee, where prevalence between the two regions was determined at 
12.9% (142/1102) and 13.6% (41/301) respectively (see Figure 4-3).  However, more 
individuals who donated blood were from Glasgow (n = 1102) than Dundee (n = 
301).  
 
Figure 4-3: T. gondii prevalence from blood donors located in Glasgow and 
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4.3.5 Seroprevalence of T. gondii from blood donors in 
relation to age and gender determined by cut off value 
Over the four year period, donations from individuals were not biased towards either 
gender, with approximately and equal number females (45.9%, 759/1403) and males 
(54.1%, 644/1403).  The majority of donations (40.7%, 571/1403) were obtained 
from the age group 31-48, whilst only 3.64% (51/1403) contributed for donations 
from the 63-69 age group (see Figure 4-4).   
 
 
Figure 4-4: Total number and age of blood donors over a four year period (2006 








































Toxoplasma gondii in animal and human hosts  
Chapter 4: Prevalence of T. gondii from human hosts in Scotland  116 
When observing T. gondii seropositivity in relation to age, there was a clear linear 
relationship between increasing age and an increasing T. gondii seropositivity.  
However the 63-69 age group had the highest prevalence at 23.5% (12/51), whilst the 
lowest prevalence of 6.37% (27/424) was observed in the 17-30 age group (see 
Figure 4-5).   
 
 
Figure 4-5: T. gondii seropositivity of Scottish blood donors in relation to age.  
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When gender is also taken into account, again seropositivity increases with age but 
there is no significant difference between T. gondii infection and gender (see Figure 
4-6).  This is particularly highlighted in the 63-69 age group, where the percent 




Figure 4-6: T. gondii seropositivity of Scottish blood donors in relation to age 
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4.4 Presence of T. gondii DNA in human brain tissue 
 
4.4.1 Prevalence of T. gondii DNA in human brain tissue over 
a five year period (2008 – 2012) 
ITS1 PCR was carried out on 151 brain samples from three pooled regions of brain 
(pons, medulla and cerebellum) per individual. Molecular detection of parasite DNA 
from all samples (irrespective of age, gender or cause of death) over a five year 
period (2008 – 2012 inclusive), has shown an overall detection rate of 17.9% 
(27/151), where prevalence varied throughout the five year period (see Table 4-5).  
In 2008 parasite DNA was detected in 22.6% (8/35) of individuals, in 2009 and 2010 
detection levels were lower 5.4% (2/37) and 15.8% (6/38) respectively.  This level 
then increased in 2011 to 26.1% (6/23) and then peaked in 2012 with a detection rate 
of 27.8% (5/15). 
 







% T. gondii 
positive 
95% CI (lower 
and upper 
values) 
2008 35 8 22.9 10.4 – 40.1 
2009 37 2 5.4 0.6 – 18.2 
2010 38 6 15.8 6.0 – 31.3 
2011 23 6 26.1 10.2 – 48.4 
2012 18 5 27.8 9.7 – 53.5 
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4.4.2 Effect of age and gender on parasite prevalence in 
humans 
Overall, a greater number of samples were obtained from males, which consisted of 
79% (120/151) of all individuals.  This gender bias towards males was evident across 
all ages, except in the 77 – 91 age group (see Figure 4-7).  Interestingly, most brain 
samples were obtained from the 49-62 age group, which accounted for 35.1% 
(53/151) of all samples. 
 
 





17 - 30 31 - 48 49 - 62 63 - 76 77 - 91 
m (n=) 10 32 45 29 4 
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Over the five year period, the prevalence of T. gondii detected in human brains 
increased with age (see Figure 4-8) , however, detection levels dropped within the 
77-91 age group, but this may be due to a reduced samples size (n = 8, as highlighted 
in Figure 4-7) compared to the other age groups. 
 
Figure 4-8: Detection of parasite DNA from human brains in relation to age and 
gender (2008 - 2012). 
 
4.4.3 Relationship between cause of death and parasite 
detection 
Anonymised information from the MRC Sudden Death Brain and Tissue Bank also 
provided details about the cause of death.  As previously described, the overall 
prevalence of T. gondii DNA detected within these brain samples was estimated at 
17.9% (see section 4.4.1), but when analysing what each individual had died from 
the results can be further split, as shown in Table 4-6.  This table highlights that the 
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attack, which accounted for 64.9% (98/151) of all cases.  The second most common 
cause of death was due to suicide (6.0%, 9/151), followed by those who died due to 
drug overdose (5.3%, 8/151). 
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Table 4-6: Cause of death, age and prevalence of T. gondii from human brains (2008 - 2012). 
Cause of death - COD 
No. of COD 
(n) 
% COD  
No. of all 
T. gondii 
cases (n) 
%  T. 
gondii 
positive 
17 - 30 31 - 48 49 - 62 63 - 76 77 - 91 Totals 
Heart attack/disease 98 64.9 18 66.7 1 21 43 29 4 98 
Brain haemorrhage 6 4.0 2 7.4 0 1 2 1 2 6 
Bronchopneumonia 1 0.7 1 3.7 0 0 1 0 0 1 
Drug over dose 8 5.3 1 3.7 3 3 1 1 0 8 
Familial amyloid polyneropathy 1 0.7 1 3.7 0 0 0 1 0 1 
Motor neurone disease 3 2.0 1 3.7 0 0 1 2 0 3 
Suicide 9 6.0 1 3.7 3 5 1 0 0 9 
Unascertained death 4 2.7 1 3.7 1 1 1 1 0 4 
Abdominal aneurysm 1 0.7 1 3.7 0 0 0 1 0 1 
Asthma 1 0.7 0 0.0 0 1 0 0 0 1 
Breast cancer 1 0.7 0 0.0 0 0 1 0 0 1 
Bronchopneumonia & coronary artery 
atherosclerosis 
1 0.7 0 0.0 0 1 0 0 0 1 
Hypertensive haematoma 1 0.7 0 0.0 0 0 0 1 0 1 
Intracerebral haematoma 1 0.7 0 0.0 0 0 0 0 1 1 
Insulin overdose 1 0.7 0 0.0 0 1 0 0 0 1 
Marfans Syndrome 2 1.3 0 0.0 0 2 0 0 0 2 
Multiple injuries 1 0.7 0 0.0 0 1 0 0 0 1 
Pancreatic carcinoma 1 0.7 0 0.0 0 0 0 0 1 1 
Peritonitis 1 0.7 0 0.0 0 0 1 0 0 1 
RTA 5 3.3 0 0.0 4 0 1 0 0 5 
Small vessel disease (brain) 1 0.7 0 0.0 0 1 0 0 0 1 
Stroke 1 0.7 0 0.0 0 1 0 0 0 1 
Sudden adult death 2 1.3 0 0.0 0 2 0 0 0 2 
TOTAL 151 100.0 27 100.0 12 41 53 37 8 151 
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Further analysis of cause of death and the molecular detection of T. gondii DNA in 
the brain of each individual, has highlighted that 66.7% (18/27) of individuals who 
died due to heart disease/heart attack, were also positive for T. gondii (see Table 
4-6).  T. gondii was detected less frequently in individuals who died from brain 
haemorrhage, bronchopneumonia, drug overdose, familial amyloid disease, motor 
neuron disease, suicide, abdominal aneurysm, and unascertained death, as 
highlighted in Figure 4-9 and Table 4-6. 
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4.4.4 Strain genotyping using SAG3 and GRA6 
Although multiple attempts were made to amplify DNA from individuals, which 
were identified as positive for T. gondii by ITS1 PCR, only three samples were able 
to be genotyped by PCR-RFLP using the SAG3 primer and one using the GRA6 
primer (see Table 4-7).  These results identified two type III and two type I alleles 
from four different individuals.  In addition, T. gondii DNA from one individual was 
successfully sequenced at the GRA6 locus (see Figure 4-10), and also at the SAG3 
locus from another individual (see Figure 4-11) further confirming the identification 
of type I and type III genotypes by PCR-RFLP. 
 
Table 4-7: T. gondii PCR-RFLP genotyping across two markers from four 
infected humans. 
        PCR-RFLP genotyping 
Sample ID Gender Age  Cause of death  SAG3 GRA6 Genotype 
019/08 M 58 Heart attack/disease na I* I 
004/10 M 50 Heart attack/disease III na III 
021/10 M 27 Drug overdose I# na I 
013/11 M 58 Heart attack/disease III* na III 
       
#
 = weak band; * = sequencing completed, na = no 
amplification   
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Figure 4-10: GRA6 sequencing of T. gondii detected from a human brain.  Consensus sequence indicates the nucleotides shared by 
a minimum of two of the three archetypal clonal lineages RH (type I), Me49 (II), and CEP (III), GenBank accession numbers 
AF239283, AF239285 and AF239287 respectively.  Sequencing shows that T. gondii type I was identified from a human brain 
(sample ID 19-08), using GRA6 primers. 
 
                         10        20        30        40        50        60        70        80        90                  
                ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Consensus GRA6  TTTTCTTGGGAGTGTCGGCGAAATGGCACACGGTGGCATCCATCTGAGGCAGAAGCGTAACTTCTGTCCTTTAACTGTCTCCACAGTTGC  
I   RH          ......................................................................G...................  
II  Me49        ........................................T.................................................  
III NED         ..........................................................................................  
19-08           ......................................................................G...................  
 
                        100       110       120       130       140       150       160       170       180         
                ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Consensus GRA6  TGTGGTCTTTGTAGTCTTCATGGGTGTACTCGTCAATTCGTTGGGTGGAGTCGCTGTCGCAGCAGACAGCGGTGGTGTTAAGCAGACCCC  
I   RH          ..........................................................................................  
II  Me49        ................................................................................G.........  
III NED         ...............T.......................................................A..................  
19-08           ..........................................................................................  
 
                        190       200       210       220       230           
                ....|....|....|....|....|....|....|....|....|....|....| 
Consensus GRA6  TTCGGAAACCGGTTCGAGCGGTGGACAGCAAGAAGCAGTGGGGACCACTGAAGAC  
I   RH          .......................................................  
II  Me49        .......................................................  
III NED         .......................................................  
19-08           .......................................................  
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Figure 4-11: SAG3 sequencing of T. gondii detected from a human brain.  Consensus sequence indicates the nucleotides shared by 
a minimum of two of the three archetypal clonal lineages RH (type I), Pru (II), and CEP (III), GenBank accession numbers 
AF340227, AF340228 and AF340229 respectively.  Sequencing shows that T. gondii type III was identified from a human brain 
(sample ID 13-11), using SAG3 primers.
                          10        20        30        40        50        60        70        80        90                  
                 ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Consensus SAG3   GGGAACCCCAGAAAGTGGGGGAGAGGCGGAGGCGGCCATCCAGGAAGCGGAGGATTGCAGCCGGGAACTGACGGGGAAACTCAAGCTGGA  
I   RH           .......................................................................A.......G..........  
II  Pru          ...................A...G......................................A...........................  
III CEP          .......................................................C........A.........................  
013-11           .......................................................C........A.........................  
 
                         100       110       120       130       140       150       160       
                 ....|....|....|....|....|....|....|....|....|....|....|....|....|....|.. 
Consensus SAG3   ACAGAAAGTTCAGCCGGCGCGAGTTCGCGAATGGCTTCCGTTGCCCTGGCGTTCCTTCTCGGTCTCCTTGTG  
I   RH           ........................................................................  
II  Pru          ....G...................................................................  
III CEP          ........................................................................  
013-11           ........................................................................  
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4.5 Discussion 
The primary aim of this study was to obtain an estimate of T. gondii seroprevalence 
in the Scottish population using two different study groups.  Firstly using samples 
from Scottish blood donors who represent a broad age range of individuals and also 
includes a similar number of samples from both males and females, (as opposed to 
the majority of T. gondii seroprevalence studies which mainly focus on women of 
childbearing age).  Secondly prevalence was determined by molecular detection of 
the parasite DNA from brain tissue in individuals who had died due to sudden death, 
with no known underlying clinical disease. 
When examining the seroprevalence of T. gondii from Scottish blood donors, the 
result over a four year period (2006 – 2009), was estimated (using the cut off value) 
at 13.0% (see Table 4-2 and Table 4-3).  This figure is slightly lower than the 
prevalence determined by molecular detection in human brains over a five year 
period (2008 – 2013), which was estimated at 17.9% (see Table 4-5).  This difference 
is likely to be due to the variation in the number of samples obtained within each age 
group, and the number of samples available at each age group.  The total number of 
individuals representing samples for the molecular detection of T. gondii were 
significantly lower  than the number of individuals recruited for serological detection 
of the parasite (n=151 and n=1403 respectively).  In addition, within the samples 
used for the molecular detection of the parasite, there was not a representative 
sample size for each age group or gender, as highlighted in Figure 4-7.  The majority 
of samples (35.1%), were collected from the 49 – 62 age group whilst only 7.9 % 
represented the 17 – 30 age group.  In contrast the age of individuals in the serology 
study was more uniform (see Figure 4-4), with the 49 – 62 age group representing 
30.2% of the population and 25.4% of the 17 – 30 age group.  These factors are 
likely to be responsible for the higher figure observed for the prevalence of T. gondii 
when using the human brain samples.  
When examining each group individually further comparisons can be made.  In 
particular the serology study shows a direct link between seropositivity and age (see 
Figure 4-5), with increasing age the as detection of T. gondii also increases.  This 
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correlation between age and prevalence of the parasite has been described in humans 
and animals (Allain et al., 1998; Alvarado-Esquivel et al., 2007; Bellali et al., 2013; 
Katzer et al., 2011), and reflects the importance of the post-natal route of acquisition 
of infection. 
The molecular detection of the parasite from human brains initially follows this 
pattern (see Figure 4-8), however prevalence begins to fall in the 77 – 91 age group.  
The observed reduction in prevalence is likely to be due to only eight individuals 
being tested and does not constitute as a representative sample size.  Had there been 
a greater number of samples available for testing, it would be likely that the trend 
observed in the current serology study would be repeated.  
 Another objective of the serology study was to examine if there was any significant 
difference between the two different locations in which individual donors lived 
(Glasgow – more samples from an urban location, Dundee – more samples from a 
rural location).  The results did not identify any significance between the two 
regions, which is in keeping with research carried out by Allain et al (1998), who 
also reported similar findings during a study examining the prevalence of T. gondii in 
pregnant women in east England.  Differences between the two locations may not 
have been observed as individuals could reside in rural locations but commute to 
urban/city areas on a daily basis for work. 
Once the serology data was analysed using the cut-off value (log ODc -0.48), 
calculated using the binormal mixture model (see Figure 4-1), it was possible to 
identify individuals who, over time, had become seropositive (or indeed those who 
had reverted back to seronegative) as shown in Table 4-4.  Clear seroconversion was 
evident in six individuals, an additional three also appeared to seroconvert however 
in these cases their sera, which tested from previous collection periods, was found to 
be borderline positive.  One donor (donor ID = 816) appeared to clearly seroconvert 
and then in the following period reverted back to seronegative (see Table 4-4).  For 
each of these ten donors all sera from every collection period were sent to D. Hill 
(United States Department of Agriculture, Beltsville, USA) for ELISA analysis using 
the sporozoite specific antigen.  The results from this analysis only identified one 
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positive serum sample (from donor = 404), indicating that this individual had been 
infected by ingestion of sporulated oocysts other than infection with bradyzoites 
(tissue cysts).  It was also observed that following the positive result from the T. 
gondii IgG ELISA, the ODc value for this sample (collection period 13/05/2008), 
was greater than any other sample tested (ODc = 1.76) as shown in Table 4-4.  
Although antibodies to the sporozoite antigen could not be detected in the remaining 
samples (indicating bradyzoite infection), it should also be noted that the ODc values 
following the T. gondii IgG ELISA were lower when compared to the sample which 
gave a positive result for the sporozoite antigen which could have affected the 
sensitivity of the assay.  In addition it has been shown that antibodies to TgERP are 
only detectable in humans (and pigs) for six to eight months after infection, with 
antibody detection rates lower in persistently infected individuals then those with 
acute infection (Hill et al., 2011).  It is possible to test for acute infection using an 
ELISA, which can detect T. gondii specific IgM antibodies.  This antibody response 
is produced one week after infection and then begins to decrease after approximately 
one month, with levels of IgM generally undetectable by about six months (Rossi, 
1998).  Therefore it may be useful to test the sera which were analysed for the 
presence of antibody to TgERP using an IgM ELISA, this would help to determine 
whether the negative results were due to a persistent infection or as a direct result of 
bradyzoite infection from consumption of infected undercooked meat. 
When a sample of human brain tissue was collected from the Sudden Death Brain 
Bank, cause of death for that specific individual was also recorded (in addition to age 
and gender).  This information was particularly useful for potentially comparing T. 
gondii prevalence to schizophrenia, suicide and fatalities from road traffic accidents.  
The cause of death reported from individuals included those who had died due to 
suicide or fatal road traffic accidents, but also a broad range of other factors, which 
caused sudden death, as listed in Table 4-6.  Although in the current study 
information is not available on the mental health status of each individual, it can be 
presumed that this sample set covers a broad range of individuals. The results from 
this study show no clear association between suicide and molecular detection of T. 
gondii, which is similar to results by Samojłowicz et al (2013)  who found no 
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significant difference between T. gondii prevalence and sudden death from victims of 
road traffic accidents.  However, suicide only accounted for 6.0% (9/151) of all cases 
(see Table 4-5).  What does initially appear to be apparent, is the number of cases 
where heart attack/disease is reported as the cause of death and detection of T. gondii 
from their hind brain.  The results show that 66.7% of individuals who were positive 
for T. gondii also died due heart attack/disease (see Table 4-6 and Figure 4-9).  
However, as can clearly be observed in Figure 4-9, a significantly greater number of 
brain samples came from cases of sudden death due to heart attack/disease, 64.9% 
(98/151) of all cases (which is the most frequent cause of death in the UK).  
Therefore it is unlikely that the prevalence of T. gondii has any role or link to those 
who die due to heart attack/disease.  Nevertheless, several publications have reported 
potential involvement with T. gondii and complications with the heart (Chandenier et 
al., 2000; Chapman et al., 1995; Dixit et al., 2007), and more recently a publication 
described a possible link to acute myocardial infarction (AMI) and T. gondii 
infection (Hamidinejat et al., 2013), where 66.7% (32/48) of cases of AMI where 
also associated with the presence of  anti-T. gondii IgG.  However any possible link 
between the parasite and heart complications will require further investigation, and 
would have to take into account lifestyle habits. 
Results from both the serological and molecular detection of the parasite provide 
more up to date information on the prevalence of the parasite within the Scottish 
population.  The results from the serology study show that there is very little 
variation within prevalence and the different collection periods (2006 – 2009), which 
varies from 11.9% (113/947) in collection period 1 to 12.9% (105/811) in collection 
period 2 (see Table 4-2).  In contrast, prevalence determined by molecular detection 
of the parasite did vary quite dramatically from year to year, with 5.4% (2/37) being 
the lowest level recorded in 2009 and 27.8 (5/18) in 2012 (see Table 4-5).  The year 
by year variation observed by molecular detection is likely to be due to both the 
inhomogeneous distribution of tissue cysts and in the case of year 2012 too small a 
sample size to be considered representative of that year.  When comparing the 
prevalence from both sets of results (serological detection vs. molecular detection), 
seropositivity from blood donors across all four collection periods (which excluded 
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repeat samples) was determined at 13.0% (183/1403) (see Table 4-2), whilst 
molecular detection was slightly higher at 17.9% (27/151) (see Table 4-5).  The 
higher prevalence rate from molecular detection of T. gondii is most likely due to 
sample collection from individuals who were older, with 64.9% of samples obtained 
from those aged 49 or over, compared to only 29.1% of samples collected from 
blood donors aged 49 or over.  As previously discussed, the correlation between 
increasing age and an increase in the prevalence of T. gondii has been reported in 
humans and animals, which provides a likely explanation for the higher prevalence 
observed within the results for molecular detection of the parasite. 
Recently a study in the UK which involved 2610 pregnant women in London 
reported a seroprevalence of  17.3% (Flatt & Shetty, 2012), which is similar to our 
reported figure for the molecular detection of the parasite (17.9%).   However, in this 
publication when the figure was adjusted to include only those of UK origin (67.7%), 
the figure dropped to 11.9%, which is identical to our reported seroprevalence figure 
for collection period 1 (see Table 4-2).  Previous seroprevalence studies from the UK 
where positivity was also measured using T. gondii IgG, levels have varied from 
7.7% (1031/13328) from pregnant women in east England in 1998 (Allain et al., 
1998), and 9.1% from pregnant women in Kent, England (Nash et al., 2005).   The 
results reported within this body of work are from both genders, across a broad age 
range (17 – 91 years), and are therefore more representative of the general population 
than studies carried out on pregnant women.  Both in this study and others the 
prevalence of T. gondii is low when compared to other European counties, where 
prevalence can be as high as 55.4% in France, 23.6% in Spain and 26% in the 
Netherlands (Bellali et al., 2013; Hofhuis et al., 2011; López-Fabal & Gómez-
Garcés, 2013), therefore there is a greater risk of women in the UK to become 
infected for the first time during pregnancy, with a greater risk of congenital 
toxoplasmosis.   
Although strain genotyping was not particularly successful (due to a high 
concentration of host DNA compared to a low concentration of parasite DNA), two 
different alleles (type I and type III) from four different individuals were identified 
(see Table 4-7).  In addition, direct sequencing of two of these amplified PCR 
Toxoplasma gondii in animal and human hosts  
Chapter 4: Prevalence of T. gondii from human hosts in Scotland  132 
products, using GRA6 and SAG3 markers, further confirmed the results observed by 
PCR-RFLP (see Figure 4-10 and Figure 4-11).  In order to obtain further genotyping 
information from T. gondii positive samples, which fail to produce any PCR 
amplicons when using the less sensitive PCR-RFLP primers, future work should 
incorporate magnetic capture PCR (MC-PCR) to isolate any T. gondii DNA that may 
be present.  It is possible that this methodology may increase the sensitivity, 
therefore resulting in more amplicons for genotyping.  MC-PCR has previously been 
used for strain genotyping of T. gondii (specifically targeting the GRA6 gene), 
whereby parasite DNA is isolated from host DNA using a GRA6 specific biotin 
labelled capture-oligonucleotide and streptavidin coated magnetic beads (Opsteegh et 
al., 2010a).  Due to the invasive process required for obtaining human tissue 
samples, information on parasite strains isolated from humans is limited, but it is 
thought that strains (in particular atypical strains) are likely to cause a difference in 
the severity of disease and hence the clinical symptoms observed (Boothroyd & 
Grigg, 2002; De Salvador-Guillouet et al., 2006; Grigg et al., 2001), similar to what 
is also seen in other species (Fernandez-Aguilar et al., 2013; Howe & Sibley, 1995; 
Miller et al., 2004). 
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Chapter 5: Vaccination and challenge of pigs to 
evaluate T. gondii tissue cyst formation 
 
Aims 
 Evaluate the effectiveness of a live attenuated strain of T. gondii (S48) in its 
ability to reduce viable tissue cysts in porcine tissues. 
 
 Investigate whether detection of parasite DNA using homogenised porcine 
tissues, prior to inoculation into mice, will be as sensitive as mouse bioassay. 
 
 Using a mouse bioassay, determine which porcine tissues the parasite 
preferentially disseminates to following challenge with either oocysts or tissue 
cysts.  
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5.1 Introduction 
Due to the omnivorous nature of pigs, they can become infected not only via 
consumption of T. gondii oocysts in the environment but also from accidentally 
consuming bradyzoites (tissue cysts) from infected rodent cadavers (Kijlstra et al., 
2008).  In addition pigs which are outdoor reared are more likely to become infected 
with the parasite compared to those reared indoors (Kijlstra et al., 2004; van der 
Giessen et al., 2007).  Although clinical signs following T. gondii infection in pigs 
are rare, and certainly not a large enough problem to warrant a commercial vaccine 
against the parasite, the formation of parasitic tissue cysts in the muscles of infected 
animals can pose a significant risk for food safety and is thought to be one of the 
most important sources of T. gondii infection for humans, particularly when pork is 
eaten undercooked or raw (Dubey et al., 1991).  Therefore, a vaccine which can 
reduce or eliminate the formation of infective tissues cysts in pigs would be 
beneficial for pork and pork products intended for human consumption.  Previous 
research into the reduction of the formation of tissue cysts in pigs has included work 
using live and killed vaccines approaches (Dubey et al., 1994; Dubey et al., 1998b; 
Garcia et al., 2005; Jongert et al., 2008; Kringel et al., 2004) (as further described in 
section 1.11.2).  It is currently not known whether the commercially available 
vaccine Toxovax
®
, which is used to protect against ovine abortion caused by T. 
gondii, offers any protection against tissue cyst formation and was highlighted as a 
“data gap” in a recent report commissioned by the UK Food Standards Agency 
(AMCSF, 2012).  Toxovax
®
 is comprised of tachyzoites from the “incomplete” strain 
of T. gondii S48.  S48 was originally isolated from a case of ovine abortion in New 
Zealand, where after approximately 3000 passages in mice it lost the ability to 
develop into tissue cysts (bradyzoites) in mice and oocysts in cats (Buxton & Innes, 
1995).    
Currently, the gold standard for assessing the viability of T. gondii tissues cysts is by 
mouse bioassay, however, not only does this method require experimental animals 
with in vivo mouse studies, but it is also time consuming, expensive and hazardous 
due to the preparation of potentially infective tissue cysts (Esteban-Redondo et al., 
1999).  An attempt to move away from this methodology would also be beneficial in 
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reducing the amount of animals used for the bioassay.  Molecular technologies have 
become more sensitive for the detection of parasite DNA, for example by use of 
nested PCR, qPCR and magnetic capture qPCR (Calderaro et al., 2006; Hurtado et 
al., 2001; Opsteegh et al., 2010a), and these alternative options should be explored.   
It is known that infection by both oocysts and bradyzoites will result in the formation 
of tissue cysts within the meat of an infected animal.  Experiments in the 1980’s 
using mouse bioassays highlight these findings (Dubey, 1988; Dubey et al., 1986), 
but as previously mentioned, molecular technologies have developed over the past 
twenty years, therefore re-assessing the distribution of parasite tissue cysts within 
specific tissues from infected animals should be re-addressed.  This information 
would be useful to researchers for determining which particular tissues would be 
most useful for detection of parasite DNA, in for example, animal experiments or 
abattoir studies.  Also knowing whether the bradyzoite (tissue cyst) stage of the M4 
strain of T. gondii was as effective at establishing itself in the host as the oocysts 
stage, would be beneficial for future animal challenge experiments.  If bradyzoite 
challenge is as effective as oocyst challenge in causing infection (both in terms of the 
resulting host immunological response, and establishment of tissue cysts), then future 
experiments using the M4 strain in pigs would not require the preparation of oocysts, 
which involves yet another animal model, the cat.    
It has been shown that low numbers of oocysts, (even one single oocyst), are 
sufficient to cause infection and subsequent development of viable tissue cysts in 
pigs (Dubey et al., 1996).  In the current study the experimental infection with either 
1000 M4 T. gondii oocysts or tissue cysts was designed to reflect a challenge, which 
may be similar to that obtained in the environment, but also a dose which would 
avoid severe clinical signs such as anorexia, severe prostration, and even death as 
observed in a previous studies where pigs were challenged with more than 10
4
 
oocysts (Dubey et al., 1998b; Garcia et al., 2008)   
 
The objective of this study was threefold; evaluate the effectiveness of a live 
attenuated strain of T. gondii (S48) in its ability to reduce viable parasitic tissue cysts 
in porcine tissues; to investigate whether detection of parasite DNA using 
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homogenised porcine tissues prior to inoculation into mice would be as sensitive as 
mouse bioassay; and to compare between the two infective stages of the parasite and 
their ability to develop into infective tissues cysts.   
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5.2 Experimental design 
An overview of the timescale of the experiment can be seen in Appendix 8.2. 
5.2.1 Pig vaccination and challenge 
A total of 23 pigs were used in the experiment which were separated into five 
experimental groups (G) (see Table 5-1 and Figure 5-1); G1 (n = 5) un-vaccinated 
and tissue cyst challenged animals, G2 (n = 5) un-vaccinated and oocyst challenged 
animals, G3 (n = 5) vaccinated and oocyst challenged animals, G4 (n = 5) vaccinated 
non-challenged animals, G5 (n = 3) un-vaccinated and non-challenged animals.  The 
five animals in G3 and G4 were vaccinated SC with 1.2x10
5
 S48 tachyzoites (see 
section 2.4.1) 4 weeks prior to experimental challenge -28dpi).  Four weeks 
following vaccination (0 dpi) animals in G2 and G3 were orally challenged with 
1000 T. gondii M4 oocysts (see section 2.6 for oocyst preparation), whilst animals in 
G1 were orally challenged with 1000 T. gondii M4 tissue cysts (see section 2.6).  All 
23 animals were culled six weeks post challenge (42 dpi) and porcine tissues 
collected at post mortem (see Table 2-2 for list of tissues collected at PM) 
 





















Vaccination and / or challenge
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Figure 5-1: Overview of experimental design for vaccination and T. gondii 
challenge of pigs. 
 
5.2.2 Mouse bioassay to assess the viability of T. gondii 
tissue cysts 
Mouse bioassay is the gold standard for determining the viability of T. gondii tissue 
cysts (as further descried in section 1.10.2).  In this study specific porcine tissues 
were removed at post mortem (see Table 2-2 for a complete list of tissues removed at 
post mortem) and a selection of these tissues from pigs in groups 1, 2 and 3 (tissue 
cyst challenged, oocyst challenged and vaccinated and oocyst challenged pigs 
respectively) were used in a mouse bioassay.  The tissues used for the bioassay were 
separated into three different 50g groups depending on the tissue type (as described 
in Table 5-2), and included the following groups; “Brain” (50g of brain), “Food” 
(12.5g each of chop, loin, left tricep and left semitendinosus) and “Other” (12.5g 
each of diaphragm, heart, tongue and masseter). 
By using specific porcine tissues from experimental groups 1, 2 and 3, not only could 
the effect of vaccination on parasite tissue cysts viability be assessed, but also the 
42 dpi 
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viability of tissue cysts from the two infective stages of the parasite, oocyst and 
bradyzoites. 
 
Table 5-2: Porcine tissues used for mouse bioassay. 
 
*A total of 50g of brain was used.  For the “food” and “other” groups 12.5g of 
the appropriate tissue was collected and used to make a total of 50g to process 
for mouse bioassay. 
 
Tissues from pigs in groups 4 and 5 (vaccinated non-challenged and the negative 
control group animals) were not included in the bioassay.  However, in these two 
groups, the same tissues which were processed for mouse bioassay were also tested 
for the presence of T. gondii DNA by ITS1 PCR (see section 2.12.2). 
 
5.3 Materials and Methods 
 
5.3.1 Temperature monitoring  
Rectal temperatures of all pigs were monitored 5 days prior to vaccination (-33 dpi) 
and up to 14 days following vaccination (-14 dpi) as described in section 2.1.2.1  
Due to the increase in the size of the animals, temperatures were recorded using a 
Thermochip
®
 (see section 2.1.2.1) -2 dpi until 14 dpi. 
Brain*
Chop, loin, left tricep, left 
semitendinosus
Other Diaphragm, heart, tongue, 
masseter
Mouse bioassay tissue group Porcine tissue
Brain
Food
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5.3.2 Clinical observations 
5.3.2.1 Pigs 
All pigs were observed daily throughout the duration of the experiment and their 
health status evaluated as described in section 2.1.2.1. 
5.3.2.2 Mice 
Mice were monitored twice daily (up to three times daily for the first 14 days after 
challenge with the bioassay inocula) and their health status evaluated as described in 
section 2.1.3.1.  Any animal which obtained a score of 3 or above was euthanized 
prior to the end of the experiment, with signs of infection including hunched 
appearance, tottering gait or reluctance to move.  
 
5.3.3 Preparation of bioassay inocula 
An acid/pepsin digest was carried out on a total of 50g of different porcine tissues as 
described in section 2.8.1 and by Dubey et al (1998).  The specific tissues used for 
bioassay are described in section 5.2.2 (see Table 5-2).  The resulting digested 
material was re-suspended in 3mls of 4x penicillin / streptomycin solution and 400µl 
of each inocula was injected into three mice by IP route. 
 
5.3.4 Molecular detection of T. gondii  
DNA was extracted from porcine tissues, mouse brains and bioassay inocula as 
described in section 2.8.1.  An ITS1 PCR (see section 2.12.2) specific for T. gondii 
was used to identify the presence of parasite DNA from these samples, PCR was 
carried out in triplicate for each sample and included a positive control and multiple 
negative controls (see section 2.12.1). 
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5.3.5 Serology 
Sera was collected from all pigs from 5 days prior to vaccination (-33 dpi) and then 
on a weekly basis until the end of the experiment (42 dpi).  Sera from the mice used 
in the bioassay was obtained at the end of the experiment (week 6), or when animals 
were euthanised due to clinical signs of T. gondii infection.  The commercially 
available ID Vet ELISA kit was used to detect IgG antibodies raised against the T. 
gondii SAG1 antigen (see section 2.10.2). 
 
5.3.6 Statistical analysis 
5.3.6.1 Comparison between T. gondii IgG levels from pigs within 
different challenge groups using the Student t-test. 
To analyse the statistical significance between the different porcine challenge groups 
following the T. gondii IgG ELISA were calculated using the Student t-test.  Levels 
of significance are quoted as “Probability” (p) where a p-value ≤0.05 indicated 
95.0% probability; ≤0.01 indicated a probability of 99.0% and ≤0.001 of indicates a 
probability of 99.9%. 
 
5.3.6.2 Mouse bioassay survival  
A Kaplan-Meir survival curve was plotted to compare the mean proportions of mice 
survivability for different groups. To compare the mean survival proportions of mice 
between different groups (tissue cyst challenged, oocyst challenged and vaccinated 
and oocyst challenged), a Fisher’s exact test was conducted within each organ (brain, 
food and other) as well as pooling the data across all organs.  This analysis was 
completed by Mintu Nath from Biomathematics and Statistics Scotland (BioSS, The 
Kings Buildings, Edinburgh, UK).  
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5.4 Pig Challenge Results 
 
5.4.1 Clinical responses in pigs following vaccination and 
challenge were minimal. 
5.4.1.1 Temperature 
Rectal temperatures of all animals were recorded from days -5 to 14 days post 
vaccination (-33 dpi to -14 dpi respectively) as described in section 5.3.1.  The mean 
animal temperature within each group did not appear to fluctuate within this time 
frame as shown in Figure 5-2.  It can also be seen that there was no obvious 
difference between the mean temperature of the animals which were vaccinated 
(groups 3 and 4) compared to those which had not been vaccinated, (groups 1, 2 and 
5).  Due to the increasing size of the animals, temperature monitoring following 
challenge (-2 dpi to 14 dpi) was not as accurate, as the technique used for recording 
temperature was an implanted Thermochip
®
.  Temperatures using this method 
fluctuated greatly due to the location of the chip resulting in vast variations of 
temperature readings, which were not reliable or informative and could not be used 
in the analysis of the experiment. 
 
Figure 5-2: Average porcine temperature per experimental group following 
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5.4.1.2 Clinical observations 
All animals were monitored daily throughout the experiment and their health status 
was scored as described in 2.1.2.1.  Throughout the experiment all animals scored 0 
for demeanour, except on 7 dpi, where five animals in groups 1 and 2 had a score of 
1.  These animals appeared subdued/depressed for approximately 24 hours, although 
they were interested in food and movement was unaffected. 
 
5.4.2 Vaccinated and challenged pigs seropositive by d21 
dpi, with no significant difference in % seropositivity 
between oocyst and tissue cyst challenged animals. 
Using the ID Vet ELISA described in section 2.10.2, all pigs tested negative for the 
presence of T. gondii IgG, at the beginning of the experiment (see Table 5-3).   
 
Table 5-3: T. gondii IgG levels in pigs prior to vaccination.  All animals were 
negative for T. gondii IgG prior to the start of the experiment (-33 dpi) 
Group % SP at -33 dpi 
1   (Tissue Cysts) 0.7 
2   (Oocysts) 0.4 
3   (Vacc + Oocysts) 0.3 
4   (Vacc) 0.2 
5   (Neg CTL) 0.6 
 
SP = % seropositivity as determined by the commercially available ID vet T. 
gondii IgG ELISA. 
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At 21 dpi all animals, apart from those in group 5 (negative control animals), tested 
IgG positive and the average % seropositivity per group was calculated (as described 
in section 2.10.2).  The average % seropositivity for animals in group 1 was 130%, 
whilst the group 2 average was 128%, group 3 had the highest average at 156% and 
group 4 an average of 137% (see Figure 5-3).   The average % seropositivity for 
those animals in group 5 was 4%, indicating that they had remained seronegative for 
T. gondii IgG.  These results not only show that the animals in groups 1 and 2 had 
successfully mounted an immune response to challenge from either tissue cysts or 
oocysts, but there was no significant difference between the two results (p = 0.787, 
see Table 5-4). Those animals in group 4 had produced an immune response to 
vaccination with the live attenuated strain of the parasite (S48) which was not 
significantly different to those animals in groups 1 (p ≤ 0.05) and 2 (p ≤ 0.05) as 
shown in Table 5-4.  Group 3 animals displayed the highest % seropositivity (156%) 
which was significantly higher (p ≤ 0.01) than animals in groups 1, 2 and 4 (see 
Table 5-4 and Figure 5-3). 
 
Table 5-4: Statistical analysis of T. gondii IgG levels from pigs within different 
challenge groups at 21 dpi.   
Comparing Group 
With Group p-value / 
Probability 2 3 4 5 
1             
    0.787 0.011 0.434 0.0000 p-value 
    n/a 95.00% n/a >99.9% Probability 
2             
      0.024 0.396 0.0000 p-value 
      95.0% n/a >99.9% Probability 
3             
        0.040 0.0000 p-value 
        95.0% >99.9% Probability 
4             
          0.0000 p-value 
          >99.9% Probability 
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Figure 5-3: Average T. gondii IgG levels in pigs 21 days after challenge.  Error 
bars plotted using the Standard Error of the Mean (SEM). 
 
In addition, animals from group 1 and 2 were also tested for the presence of T. gondii 
IgG at 7 and 14 days PC (Figure 5-4).  At 7 days PC both groups were seronegative, 
however, at 14 days PC the average percent seropositivity had increased within both 
groups (group 1 SP = 89%, group 2 SP = 72%) indicating a T. gondii IgG positive 
result.  At day 7 post challenge there was no significant difference observed in 
percentage seropositivity between group 1 and group 2. 
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Figure 5-4: Average T. gondii IgG levels in pigs 14 days after challenge.  Error 
bars plotted using the Standard Error of the Mean (SEM). 
 
5.4.3 T. gondii  DNA detected in a limited number of pig 
tissues. 
As highlighted in the experimental design (see section 5.2) all animals were culled 
six weeks post challenge. At post mortem thirty five different tissue samples (see 
2.1.3.2) were collected from each animal, of which 16 were used for bioassay and 
molecular detection of T. gondii directly from pig tissue (see Table 2-2).  T. gondii 
was only detectable by ITS1 PCR in five tissues from two different animals from 
group 1, which had been challenged with T. gondii tissues cysts alone (see Table 
5-5).  The results show that parasite DNA was detected in four different tissues 
(brain – CNS1, heart, chop and masseter) from animal 830, and also from one tissue  
(heart) from animal 832, both pigs belonged to group 1 (tissue cyst infected animals).  
T. gondii DNA was not detected in any of the other tissues from pigs in group 1, 
therefore 6.25% (5/80) of all tissues from group 1 were positive for T. gondii.  In 
addition, parasite DNA could not be detected by ITS1 PCR from any tissues from 

























Day Number Post Challenge (PC) 
Group 1 (Tissue cysts) 
Group 2 (Oocysts) 
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Table 5-5: Detection of parasite DNA from porcine tissues.  A total of five 
tissues from two different animals were positive by ITS1 PCR, all other porcine 
tissues from the remaining experimental groups were ITS1 negative. 
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5.5 Mouse Bioassay Results 
 
5.5.1 Mouse survival rate as an indication of viable T. gondii 
tissue cysts from pig tissues - mouse bioassay  
 
5.5.1.1 Overall Survival rates 
The mouse bioassay has been described as the gold standard in determining the 
viability of T. gondii tissue cysts (see section 1.10.2).   Porcine tissues were collected 
at post mortem, and sixteen tissues were processed for mouse bioassay as described 
in Table 2-2.  In total 68.9% (93/135) of mice survived until the end of the six week 
experiment (see Figure 5-5), although 42 mice were culled prior to the end of the six 
week bioassay (2 mice on day 10, 19 on day 11, 19 on day 12 and 2 on day 18) as 
their health status score (see section 2.1.3.1) was recorded as 3 or above due to signs 
of T. gondii infection.   
 
Figure 5-5: Overall mouse survival. 
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5.5.1.2 Mouse survival is greater in mice inoculated with tissues from 
vaccinated and challenged pigs, with no significant difference in 
mortality between mice inoculated with tissues from oocyst or 
bradyzoite challenged pigs.  
When further analysing the results in relation to mouse survival with each individual 
challenge inocula (Table 5-2), the results show that at the end of the 6 week bioassay 
100% (45/45) of group 3 mice (animals which had been inoculated with tissues from 
pigs which had been vaccinated with S48 and then challenged with oocysts of the 
M4 strain of T. gondii) had survived (see Figure 5-6 and Figure 5-7).  However, mice 
in both groups 1 and 2 (animals had received homogenised tissues from pigs infected 
with M4 T. gondii tissue cysts or oocysts) began to die within 10 days post challenge 
(see Figure 5-6).  The mouse survival rate at the end of the 6 week bioassay within 
groups 1 and 2 were 55.6% (25/45) and 51.1% (23/45) respectively (see Figure 5-6 
and Figure 5-7).  By week 6 there is a significant difference (p = 1.545e-08)  between 
those mice which received porcine tissues from animals in group 3 (vaccinated and 
oocyst challenged pigs) compared to mice which received tissues from animals 
infected by the same stage of the parasite (oocysts) which had not been vaccinated 
(group 2), as shown in Figure 5-6.  What can also be observed from this figure is that 
there is no significant differnce (p = 0.833)  between the mouse survival rates from 
animals in group 1 and 2, representing the two infective stages of T. gondii (tissue 
cyst or oocyst infection). 
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Figure 5-6: Mouse survival rates in relation to challenge inocula. There is no significant difference between groups 1 and 2, whilst 
there is a significant difference between groups 2 and 3. 
p = 0.8328 
p = 1.545e-08 
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When further comparing mouse survival and the two infective stages of T. gondii 
(tissue cysts and oocysts) and also taking into account the different tissue groups 
used to inoculate mice (brain, food and other – see Table 5-2), the “other” and 
“brain” tissue groups appear to cause a significantly higher number of deaths than the 
food group, as shown in Figure 5-8.  The mouse survival curves in Figure 5-9 for 
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Figure 5-9: Mouse survival rates from animals in group 1 in relation to specific porcine tissues.  “Brain” and “Other” group 
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Figure 5-10: Mouse survival rates from animals in group 2 in relation to specific porcine tissues.  “Brain” and “Other” group 
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5.5.2 Molecular detection of T. gondii from mouse brain is 
more sensitive than DNA extracted from bioassay 
inocula. 
From the 42 mice which were culled prior to the end of the six week mouse bioassay 
(see section 5.5.1.1), T. gondii DNA was detected in 100% (42/42) of these mice by 
ITS1 PCR, using DNA which had been extracted from each individual mouse brain 
as summarised in Table 5-6 and in more detail showing each individual mouse result 
in Table 5-7.  In should also be noted that three mice, which survived until the end of 
the experiment, were also ITS1 positive.  These mice had been inoculated with 
porcine tissues from animals in either group 1 or group 2 (tissue cyst challenged or 
oocyst challenged pigs respectively).  When mouse brain DNA was extracted from 
the remaining 90 (66.7%) mice, which had survived until week 6 PI, all brains were 
negative for T. gondii DNA (see Table 5-7).   
 
 
Table 5-6: Summary of T. gondii DNA detected by ITS1 PCR in mouse brains 
following bioassay with porcine tissues. 
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Table 5-7: Detection of T. gondii DNA by ITS1 PCR following bioassay from 
individual mouse brains – individual mouse data. 
 























































































































































































































































































ITS1 Positive ITS1 Negative
d = culled due to signs of Toxo; * = survived until Wk6 but ITS1 positive; tc = tissue cysts observed by light microscopy.
b = mice inoculated with homogenised tissues from the porcine "brain" group.
f  = mice inoculated with homogenised tissues from the porcine "food" group.
o = mice inoculated with homogenised tissues from the porcine "other" group.




Group 1                
(Tissue Cysts)
Mouse No.
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DNA which had been extracted from the inocula used to challenge the mice was also 
tested for the presence of T. gondii DNA by ITS1 PCR.  All inocula (n = 45) were 
tested (15 inocula per experimental group).  The results from this show that the 
inocula comprised of porcine tissues from pigs in group 1 (tissue cyst challenged 
pigs), 33.3% (5/15) inocula were positive for T. gondii DNA, whilst the inocula 
generated from group 2 pigs (oocyst challenged pigs), 46.7% (7/15) of inocula were 
positive.  However, T. gondii DNA could not be detected in any of the inocula (0/15) 
comprised from tissues of the group 3 pigs (vaccinated and challenged pigs) as 
highlighted in Table 5-8).   
 
Table 5-8: Comparison between detection of T. gondii DNA by ITS1 PCR from 




A comparison between parasite DNA detected directly from the brains of 
experimental mice in the bioassay and the presence or absence of DNA detected 
from exactly same the material used to challenge mice can be seen in Table 5-8.  
This comparison shows that although parasite DNA could be detected in the inocula 
from both pigs in group 1 and 2, mouse bioassay with the inocula and subsequent 
detection of T. gondii DNA in the brain is more sensitive than testing for the 
1   (Tissue cysts) 33.3 (5/15) 53.3 (8/15) 20 (3/15) 
2   (Oocyst) 46.7 (7/15) 60.0 (9/15) 13.3 (2/15) 
3   (Vacc+oocyst) 0 (0/15) 0 (0/15) 0 (0/15) 
Total 26.7 (12/45) 37.8 (17/45) 11.1 (5/45) 
Inocula generated from  
pigs - group no. 
Inocula ITS1 positive  
(%) 
Mouse brain identified as ITS1  
positve a  (%)  
Infections undetected by  
PCR of inocula alone (%) 
a  = to enable the comparison one ITS1 positive mouse indicates a positive result for using the same challenge  
inocula.   
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presence of parasite DNA in the inocula alone, as 20% of infections were undetected 
from group 1 and 13.3% from group 2. 
 
5.5.3 Limited serological detection of T. gondii  in mice 
following bioassay. 
Serum samples from all mice (n=135) were collected at post mortem and tested for 
the presence T. gondii IgG antibodies using the commercially available ID vet 
ELISA (see section 2.10.2).  One mouse (mouse number C11-2), which was culled 
on day 42, tested IgG positive with 189% seropositivity (T. gondii DNA was also 
detected from the brain of this mouse (see Table 5-7).  Another mouse (mouse 
number C5-3) which was culled on day 18 gave a borderline result of 44% 
seropositivity (T. gondii DNA was also detected from the brain of this animal, and 
upon microscopic examination of a brain smear, a small tissue cyst was also 
observed from this mouse (see Table 5-7).  Mouse C11-1 was classified as 
seronegative however a value of 23% seropositivity was greater than all the 
remaining mice where seropositivity was below 3%, again this animal was 
euthanized due to signs of T. gondii infection on d18 PI (see Table 5-9) and tested 
positive by PCR (see Table 5-7) 
 




C5-3 1 44 Borderline d18
C11-1 2 23 Negative d18
C11-2 2 189 Positive d42
Mouse no.  IgG seropositivity 
(%)
Day PI mouse 
euthanised
Result
All remaining mice (n=132) were IgG seronegative (below 3% SP)
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5.6 Discussion 
Mouse bioassay to assess the success of vaccination: 
The results from the mouse bioassay clearly show that vaccination with a live 
attenuated strain of the parasite (S48) and subsequent challenge with T. gondii 
oocysts (M4) in pigs is particularly successful in preventing infective tissue cysts 
from establishing within porcine tissues.  Mouse survival rates from the bioassay at 6 
weeks PI show a clear difference between those mice inoculated with porcine tissues 
from pigs in group 2 (oocyst challenged pigs), compared to mice inoculated with 
porcine tissues from pigs in group 3 (vaccinated and oocyst challenged pigs) (see 
Figure 5-6 and Figure 5-7).  100% of mice inoculated with tissues from group 3 pigs 
survived until the end of the experiment, whilst only 51.1% of mice inoculated with 
tissues from pigs in group 2 survived, with the first four mice culled on day 11 PI 
and a total of 22 mice culled by day 18 (see Figure 5-6).  As is has been observed 
that the M4 strain (type II) of T. gondii is particularly virulent in Porton mice (L. 
Gibbard, Moredun Bioservices – personal communication), any viable tissue cysts 
present in the inocula (homogenised porcine tissue) will cause clinical symptoms 
with the resulting euthanasia of mice.  Therefore in this study reporting of mouse 
survival was important, as it indicated the presence or absence of viable tissue cysts.  
As little as one tissue cyst (containing possibly thousands of infective bradyzoites) is 
enough to cause infection (Dubey et al., 1998a).   
Other research, which has studied the vaccination of pigs to reduce tissue cyst 
burden, has mainly focused on microscopic identification of tissue cysts and / or 
detection of parasite DNA from mice used in the bioassay (Cunha et al., 2011; 
Dubey et al., 1994; Dubey et al., 1998b; Freire et al., 2003; Garcia et al., 2006; 
Garcia et al., 2005; Kringel et al., 2004), in these studies there is no detailed  
information about mouse survival and clinical signs of T. gondii during the bioassay 
itself, perhaps in these experiments euthanasia of mice due to signs of T. gondii 
infection (such as hunched appearance, tottering gait and moribund) was not 
common and the majority of mice survived until the end of the study.  In fact, very 
few T. gondii studies, which incorporate mouse bioassay to assess the viability of 
tissue cysts, describe mouse survival rates in any detail.  Research by Pena et al 
(2006), did report mouse mortality rates following bioassay of cat tissues in relation 
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to the genotype present, however, the majority of literature which report using this 
technique (mouse bioassay) do not provide this information. 
In the current study, molecular detection of T. gondii DNA from mouse brain 
following bioassay was also completed.  Parasite DNA was detected in 0% (0/45) of 
mice following challenge with inocula comprised of porcine tissues from animals in 
group 3 (vaccinated and oocysts challenged pigs), whilst in the positive control 
groups parasite DNA was detected in 46.7% (21/45) of mice following challenge 
with inocula comprised of porcine tissues from animals in group 1 (tissue cyst 
challenge pigs), and 53.3% (24/45) of mice following challenge with inocula from 
pigs in group 2 (oocyst challenged pigs) (see Table 5-6).  Other research, 
investigating vaccination and T. gondii challenge of pigs and subsequent mouse 
bioassay, have focused on the microscopic detection of tissues cysts from mouse 
brain following bioassay (da Cunha et al., 2012; Dubey et al., 1998b; Dubey et al., 
1991; Garcia et al., 2005) other than detection of T. gondii DNA from the mouse 
brain.  Therefore it is difficult to draw direct comparisons between these similar 
vaccination and challenge experiments, however, as 100% of mice from the bioassay 
survived following inoculation with tissues from pigs vaccinated and oocyst 
challenge, vaccination with S48 tachyzoites is a promising strategy for reducing 
tissue cyst burden in pigs.  Previous research into vaccination of pigs against T. 
gondii, which have incorporated mouse bioassay, have not shown such a protective 
response against tissue cyst formation in mouse brains.  For example, following 
immunisation of pigs with crude T. gondii rhoptry proteins plus Quil-A, da Cunha et 
al (2012) found only partial protection from formation of tissue cysts in mouse brains 
following bioassay of porcine tissues, with the parasite detected in 5/11 (45.4%) of 
mice in the vaccinated and challenged group.  In a similar experiment, partial 
protection was observed by Garcia et al (2005), who used T. gondii rhoptry proteins 
containing immuostimulating complexes (ISCOMS) as an adjuvant to vaccinate pigs.  
Dubey et al (1998b) tested a vaccine incorporating a low dose of irradiated T. gondii 
oocysts, and although fewer tissue cysts in mice were observed, cysts were observed 
in 45/110 (40.9%) of mice which had received porcine tissues from vaccinated pigs.  
Further work by Dubey et al (1991), who used tachyzoites of a non-persistent strain 
of T. gondii (RH) to vaccinate pigs, again when porcine tissues were used in mouse 
Toxoplasma gondii in animal and human hosts  
Chapter 5: Vaccination and challenge of pigs to evaluate T. gondii tissue cyst 
formation  161 
bioassay only found partial protection with fewer tissues cysts in mice.  In summary, 
none of the literature currently available can describe 100% protection against tissue 
cyst formation in mice, following bioassay of porcine tissues.   
 
From the current results, it appears that the vaccine (S48) alone does not induce 
tissue cysts as results from the mouse bioassay, which included porcine tissues from 
the vaccinated and challenged animals, were all PCR negative for T. gondii.  If a 
positive had been obtained from this group, the experiment had been designed to 
verify whether infection was due to vaccination (S48) or oocyst challenge (M4).  
Both S48 and M4 have different genotypes (S48 = type I, M4 = type II), and by 
incorporating PCR-RFLP genotyping, it would be possible to ascertain whether 
infection was due to vaccination or oocyst challenge.  However, a bioassay 
incorporating porcine tissues from animals that were vaccinated alone (which was 
not included in this study), could further support this result, although it is unlikely 
that positives will be identified.  
 
Comparison between T. gondii oocyst and bradyzoite infection in pigs and viability 
of tissue cysts in the mouse bioassay. 
When comparing mouse survival rates between animals, which had been challenged 
with inocula from tissues of pigs in group 1 (tissue cyst challenged pigs) and group 2 
(oocyst challenged pigs), no significant difference was observed between mouse 
mortality rates resulting from the different infective stages of the parasite (see Figure 
5-7). Both infective stages appear to cause similar levels of infection, although a 
slight difference in clinical observations was seen in tissue cyst challenged pigs 
(group 1).  In addition the IgG response in pigs following challenge with these two 
stages of the parasite did not differ significantly (see Figure 5-3 and Table 5-4).  
However, what was apparent was the difference in mouse mortality between the 
different porcine tissue groups (e.g. “brain”, “other” and “food” groups) used to 
inoculate mice (see Figure 5-8).  A greater number of mortalities occurred from mice 
inoculated with porcine tissues from both the “other” group (which was comprised of 
12.5g each of heart, diaphragm, tongue and masseter tissues) and the “brain” group 
(which was comprised of 50g pig brain).  Molecular detection of parasite DNA from 
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mouse brain confirmed that all observed mouse mortalities were due to T. gondii 
infection (see Table 5-6). 
A similar study, which investigated the distribution of  parasite tissue cysts within 
porcine tissues, was carried out in the 1980’s (Dubey et al., 1986).  The work 
investigated two oocyst challenged and four naturally infected pigs, and following 
acid/pepsin digest and mouse bioassay of 50 – 100g of each individual tissue (which 
included six commercial cuts of meat and six other organs including brain, heart, 
tongue and diaphragm), showed by microscopic examination of mouse brains, that T. 
gondii tissue cysts were present in a greater number in mice that had received the 
inocula containing three commercial cuts of meat (Boston butt, spareribs and bacon) 
and also three organs (brain, tongue and heart).   However, in the naturally infected 
pigs, tissue cysts were present in a greater number of mice from only two 
commercial cuts of meat (arm picnic and Boston butt).  This work was completed 
prior to today’s more commonly used molecular methodologies and depended upon 
microscopic confirmation of T. gondii tissue cysts from impression smears of mouse 
brain. 
These results along with the current results from this research confirm that porcine 
tissues such as brain or highly active muscles (such as heart, tongue, diaphragm and 
masseter), are more likely to harbour a greater number of viable tissue cysts.  This 
knowledge is useful for future research, particularly for collection of tissues from 
either experimental animals or from animals slaughtered at an abattoir. 
 
Molecular and serological detection of T. gondii compared to mouse bioassay. 
In the current study, T. gondii DNA was detected in the brains of all mice which had 
been euthanised prior to the end of the experiment (see Table 5-7), again highlighting 
the virulence of the M4 strain in Porton mice. All except three mice, which survived 
until the end of the experiment, were T. gondii negative, which included 1 mouse 
from group 1 (tissue cyst challenged mice – mouse number C5-4), and 2 mice from 
group 2 (oocysts challenged mice – mouse numbers C11-1 and C11-2) as shown in 
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Table 5-7.  The remaining mice were all T. gondii negative, which included 53.3% 
(24/45) of mice from group 1 (tissue cyst challenged mice), 46.7% (21/45) of mice 
from group 2 (oocysts challenged mice) and 100% (45/45) of mice from group 3 
(vaccinated and oocyst challenged mice), as described in Table 5-6).   
Overall, the mouse bioassay was a more sensitive method for determining the 
presence of parasite tissue cysts, in comparison to PCR on DNA extracted from the 
same inocula used to infect mice in the bioassay; parasite DNA could only be 
detected in 26.7% (12/45) of samples, compared to 37.8% (17/45) from mouse brains 
following bioassay (see Table 5-8).  In this study, testing only the inocula by PCR 
would have resulted in 11.1% (5/45) of infections being undetected when compared 
to T. gondii DNA detection in mouse brains following the bioassay.  Although in this 
instance PCR was not a suitable replacement for mouse bioassay, incorporation of 
this methodology may allow for a reduction in the number of animals that would be 
required for the mouse bioassay.  Another method to consider for use on the bioassay 
inocula, would be magnetic capture qPCR (MC-qPCR).  This technique has been 
described for isolation of T. gondii DNA from meat samples, where the ratio of host 
DNA to parasite DNA is high (Opsteegh et al., 2010a), this method also enables the 
quantification of parasite DNA, which in turn could be related to parasite burden.  
However, the mouse bioassay is currently the only technique available to assess the 
viability of tissue cysts, compared to the detection of parasite DNA using PCR. 
 
An ELISA was carried out on all mouse sera collected at post mortem (n = 135) for 
the detection of IgG antibodies against the T. gondii antigen P30 (SAG3) (see Table 
5-9).  Only 1 mouse (C11-2) was identified as seropositive by ELISA (% 
seropositivity = 189), this individual mouse survived until the end of the experiment, 
and DNA extracted from the brain was also positive by PCR (see Table 5-6).  
Another mouse (C5-3), which tested borderline positive by ELISA (% seropositivity 
= 44) was culled on day 18, parasite DNA was also detected from its brain by ITS1 
PCR and on microscopic examination of a brain smear a single tissue cyst was also 
observed (see Table 5-7).  Therefore, it is likely that those animals, which were 
culled between days 10 and 18, which also tested positive for the presence of T. 
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gondii DNA in their brains, had only just started to mount an immune response 
against the parasite, however, the levels of IgG present were below that detectable by 
the ELISA.   
 
Detection of T. gondii directly from individual porcine tissues. 
As previously discussed, different porcine tissues for the mouse bioassay were 
pooled and grouped (see Table 5-2), however, DNA was extracted from each 
individual tissue used to produce the inocula to examine for the presence of T. gondii 
DNA.  Unfortunately, parasite DNA could only be detected in 2 pigs from group 1 
(tissue cyst challenged pigs) from heart, masseter, chop and brain (see Table 5-5).  
The most likely reasons as to why detection of parasite DNA was lower in the 
individual pig tissues than that observed from the inocula, could be due to two 
factors.  Firstly, the sample size of tissue used for DNA extraction, as only 1g was 
used compared to a total of 50g pooled sample used for preparation of the mouse 
inocula, therefore due to the inhomogeneous nature of the distribution of T. gondii 
tissue cysts, the likelihood of a 50g tissue sample containing a parasite tissue cyst is 
more probable than from a 1g sample.  Secondly, pigs were challenged with either 
1000 T. gondii oocysts or 1000 tissue cysts, which is a lower dose than animals 
recently received during similar T. gondii challenge experiment in lambs, using the 
same Moredun M4 stain of T. gondii (Katzer et al., 2014 (under review)).  In this 
experiment lambs were challenged with 500,000 M4 oocysts, and detection of 
parasite DNA by PCR using just 1g of ovine tissue was successful, therefore it is 
probable that due to the lower dose of either oocysts or tissue cysts (bradyzoites) in 
pigs, there are a fewer number of  established cysts in porcine tissues.  One way to 
address this problem would be to take a larger sample of each individual tissue, carry 
out an acid/pepsin digest (see section 2.8.1) and to test for the presence of T. gondii 
DNA from this concentrated sample.  During the lamb experiment, a serial cull was 
carried out which provided evidence of a decrease in detection rate of T. gondii DNA 
by 42 dpi.  This reduction in detection of parasites may be due to a mounting 
immune response in the animals and subsequent protection from establishment from 
the of the parasite in the host.  A serial cull was not included in the pig experiment 
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and all animals were culled at 42 dpi, therefore time may have played an important 
role for the limited detection of parasite DNA directly from porcine tissues. 
In addition the sensitivity could be further increased by magnetic capture of T. gondii 
DNA, as described by Opseegh et al (2011) with subsequent ITS1 PCR (as used in 
this study) or even qPCR to enable quantification of tissue cysts. 
 
Serological detection of T. gondii specific antibodies in pigs following vaccination 
and challenge. 
Pigs generally go onto develop efficient protective immunity against T. gondii and 
quickly recover from infection without any obvious clinical signs.  A specific 
humoral immune response can be detected following infection of pigs, with IgM 
antibodies against T. gondii detectable around 8-10 dpi and IgG within 10-17 dpi 
(Garcia et al., 2006; Lind et al., 1997).  Although IgM levels were not monitored 
within the current study, results for IgG antibody levels against the parasite show that 
all pigs which were either vaccinated and / or challenged mounted an immune 
response against the parasite as expected.  T. gondii IgG levels were evaluated at 
days 7, 14 and 21dpi.  These results show that although an antibody response can be 
detected at day 14 dpi, seropositivity was greater at day 21 dpi (see Figure 5-3).  
Analysis of these results also show that at day 21dpi there was no significant 
difference between % seropositivity in pigs from group 1 and 2, infected with 
different stages of the parasite (oocysts vs bradyzoites) (see Figure 5-3).  However, 
these results also show that pigs, which had been vaccinated using S48 tachyzoites at 
-28 dpi and challenged 4 weeks later with 1000 T. gondii M4 oocysts (group 3), had 
significantly higher IgG levels (95% p < 0.05) than those animals which were 
challenged with 1000 M4 oocysts alone (group 2).  This result is not surprising as it 
has been shown that vaccination of sheep with S48 to prevent ovine abortion, 
initiates a protective cell mediated immune response in the animal, which involves 
IFNγ,  CD8
+
  and  CD4
+
 T cells (Innes et al., 1995).  The effect of this immune 
response in relation to IgG levels can be seen from the pigs, which were vaccinated 
alone (group 4), showing a seropositivity of 136% (see Figure 5-3).  It would appear 
as observed in sheep by Innes et al (1995), that the immune response in animals from 
group 3 had been primed by vaccination and the subsequent challenge with T. gondii 
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oocysts 4 weeks post vaccination increased this response.  During this study, samples 
have been collected that will allow future analysis of the cell-mediated and humoral 
immune response induced by vaccination. 
 
In conclusion, the vaccination of pigs with the S48 strain of T. gondii, followed by 
challenge with oocysts of the M4 strain and subsequent mouse bioassay (to enable 
the detection of viable tissue cysts), has shown a significant degree of mouse survival 
when compared to animals which received tissues from oocyst challenged (but non-
vaccinated) pigs.  However, detection of parasite DNA directly from homogenised 
porcine tissues used to inoculate mice was not as sensitive as detection of parasite 
DNA from the brains of the mice used in the bioassay.  The bioassay is likely to be a 
more sensitive method for detection due to the multiplication of the parasite in vivo.  
In addition, the mouse bioassay can also asses the viability of T. gondii tissue cysts, 
which cannot be achieved by molecular detection alone.  The mouse bioassay also 
showed that there was no significant difference in the mouse mortality rate (or the 
molecular detection of parasite DNA from these mice) when animals were inoculated 
with porcine tissues from pigs which had previously been infected with either tissue 
cysts or oocysts.  However, there was a difference in mouse survival (and the 
detection of parasite DNA) depending on which tissue group the mice had been 
inoculated with.  A greater number of mice survived which had received porcine 
tissues from the “Food” tissue group (irrespective of whether they had received 
porcine tissues from tissue cyst or oocyst infected pigs), compared to mice which had 
received tissues from the “Brain” and “Other” tissue groups, indicating a greater 
number of viable tissue cysts within tissues from the “Brain” and “Other” groups. 
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Chapter 6: General discussion 
The protozoan parasite T. gondii is widespread in both human and animal hosts.  
Felids (the definitive host) play a pivotal role in the life cycle of the parasite as 
oocysts are excreted into the environment from their faeces (Hutchison et al., 1969; 
Hutchison et al., 1971).  However, once the parasite infects an intermediate host it 
remains persistently infected due to the cyst forming nature of the parasite.  Tissue 
cysts (which contain infective bradyzoites) are most likely to form in the brain and 
muscle tissue (Dubey, 1988) of an infected host and are a source of contamination 
for both carnivores and omnivores.   
Wildlife and livestock are intermediate hosts for T. gondii.  In Great Britain very 
little information is known about the prevalence or genotypes present within these 
populations.  In Chapter 3 (Prevalence and genetic diversity of T. gondii from wild 
mammalian carnivores in Great Britain), the overall prevalence of T. gondii from six 
different species of wild carnivores from Great Britain was estimated at 22.8% 
(89/390), which varied depending on the host species.  Genotyping of DNA from T. 
gondii positive animals identified 90.6% (29/32) to be infected with the type II 
lineage of the parasite (see Table 3-4). This result is not surprising, especially as type 
II has been reported to be the predominant lineage found in wildlife from Europe and 
North America (Ajzenberg et al., 2004; Aubert et al., 2010).  However, the results 
from this chapter also identified a type III lineage and two alleles for type I from 
three different polecats, indicating a degree of genetic diversity within this wildlife 
species and potentially the environment.  Due to urban expansion the ecosystems 
which wildlife inhabit are changing, with the potential for  zoonotic “spillover” from 
wildlife to livestock and ultimately human populations likely to increase (Thompson, 
2013).  Therefore, a greater knowledge of the prevalence of T. gondii in wildlife and 
the stains present within these species is becoming increasingly more important.   
Future work, which would be complimentary to this research, would be to investigate 
the prevalence of T. gondii within other wildlife species (not necessarily carnivores), 
which are used as sources of food for human consumption in Great Britain, such as 
rabbit, deer and pheasant.   As described in Chapter 1 (Introduction), the 
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seroprevalence of T. gondii in livestock species (such as sheep in pigs) from other 
countries has been shown to be relatively high.  Therefore, it would also be 
beneficial to determine the prevalence of the parasite and the genotypes present from 
these species within Great Britain, particularly as foodborne transmission of T. 
gondii to humans is most likely to occur from consuming undercooked or raw meat 
from these animals (Tenter et al., 2000) 
Until recently it has not been possible to identify whether acquired infection in 
humans is due tissue cyst or oocyst contamination.  But in 2011 the identification of 
a sporozoite specific antigen (TgERP) enabled researchers to identify whether an 
individual had been infected via T. gondii oocysts (Hill et al., 2011).  In Chapter 4 
(Prevalence of T. gondii from human hosts in Scotland), this methodology was 
implemented on serum samples from Scottish blood donors which had recently 
seroconverted from T. gondii seronegative to seropositive, as identification of the 
antigen is only possible for six to eight months after infection.  Although only one 
sample tested positive (see Table 4-4), indicating that infection was predominantly 
due to consumption of tissue cysts, it was also observed that the ODc values from the 
ELISA used to detect T. gondii IgG were lower when compared to the serum sample 
which generated the positive TgERP result (see Table 4-4).  Therefore it is possible 
that some of the TgERP negative sera may have tested positive, but it was not 
possible to detect this due to the low concentration of antibody.  This methodology 
will prove to be important in the future, particularly when studying disease outbreaks 
where the cause of infection is unknown, or in countries or regions where T. gondii 
prevalence is high, such as Brazil.  Such information may be useful for 
epidemiological studies and will also enable scientist to implement specific strategies 
to prevent infection based on which stage of the parasite most commonly causes 
infection.  
The results from Chapter 4 also provide up to date information about the prevalence 
of the parasite in humans, data which is lacking for the UK population (AMCSF, 
2012).  The prevalence was calculated using two different study groups.  Firstly, the 
prevalence of the parasite was determined using DNA samples from the Sudden 
Death Brain Bank, collected over a five year period (2008 – 2012), where an overall 
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prevalence of 17.9% (27/151) was detected, and a general trend towards an increase 
in prevalence with increase in age was also observed (see Figure 4-8).   The second 
study population, which included serum samples from Scottish blood donors over a 
four year period (2006 – 2009), found an overall seroprevalence of  13.0%  
(183/1403) Table 4-2 (when calculated using a specific cut off value derived from a 
binormal mixture model – see Figure 4-1).  Although both study groups contained 
samples from a broad section of the population (a “healthy” population, not known to 
be predisposed to illness), there was a 4.9% difference in prevalence between the two 
groups.  The most likely explanation for this difference is because the samples 
obtained from the Sudden Death Brain Bank were predominantly collected from 
individuals who were over 48 years of age, whilst the samples collected from blood 
donors were much more equally spread across all age groups (see Figure 4-7 and 
Figure 4-4).  The prevalence of T. gondii infection within both groups is relatively 
low when compared to that of other countries such as Germany or France, where 
prevalence has been reported to be as high as 59.0% (n=4854) and 54.0% (n=13459) 
respectively (Fiedler et al., 1999; Pappas et al., 2009).  Therefore, within Great 
Britain a greater percentage of individuals are at risk of infection, particularly when 
taking into consideration women of child bearing age and the risk of congenital 
toxoplasmosis.  In both study groups there was a correlation between increasing age 
and an increase in T. gondii prevalence, indicating that acquired infection plays an 
important role within the British population. 
To complement the genotyping results obtained from carnivorous wildlife in Chapter 
3, strain genotyping was also completed for human DNA samples in which T. gondii 
was detected.  Due to a low concentration of parasite DNA, genotyping was 
successful for only four human samples, which identified alleles for type I and III 
lineages of T. gondii (see Table 4-7).  This result was particularly interesting, not 
only because type II is the most common genotype in Europe and North America, but 
also because in Chapter 3 the predominant linage identified from carnivorous 
wildlife was type II (see Table 3-4).  Following this result, further genotyping of 
human samples would be beneficial in order to assess whether type I and III strains 
are predominantly found in a “healthy” human population.  One way in which this 
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could be achieved, using the DNA extracted from the human brains obtained from 
the Sudden Death Brain Bank, would be to use magnetic-capture PCR (MC-PCR) 
(Opsteegh et al., 2010a) to separate T. gondii DNA from host DNA, which would 
increase the sensitivity of the genotyping PCR. 
The results from Chapter 4 describe an increase in seroprevalence in relation to an 
increase in age (indicating acquired infection), and one of the most likely sources of 
acquired infection is from consumption of T. gondii tissue cysts from raw or under 
cooked infected meat (Cook et al., 2000).  Therefore, vaccination to reduce or 
prevent tissue cyst formation in food producing animals could help to reduce the 
infection rate in humans and the disease burden associated with this (which can be 
greater than that reported for Campylobacter or E. coli - see Figure 1-8) (Havelaar et 
al., 2012). 
Pork is has been described to be one of the main sources of foodborne transmission 
of T. gondii (see Figure 1-6) (Dubey, 2009; Tenter et al., 2000).  The research carried 
out in Chapter 5 (Vaccination and challenge of pigs to evaluate T. gondii tissue cyst 
formation) used the S48 strain of the parasite (which is used in Toxovax
®
, the 
commercial vaccine against ovine toxoplasmosis) to assess whether it was possible to 
reduce the number of T. gondii tissue cysts in porcine tissues, potentially making 
pork a safer meat for human consumption.  Following vaccination and oocyst 
challenge to determine whether of viable tissue cysts were present, porcine tissues 
from the experiment were used in a mouse bioassay.  Not only did 100% (45/45) of 
mice which received porcine tissues from vaccinated and challenged pigs, survive, 
but no parasite DNA was detected in their brains.  In contrast, mice which received 
porcine tissues from un-vaccinated and challenged pigs, resulted in survival of 51.1% 
(23/45) of mice (see Figure 5-6 and Figure 5-7).  These results are promising, as this 
is the first description of 100% protection against tissue cyst formation in mice 
following mouse bioassay of porcine tissues from pigs used in a vaccination and 
challenge experiment.  The results also begin to answer the question raised by the 
Food Standards Agency, as in a recent report published by the Advisory Committee 
on the Microbiological Safety of Food (ACMSF), the document states that one of the 
knowledge gaps relevant to a risk assessment in the UK is: “vaccines based on live 
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attenuated strains of tachyzoites are effective in reducing morbidity in sheep but it is 
not known whether vaccination has any effect on the formation of tissue cysts” 
(AMCSF, 2012).  From the current research it is now clear that S48 does have an 
effect in reducing the formation of tissue cysts in pigs.  The vaccination of other 
“high risk” livestock species should be addressed, however, it has also recently been 
demonstrated that the effect of vaccination of sheep with S48 also results in a 
reduction in the number of ovine tissue samples in which parasite DNA can be 
detected (Katzer et al., 2014 (under review)).  Despite the success of these results, it 
would be more desirable to have a vaccine that is not based on live tachyzoites, 
which would be a safer alternative for use in livestock species.  Therefore, as 
discussed in Chapter 1, future research into the development of vaccines for T. gondii 
should focus on DNA or subunit vaccines, which are thought to be safer for animal 
and human use (Ivory & Chadee, 2004). 
To determine whether molecular detection of parasite DNA by PCR could replace 
mouse bioassay (a reduction in the use of animal numbers is desirable in any area of 
scientific research), Chapter 5 also analysed the molecular detection of T. gondii 
DNA from bioassay inocula (homogenised porcine tissues which had been subjected 
to an acid / pepsin digest to concentrate any tissue cysts present) prior to inoculation 
into mice.  When using PCR to detect T. gondii DNA directly from the bioassay 
inocula, parasite DNA was detected in 26.7% (12/45) of samples, compared to 
detection in 37.8% (17/45) of samples from mouse brains following bioassay (see 
Table 5-8).  In this instance, the mouse bioassay is more sensitive for the detection of 
T. gondii from animal tissues, which is not surprising, as the parasite multiplies 
within the mouse as infection continues over the length of the experiment (in this 
case, 6 weeks).  However, in the future, molecular detection of T. gondii directly 
from bioassay inocula may allow researchers to reduce the number of animals used 
in the mouse bioassay.  As mouse bioassay is currently the only method available to 
test the viability of tissue cysts, it is unlikely that any molecular based detection 
method will replace this technique in the near future. 
The data described within this thesis is important for addressing many of the issues 
raised in the recent report published by the AMCSF, which highlighted a number of 
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knowledge gaps regarding the prevalence of T. gondii in both animal and human 
hosts from the UK.  Results regarding the prevalence of T. gondii in humans is 
particularly useful for health professionals, especially as 87% (1220/1403) of the 
human serum samples tested in Chapter 4 were seronegative, indicating a large 
percent of the population at risk from infection, which includes women of child 
bearing age who are most at risk during pregnancy, with the potential for congenital 
transmission of the parasite to the foetus (congenital toxoplasmosis).  Although the 
parasite is killed by proper cooking of pork and pork products, there are also 
traditional dishes which include raw pork, such as the Thai dish Nam Mu Sod (raw 
pork parcels), and instances where the meat is not thoroughly cooked, such as 
accidentally undercooking pork sausages on a BBQ.  Therefore, from a public health 
and food safety point of view, the thesis not only provides useful information on the 
distribution of the parasite within different porcine tissues, including those sold for 
human consumption, it also provides promising results to the effectiveness of the S48 
of T. gondii as a vaccine to reduce tissue cyst formation in pigs.   
T. gondii is a parasite of significant public health importance and more research 
should be undertaken to understand the link between infection in food animals and 
the potential risk of transmission to humans from consuming infected meat.   
 
Future studies 
There are many knowledge gaps which should be addressed regarding the prevalence 
and public health impact of T. gondii in the UK.  A continuation of this research 
should involve a serological study examining the seroprevalence of T. gondii in pigs 
from the UK.  The study should ensure that pigs from different housing systems are 
tested (indoor vs. outdoor reared animals), as it is likely that outdoor reared pigs will 
have a higher seroprevalence compared to indoor reared pigs, as observed in other 
countries.  It would also be interesting to examine a link between serology and tissue 
cyst burden.   This is something that can initially be achieved using the samples 
collected from the porcine challenge experiment in Chapter 5.  By carrying out a 
qPCR on DNA extracted from different tissues and comparing this to the OD values 
Toxoplasma gondii in animal and human hosts  
Chapter 6: General discussion  173 
from the ELISA, a link between seroprevalence and tissue cyst burden could be 
determined.  A link between serology and tissue cyst burden would be useful for 
determining the potential risk of infection from porcine tissues, particularly from 
slaughtered animals, where the meat will be used for human consumption.  It would 
also be beneficial to examine other livestock species for the presence of tissue cysts, 
especially as meat such as beef can be eaten raw in the UK, in dishes such as steak 
tartare or beef carpaccio.  It is also important to understand which genotypes are 
present within different UK livestock species (such as pigs, cattle and sheep).  Not 
only will this assist in understanding the transmission of the parasite (particularly 
when it is known which strains are present in wildlife and humans), but, in humans, 
clinical symptoms can vary depending on the strain (as observed with atypical strains 
of T. gondii), therefore, from a public health perspective, it is important to know 
whether these strains are present within livestock species from the UK.   
The technique MC-qPCR, which separates T. gondii DNA from host DNA, was not 
used within the current study.   Research which compares the sensitivity of this 
technique with conventional PCR would be beneficial, particularly when the amount 
of host DNA is expected to be high compared to parasite DNA (for example in the 
human brain samples described in Chapter 4, or when samples are collected from an 
abattoir - where the parasite burden is likely to be lower from a naturally infected 
animal, than one which has been infected experimentally).  Finally, to determine 
which stage of the parasite (oocysts or tissue cysts) is the most common cause of 
human infection, further research should be completed using the sporozoite specific 
antigen (TgERP), using human serum samples from the UK.  Data generated from 
such an experiment will help to assess the risk associated with infection from tissues 
cysts consumed from raw or undercooked meat, or whether oocysts play a more 
important role in human infection. 
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Chapter 8: Appendix 
8.1  Solutions and media 
 
8.1.1 Acid/pepsin solution 
For the preparation of 500mls acid/pepsin solution 
 Pepsin
*
     2.6g 
 Sodium chloride   5.0g 
 Hydrochloric acid   7.0mls 
*
Porcine stomach pepsin, 1:10,000 biological activity. 
Made up to 500mls with dH2O 
  
8.1.2  Antigen extraction buffer 
For preparation of 20mls extraction buffer: 
Pepstatin    2µg/ml 
PMSF     1mM 
Sodium phosphate   50mM 
EDTA     2mM 
Made up to 20mls with the addition of dH2O.  It should be noted that stock reagents 
pepstatin and PMSF should be dissolved in ethanol. 
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8.1.3  Carbonate buffer (pH9.6) 
For preparation of 1000mls of carbonate buffer 
 Sodium carbonate   1.59g 
 Sodium bicarbonate   2.93g 
Made up to 1000mls with the addition of dH2O. 
 
8.1.4  IMDM 5% FCS  
Iscove’s Modified Dublecco’s Media (IMDM) containing 5% Foetal Calf Serum 
(FCS) was prepared as follows: 
IMDM    500mls 
 FCS    25mls 
 Penicillin   100 units/ml  
 Streptomycin   100µg/ml 
 L-glutamine   292µg/ml 
 
8.1.5 IMDM 2% FCS 
 IMDM containing 2% Foetal Calf Serum (FCS) was prepared as follows: 
 IMDM    500mls 
 FCS    10mls 
 Penicillin   100 units/ml  
 Streptomycin   100µg/ml 
 L-glutamine   292µg/ml 
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8.1.6  Phosphate buffered saline (PBS) pH7.4 
A 10x solution was prepared in 800mls dH2O: 
Sodium chloride     0g 
Potassium chloride     2g 
Sodium dihydrogen phosphate heptahydrate   26.8g 
Potassium dihydrogen phosphate   2.4g 
pH was adjusted to 7.4 with HCl; dH2O added to a final volume of 1000mls then 
autoclaved.  The 10x solution diluted 1:10 with dH2O (1x PBS). 
 
8.1.7 PBS Tween (PBST)  
PBS containing 0.05% Tween 20 was prepared as follows: 
 PBS (1x)   1000mls 
 Tween 20   500µl 
The final solution was autoclaved. 
 
8.1.8 Saturated salt solution 
For preparation of 1000mls saturated salt solution: 
 Sodium chloride  400g 
dH2O     1000mls 
The solution will contain particles of sodium chloride which have not fully dissolved, 
this is a normal characteristic of a saturated salt solution. 
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8.1.9  1.2% Sodium bicarbonate  
For preparation of 100mls sodium bicarbonate solution 
Sodium bicarbonate  1.2g 
dH2O    100mls 
This solution is made fresh for use in the mouse bioassay. 
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8.2 Timescale overview of pig experiment 
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8.3 Detection of oocysts from cat faeces 
Initial detection from ~ 1g faeces       
         
Apollo     Zeus    
         
  Faeces Oocyst    Faeces Oocyst 
Date Days P.I Weight (g) Yield  Date Days P.I Weight (g) Yield 
24-Mar-12 3 55 -  24-Mar-12 3 37 - 
25-Mar-12 4 23 -  25-Mar-12 4 23 - 
26-Mar-12 5 28 95  26-Mar-12 5 25 37 
27-Mar-12 6 57 64 / field  27-Mar-12 6 22 113 / field 
28-Mar-12 7 12 25 / field  28-Mar-12 7 24 56 / field 
29-Mar-12 8 30 68 / field  29-Mar-12 8 23 36 / field 
30-Mar-12 9 22 15 / field  30-Mar-12 9 20 13 / field 
31-Mar-12 10 16 122 / trav  31-Mar-12 10 18 99 / trav 
01-Apr-12 11 18 38 / trav  01-Apr-12 11 24 23 / trav 
02-Apr-12 12 32 22 / trav  02-Apr-12 12 25 0.8 / trav 
03-Apr-12 13 22 5 / trav  03-Apr-12 13 19 - 
04-Apr-12 14 26 2 / trav  04-Apr-12 14 19 - 
05-Apr-12 15 26 -  05-Apr-12 15 19 - 
06-Apr-12 16 pool* 37 -  06-Apr-12 16 pool* 37 - 
07-Apr-12 17 pool* 73 -  07-Apr-12 17 pool* 73 - 
08-Apr-12 18 pool* 21 -  08-Apr-12 18 pool* 21 - 
09-Apr-12 19 no sample n/a  09-Apr-12 19 no sample n/a 
10-Apr-12 20 pool* 108 -  10-Apr-12 20 pooled* 108 - 
         
* = pooled sample from both animals       
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8.4  Research ethics committee approval 
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8.5 Publications from the thesis 
 
 
 
 
 
 
